
<html lang="en"     class="pb-page"  data-request-id="b9d4fcf9-940d-4e4a-96d6-5b2b50ae1008"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2015.58.issue-23;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.5b01227"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration" /></meta><meta name="dc.Creator" content="Erik L.  Meredith" /></meta><meta name="dc.Creator" content="Nello  Mainolfi" /></meta><meta name="dc.Creator" content="Stephen  Poor" /></meta><meta name="dc.Creator" content="Yubin  Qiu" /></meta><meta name="dc.Creator" content="Karl  Miranda" /></meta><meta name="dc.Creator" content="James  Powers" /></meta><meta name="dc.Creator" content="Donglei  Liu" /></meta><meta name="dc.Creator" content="Fupeng  Ma" /></meta><meta name="dc.Creator" content="Catherine  Solovay" /></meta><meta name="dc.Creator" content="Chang  Rao" /></meta><meta name="dc.Creator" content="Leland  Johnson" /></meta><meta name="dc.Creator" content="Nan  Ji" /></meta><meta name="dc.Creator" content="Gerald  Artman" /></meta><meta name="dc.Creator" content="Leo  Hardegger" /></meta><meta name="dc.Creator" content="Shawn  Hanks" /></meta><meta name="dc.Creator" content="Siyuan  Shen" /></meta><meta name="dc.Creator" content="Amber  Woolfenden" /></meta><meta name="dc.Creator" content="Elizabeth  Fassbender" /></meta><meta name="dc.Creator" content="Jeremy M.  Sivak" /></meta><meta name="dc.Creator" content="Yiqin  Zhang" /></meta><meta name="dc.Creator" content="Debby  Long" /></meta><meta name="dc.Creator" content="Rosemarie  Cepeda" /></meta><meta name="dc.Creator" content="Fang  Liu" /></meta><meta name="dc.Creator" content="Vinayak P.  Hosagrahara" /></meta><meta name="dc.Creator" content="Wendy  Lee" /></meta><meta name="dc.Creator" content="Peter  Tarsa" /></meta><meta name="dc.Creator" content="Karen  Anderson" /></meta><meta name="dc.Creator" content="Jason  Elliott" /></meta><meta name="dc.Creator" content="Bruce  Jaffee" /></meta><meta name="dc.Description" content="The benefit of intravitreal anti-VEGF therapy in treating wet age-related macular degeneration (AMD) is well established. Identification of VEGFR-2 inhibitors with optimal ADME properties for an oc..." /></meta><meta name="Description" content="The benefit of intravitreal anti-VEGF therapy in treating wet age-related macular degeneration (AMD) is well established. Identification of VEGFR-2 inhibitors with optimal ADME properties for an oc..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 30, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01227" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01227" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01227" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01227" /></link>
        
    
    

<title>Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01227" /></meta><meta property="og:title" content="Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0013.jpeg" /></meta><meta property="og:description" content="The benefit of intravitreal anti-VEGF therapy in treating wet age-related macular degeneration (AMD) is well established. Identification of VEGFR-2 inhibitors with optimal ADME properties for an ocular indication provides opportunities for dosing routes beyond intravitreal injection. We employed a high–throughput in vivo screening strategy with rodent models of choroidal neovascularization and iterative compound design to identify VEGFR-2 inhibitors with potential to benefit wet AMD patients. These compounds demonstrate preferential ocular tissue distribution and efficacy after oral administration while minimizing systemic exposure." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01227"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01227">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01227&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01227&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01227&amp;href=/doi/10.1021/acs.jmedchem.5b01227" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 9273-9286</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01188" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01088" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Erik+L.++Meredith">Erik L. Meredith</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nello++Mainolfi">Nello Mainolfi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen++Poor">Stephen Poor</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yubin++Qiu">Yubin Qiu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karl++Miranda">Karl Miranda</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James++Powers">James Powers</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donglei++Liu">Donglei Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fupeng++Ma">Fupeng Ma</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Catherine++Solovay">Catherine Solovay</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chang++Rao">Chang Rao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leland++Johnson">Leland Johnson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nan++Ji">Nan Ji</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gerald++Artman">Gerald Artman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leo++Hardegger">Leo Hardegger</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shawn++Hanks">Shawn Hanks</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Siyuan++Shen">Siyuan Shen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amber++Woolfenden">Amber Woolfenden</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth++Fassbender">Elizabeth Fassbender</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeremy+M.++Sivak">Jeremy M. Sivak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yiqin++Zhang">Yiqin Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Debby++Long">Debby Long</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rosemarie++Cepeda">Rosemarie Cepeda</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fang++Liu">Fang Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vinayak+P.++Hosagrahara">Vinayak P. Hosagrahara</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wendy++Lee">Wendy Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Tarsa">Peter Tarsa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karen++Anderson">Karen Anderson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jason++Elliott">Jason Elliott</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bruce++Jaffee">Bruce Jaffee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Ophthalmology, Novartis Institutes for BioMedical Research, 500 Technology Square, Cambridge, Massachusetts 02139, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Metabolism and Pharmacokinetics, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Chemical and Pharmaceutical Profiling, Novartis Institutes for BioMedical Research, 500 Technology Square, Cambridge, Massachusetts 02139, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#4b2e39222065262e392e2f223f230b25243d2a393f223865282426"><span class="__cf_email__" data-cfemail="3f5a4d565411525a4d5a5b564b577f5150495e4d4b564c115c5052">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01227&amp;href=/doi/10.1021%2Facs.jmedchem.5b01227" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 9273–9286</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 15, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 August 2015</li><li><span class="item_label"><b>Published</b> online</span>30 November 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 December 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01227" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01227</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9273%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DErik%2BL.%2BMeredith%252C%2BNello%2BMainolfi%252C%2BStephen%2BPoor%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D23%26contentID%3Dacs.jmedchem.5b01227%26title%3DDiscovery%2Bof%2BOral%2BVEGFR-2%2BInhibitors%2Bwith%2BProlonged%2BOcular%2BRetention%2BThat%2BAre%2BEfficacious%2Bin%2BModels%2Bof%2BWet%2BAge-Related%2BMacular%2BDegeneration%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9286%26publicationDate%3DDecember%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01227"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2931</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">19</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01227" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Erik&quot;,&quot;last_name&quot;:&quot;L. Meredith&quot;},{&quot;first_name&quot;:&quot;Nello&quot;,&quot;last_name&quot;:&quot;Mainolfi&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;Poor&quot;},{&quot;first_name&quot;:&quot;Yubin&quot;,&quot;last_name&quot;:&quot;Qiu&quot;},{&quot;first_name&quot;:&quot;Karl&quot;,&quot;last_name&quot;:&quot;Miranda&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Powers&quot;},{&quot;first_name&quot;:&quot;Donglei&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Fupeng&quot;,&quot;last_name&quot;:&quot;Ma&quot;},{&quot;first_name&quot;:&quot;Catherine&quot;,&quot;last_name&quot;:&quot;Solovay&quot;},{&quot;first_name&quot;:&quot;Chang&quot;,&quot;last_name&quot;:&quot;Rao&quot;},{&quot;first_name&quot;:&quot;Leland&quot;,&quot;last_name&quot;:&quot;Johnson&quot;},{&quot;first_name&quot;:&quot;Nan&quot;,&quot;last_name&quot;:&quot;Ji&quot;},{&quot;first_name&quot;:&quot;Gerald&quot;,&quot;last_name&quot;:&quot;Artman&quot;},{&quot;first_name&quot;:&quot;Leo&quot;,&quot;last_name&quot;:&quot;Hardegger&quot;},{&quot;first_name&quot;:&quot;Shawn&quot;,&quot;last_name&quot;:&quot;Hanks&quot;},{&quot;first_name&quot;:&quot;Siyuan&quot;,&quot;last_name&quot;:&quot;Shen&quot;},{&quot;first_name&quot;:&quot;Amber&quot;,&quot;last_name&quot;:&quot;Woolfenden&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;Fassbender&quot;},{&quot;first_name&quot;:&quot;Jeremy&quot;,&quot;last_name&quot;:&quot;M. Sivak&quot;},{&quot;first_name&quot;:&quot;Yiqin&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Debby&quot;,&quot;last_name&quot;:&quot;Long&quot;},{&quot;first_name&quot;:&quot;Rosemarie&quot;,&quot;last_name&quot;:&quot;Cepeda&quot;},{&quot;first_name&quot;:&quot;Fang&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Vinayak&quot;,&quot;last_name&quot;:&quot;P. Hosagrahara&quot;},{&quot;first_name&quot;:&quot;Wendy&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Tarsa&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;Anderson&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;Elliott&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;Jaffee&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;9273-9286&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01227&quot;},&quot;abstract&quot;:&quot;The benefit of intravitreal anti-VEGF therapy in treating wet age-related macular degeneration (AMD) is well established. Identification of VEGFR-2 inhibitors with optimal ADME properties for an ocular indication provides opportunities for dosing routes beyond intravitreal injection. We employed a high–throughput in vivo screening strategy with rodent models of choroidal neovascularization and iterative compound design to identify VEGFR-2 inhibitors with potential to benefit wet AMD patients. These compounds demonstrate preferential ocular tissue distribution and efficacy after oral administration while minimizing systemic exposure.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01227&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01227" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01227&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01227" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01227&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01227" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01227&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01227&amp;href=/doi/10.1021/acs.jmedchem.5b01227" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01227" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01227" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01227%26sid%3Dliteratum%253Aachs%26pmid%3D26568411%26genre%3Darticle%26aulast%3DMeredith%26date%3D2015%26atitle%3DDiscovery%2Bof%2BOral%2BVEGFR-2%2BInhibitors%2Bwith%2BProlonged%2BOcular%2BRetention%2BThat%2BAre%2BEfficacious%2Bin%2BModels%2Bof%2BWet%2BAge-Related%2BMacular%2BDegeneration%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D23%26spage%3D9273%26epage%3D9286%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/jmcmar.2015.58.issue-23/20151210/jmcmar.2015.58.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/medium/jm-2015-01227y_0013.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01227&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The benefit of intravitreal anti-VEGF therapy in treating wet age-related macular degeneration (AMD) is well established. Identification of VEGFR-2 inhibitors with optimal ADME properties for an ocular indication provides opportunities for dosing routes beyond intravitreal injection. We employed a high–throughput <i>in vivo</i> screening strategy with rodent models of choroidal neovascularization and iterative compound design to identify VEGFR-2 inhibitors with potential to benefit wet AMD patients. These compounds demonstrate preferential ocular tissue distribution and efficacy after oral administration while minimizing systemic exposure.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44140" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44140" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Age-related macular degeneration (AMD) is an eye disease that causes vision loss due to pathology in the macula, the area of the retina that enables sharp and detailed vision. AMD is responsible for the majority of cases of blindness and visual impairment in aged adults. In the wet form of AMD, choroidal blood vessels (choroidal neovascularization, CNV) sprout and expand into the submacular space leaking fluid and blood. This leads to retinal edema, scar tissue formation, and irreversible damage to the macula. The current approved therapies for wet AMD are the anti-VEGF-A antibody ranibizumab, the anti-VEGF-A aptamer pegaptanib, and the anti-VEGF-A and PLGF fusion protein aflibercept. All are delivered by intravitreal injection (i.v.t.), a procedure that carries a small, but significant, risk of blinding complications including endophthalmitis, retinal detachment, or uveitis. Ranibizumab and aflibercept are the most effective, stabilizing vision in 60% patients and significantly improving vision (gain of 3 lines of vision on an ETDRS reading chart) in approximately 1/3 of patients.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Injections are administered monthly or bimonthly, which is a significant burden for patients and retinal doctors. Even with anti-VEGF therapy, wet AMD patients still have substantial visual deficit.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> We envisioned an opportunity for a less invasive wet AMD therapy based on an orally available inhibitor of the receptor tyrosine kinase (RTK) VEGFR-2 (KDR, Flt-1). An oral therapy may provide greater efficacy than intravitreal therapy by enabling more frequent dosing and greater target tissue exposure.</div><div class="NLM_p">The role of VEGF-A in the regulation of angiogenesis is well established. Although new vessel growth and maturation are highly complex processes, requiring the sequential activation of a series of receptors by numerous ligands, VEGF-A signaling is a critical rate-limiting step.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> VEGF-A promotes growth of vascular endothelial cells and is also known to induce vascular leakage.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Ocular VEGF-A levels are increased in preclinical models and human diseases of ocular angiogenesis including wet AMD,<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> diabetic retinopathy, and retinal vein occlusions.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a></div><div class="NLM_p">VEGF-A binds to two related receptor tyrosine kinases, VEGFR-1 and VEGFR-2, which both have an extracellular domain consisting of 7 immunoglobulin-like domains, a single transmembrane region, and a consensus tyrosine kinase sequence that is interrupted by a kinase-insert domain.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> VEGFR-2 (KDR or Flt-1) is implicated in all aspects of normal and pathological vascular endothelial cell biology. VEGFR-2 is the major mediator of the mitogenic, angiogenic, and permeability-enhancing effects of VEGF-A. VEGFR-2 null mice die <i>in utero</i> between days 8.5–9.5 and are characterized by a lack of vasculogenesis and failure to develop organized blood vessels.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Upon VEGF-A binding, VEGFR-2 undergoes dimerization and ligand-dependent tyrosine phosphorylation in intact cells, resulting in a mitogenic, chemotactic, and survival signal.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Systemic inhibition of the VEGF pathway is known to cause on-target side effects including hypertension, proteinuria, bleeding, thromboembolism, and gastrointestinal perforation.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Our strategy to mitigate the risk of systemic VEGF inhibition was to identify compounds with preferential distribution and retention in ocular tissues (retina and retinal pigment epithelium/choroid) compared to the plasma.</div><div class="NLM_p">There are a number of approved orally administered VEGFR-2 inhibitors for oncology indications and several have been investigated in wet AMD.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> In a published case study, treatment with oral sorafenib correlated with reduced retinal edema and increased visual acuity.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> More recently, orally dosed pazopanib is reported to improve vision, reduce edema, and reduce neovascularization in wet AMD patients.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Despite the fact the doses used were markedly less than those in oncology indications, systemic side effects were still observed. Thus, a compound that more selectively targets ocular tissues than marketed oncology drugs would potentially be an effective and safer therapy for wet AMD patients.</div><div class="NLM_p">To achieve our objective of identifying compounds with preferential ocular distribution, we understood that relatively high-throughput <i>in vivo</i> models of ocular angiogenesis would be needed to establish both ocular efficacy and tissue distribution relationships. The primary <i>in vivo</i> models utilized were laser-induced choroidal neovascularization (CNV) in mice and in rats. Briefly, photocoagulating green laser pulses are applied to the eye in order to cause a focal rupture of Bruch’s membrane, an extracellular matrix between the retina and choroid. Rupture of Bruch’s membrane induces production of local inflammatory factors and VEGF resulting in choroidal neovascularization (CNV). CNV formation in response to laser injury has been demonstrated in humans, monkeys, pigs, and rodents and is a VEGF-dependent pathology.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">Evaluation of several internal VEGFR-2 kinase inhibitors in the mouse CNV model provided <b>1</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) as a promising starting point for chemistry optimization. The compound demonstrated a modest level of inhibition (44%) but had poor aqueous solubility (<5 μM at pH 6.8). Thus, we undertook a strategy to identify compounds with greater efficacy and improved ADME properties.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. <i>In Vitro</i> Inhibition Data (KDR Biochemical; BaF3 Cellular) and <i>in Vivo</i> (% Inhibition of Mouse CNV) for Selected Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/medium/jm-2015-01227y_0008.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/medium/jm-2015-01227y_0009.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Values are the mean of at least two experiments (IC<sub>50</sub>, nM).</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Compounds dosed q.d. orally as 0.5% CMC/0.1% Tween 80.</p></div></div><div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The preparation of monocyclic pyrimidine analogues such as <b>6</b> was carried out as described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Coupling of indole <b>2</b> with pyrimidine <b>3</b><a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> was achieved by treatment with DBU. Formation of the urea was then accomplished by trapping the lithium anion of the indole with the desired phenylisocyanates. Removal of the benzyl protecting group with TFA provided alcohol <b>5</b>, which was readily converted to methylamine <b>6</b> by conversion first to the mesylate and then displacement with methylamine.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/medium/jm-2015-01227y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01227&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) DBU, CH<sub>3</sub>CN, 75%; (ii) NaH, R<sup>2</sup>NCO, DMF, −50 °C to rt, 88%; (iii) TFA, 100 °C, 74%; (iv) Ms<sub>2</sub>O, pyridine, THF; (v) CH<sub>3</sub>NH<sub>2</sub>, MeOH, 54%, 2 steps.</p></p></figure><div class="NLM_p">The bicyclic pyrimidine intermediates <b>8</b> and <b>10</b> were accessible from the corresponding β-ketoesters <b>7</b> and <b>9</b>, respectively (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Treatment of each β-ketoester <b>7</b> and <b>9</b> with formamidine acetate provided the corresponding hydroxypyrimidine, which then underwent a protecting group swap from benzyl to Boc. Conversion to the chloropyrimidines <b>8</b> and <b>10</b> was then accomplished by reaction with carbon tetrachloride and triphenylphospine.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/medium/jm-2015-01227y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01227&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) formamidine acetate, EtONa, EtOH, reflux, 90%; (ii) Pd/C, Boc<sub>2</sub>O, MeOH/THF; (iii) CCl<sub>4</sub>, PPh<sub>3</sub>, DCE, reflux, 80%, 2 steps.</p></p></figure><div class="NLM_p">The 8-methyl substituted bicyclic pyrimidine <b>15</b> was prepared as outlined in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. The β-ketoester <b>14</b> was converted to the corresponding Boc protected chloropyrimidine by analogy to that of <b>8</b> and <b>10</b>.</div><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/medium/jm-2015-01227y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01227&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) <b>11</b>, <b>12</b>, NaBH(OAc)<sub>3</sub>, TEA, DCE; (ii) ethyl oxobutanoate, NaBH(OAc)<sub>3</sub>, DCE; (iii) <i>t</i>BuOK, toluene; (iv) formamidine acetate, EtONa, EtOH, reflux, 36% 4 steps; (v) Pd/C, Boc<sub>2</sub>O, MeOH; (vi) CCl<sub>4</sub>, PPh<sub>3</sub>, DCE, reflux 57%, 2 steps.</p></p></figure><div class="NLM_p">The chiral chloropyrimidines <b>21</b> and <b>22</b> were prepared starting from (<i>S</i>)-α-methylbenzylamine, which underwent reductive amination with <b>16</b> and then ethyl glyoxylate to provide diester <b>18</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Claisen condensation of <b>18</b> then provided diastereomers <b>19</b> and <b>20</b>, which were separated by flash chromatography. Conversion of each diastereomer <b>19</b> and <b>20</b> to the corresponding chloropyrimidines <b>21</b> and <b>22</b> was achieved under the same conditions as those described above.</div><figure id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/medium/jm-2015-01227y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01227&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) <b>16</b>, <b>17</b>, NaBH(OAc)<sub>3</sub>, DCE; (ii) ethyl glyoxylate, NaBH(OAc)<sub>3</sub>, DCE; (iii) <i>t</i>BuOK, toluene, 50–70%, 3 steps; (iv) formamidine acetate, EtONa, EtOH, reflux, 93%; (v) Pd/C, Boc<sub>2</sub>O, EtOH, 80%, 2 steps; (vi) CCl<sub>4</sub>, PPh<sub>3</sub>, DCE, reflux, 51%.</p></p></figure><div class="NLM_p">The 6,5-bicyclic pyrimidine <b>24</b> was prepared by condensation of the commercially available β-ketoester <b>23</b> with formamidine acetate (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). Construction of the methyl substituted 6,5-bicyclic pyrimidine was as described in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. In each of these cases, the hydroxy pyrimidines were used in the subsequent coupling steps as the chloro derivatives were found to be both difficult to prepare and use due to instability.</div><figure id="sch5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/medium/jm-2015-01227y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01227&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) formamidine acetate, EtONa, EtOH, reflux, 24%.</p></p></figure><figure id="sch6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/medium/jm-2015-01227y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01227&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NaH, toluene, 0 °C to rt; (ii) formamidine acetate, EtONa, EtOH, reflux, ∼ 20%.</p></p></figure><div class="NLM_p">Coupling of the bicyclic pyrimidines <b>10</b>, <b>15</b>, <b>21</b>, and <b>22</b> to the hydroxyindole was achieved by treatment with DBU to give the corresponding derivatives <b>30</b> (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>). The 6,5-bicyclic pyrimidines <b>24</b> and <b>28</b> were efficiently coupled to <b>29</b> with PyBop and DBU.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Formation of the desired urea analogues <b>33</b> was achieved by treatment of the sodium anion of <b>30</b> with either a preformed phenylcarbamate or a commercially available isocyanate. The aminopyrazoles and aminoisoxazoles <b>31</b> that were not commercially available were prepared as described previously.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> The Boc protecting group was then removed upon treatment with TFA to provide the desired compounds <b>33</b> for testing against VEGFR-2.</div><figure id="sch7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/medium/jm-2015-01227y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01227&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) <b>10</b>, <b>15</b>, <b>21</b>, or <b>22</b>, DBU, CH<sub>3</sub>CN, reflux, 90%; (ii) <b>24</b> or <b>28</b>, PyBop, acetonitrile, DBU, 64%; (iii) <b>25</b>, phenyl chloroformate, pyridine, 86%; (iv) <b>32</b> or R<sup>2</sup>NCO, NaH, THF, 0 °C-rt, 50%; (v) TFA, DCM, 92%.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Compound Evaluation</h3><div class="NLM_p"><i>In vitro</i> inhibition of VEGFR-2 receptor tyrosine kinase was assessed with two primary assays: a KDR receptor tyrosine kinase biochemical assay and a cellular assay with BaF3-Tel-KDR cells that are engineered to constitutively require VEGFR-2 kinase domain activity for survival and proliferation. Select compounds were evaluated for selectivity in a panel of 62 kinases.</div><div class="NLM_p">Early in our effort, it was found that some of the compounds also inhibited hERG, which is a potassium ion channel that can cause long QT syndrome and cardiac dysfunction. As we aimed to minimize the associated systemic risk, compounds were analyzed in an automated Q-patch assay to determine their activity on the hERG channel.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">As we sought to identify compounds that selectively distributed to the ocular tissues, we did not apply the usual <i>in vitro</i> PK-ADME filters prior to <i>in vivo</i> evaluation. Priority was given to compounds that had demonstrated good aqueous solubility,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> yet generally those with good <i>in vitro</i> potency were selected for evaluation in the mouse laser CNV model (C57BL/6) at a single dose of 10 mg/kg (p.o.). This screening dose was selected based on early efficacy studies with existing VEGFR-2 inhibitors, such as <b>1</b>, and was not expected to cause any acute side effects that would compromise a given study. Compounds were formulated as suspensions (0.5% methyl cellulose, Tween 80, and water) to better inform our understanding of their intrinsic ADME properties. Each compound was dosed starting the day of laser application and continued daily with the last dose given on day 6 and CNV area measurement on day 7. Comparison of CNV area in animals dosed with compound or placebo was used to establish percent inhibition.</div><div class="NLM_p last">Compounds exhibiting >60% inhibition at the 10 mg/kg screening dose were further evaluated in mouse CNV dose–response studies to establish ED<sub>50</sub> and ED<sub>90</sub> relationships. Compounds with an ED<sub>90</sub> < 20 mg/kg in the mouse CNV assay were then characterized in the rat laser CNV model (Brown Norway). To understand the correlation between efficacy and exposure, the distribution profiles for select compounds were determined by orally dosing Brown Norway rats and measuring time course drug exposures in the plasma and ocular tissues (retina and retinal pigment epithelium/choroid/sclera complex). Further understanding of the ADME profiles for select compounds was accomplished by discrete i.v./p.o. PK studies in Brown Norway rats.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48336" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48336" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Early on, we recognized the need to improve on the aqueous solubility of compound <b>1</b>. It was anticipated that greater aqueous solubility would provide increased oral bioavailability and as a consequence better efficacy. X-ray cocrystal structures of related VEGFR-2 inhibitors indicated that incorporation of ionizable groups on the pyrimidine should be possible. An important early finding was that the aminopyrimidine of <b>1</b> was not required for potency as <b>5a</b> proved to be equipotent in the biochemical assay and have similar efficacy in the mouse CNV model (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>; 45% inhibition). A basic amine was introduced to give compound <b>6a</b>, which demonstrated similar potency <i>in vitro</i> and importantly increased efficacy <i>in vivo</i> (67% inhibition). As anticipated, <b>6a</b> had improved aqueous solubility (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>; 64 μM) relative to that of <b>1</b>. Incorporation of a fluoro substituent in the 4-position of the aniline as in <b>6b</b> provided a boost in efficacy as the compound showed 92% inhibition of neovascularization in the mouse at the 10 mg/kg dose.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Comparison of Aqueous Solubility for Selected VEGFR-2 Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">aq sol pH 6.8 (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">< 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="left">64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33a</b></td><td class="colsep0 rowsep0" align="left">84</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33f</b></td><td class="colsep0 rowsep0" align="left"><5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33j</b></td><td class="colsep0 rowsep0" align="left">190</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33k</b></td><td class="colsep0 rowsep0" align="left">833</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33l</b></td><td class="colsep0 rowsep0" align="left">682</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33m</b></td><td class="colsep0 rowsep0" align="left">252</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33n</b></td><td class="colsep0 rowsep0" align="left">450</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33o</b></td><td class="colsep0 rowsep0" align="left">489</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33q</b></td><td class="colsep0 rowsep0" align="left">167</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33r</b></td><td class="colsep0 rowsep0" align="left">126</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33s</b></td><td class="colsep0 rowsep0" align="left">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33t</b></td><td class="colsep0 rowsep0" align="left">232</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33v</b></td><td class="colsep0 rowsep0" align="left">110</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33w</b></td><td class="colsep0 rowsep0" align="left">37</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Aqueous high-throughput equilibrium solubility (see ref <a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">26</a>).</p></div></div></div><div class="NLM_p">Collectively, these compounds demonstrated the potential for optimization through inclusion of the basic amine moiety; however, <b>6b</b> was found to have an undesirable level of activity on the hERG channel (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>; IC<sub>50</sub> 5800 nM). To optimize <i>in vivo</i> efficacy while balancing hERG activity and aqueous solubility, we focused our efforts on the basic amine region and the urea side chain of <b>6b</b>. Our exploration centered on altering both the p<i>K</i><sub>a</sub> and the steric environment of the amine as well as reducing the lipophilicity of the urea side chain. It was thought that a combination of these changes would provide the desired efficacy while reducing hERG liability.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Comparison of hERG Activity for Selected VEGFR-2 Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">hERG IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="left">5800</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33a</b></td><td class="colsep0 rowsep0" align="left">8900</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33c</b></td><td class="colsep0 rowsep0" align="left">10700</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33g</b></td><td class="colsep0 rowsep0" align="left">15600</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33m</b></td><td class="colsep0 rowsep0" align="left">>30000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33n</b></td><td class="colsep0 rowsep0" align="left">27400</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33q</b></td><td class="colsep0 rowsep0" align="left">7000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33r</b></td><td class="colsep0 rowsep0" align="left">11100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33s</b></td><td class="colsep0 rowsep0" align="left">23500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33v</b></td><td class="colsep0 rowsep0" align="left">>30000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Automated Q-patch assay.</p></div></div></div><div class="NLM_p">Rigidification of the amine side chain by incorporation into the 6,6-bicyclic pyrimidine <b>33a</b> was well tolerated as it gave 87% inhibition in the mouse CNV model with modest aqueous solubility (84 μM). However, no substantial reduction in hERG activity was realized (IC<sub>50</sub> 8900 nM). Intriguingly, the isomeric 6,6-bicyclic pyrimidine <b>33b</b> provided no significant inhibition <i>in vivo</i> despite having good potency in the enzymatic and cellular assays.</div><div class="NLM_p">To further probe the sensitivity of this region to substitution, the enantiomeric methyl analogues <b>33c</b> and <b>33d</b> were prepared. These compounds again highlighted a similar pattern of disconnect between the <i>in vitro</i> and the <i>in vivo</i> efficacy as <b>33c</b>, the (<i>S</i>)-enantiomer, demonstrated greater efficacy despite similar <i>in vitro</i> potency to the (<i>R</i>)-enantiomer <b>33d</b>. Acetylation of the amine as in <b>33e</b> caused a complete loss of efficacy in the mouse model, while retention of the basic amine as in the ethyl derivative <b>33f</b> provided 81% inhibition. However, the tertiary amine <b>33f</b> reduced the aqueous solubility (<5 μM).</div><div class="NLM_p">Reduction of amine p<i>K</i><sub>a</sub> was achieved with the 6,5-bicyclic pyrimidine <b>33g</b>. This compound was found to be efficacious (68% inhibition) in the mouse model and demonstrated reduced hERG activity (IC<sub>50</sub> 15600 nM). In this instance, however, the addition of a methyl group to the bicycle as in <b>33h</b> and <b>33i</b> attenuated the efficacy.</div><div class="NLM_p">The pyridyl analogue <b>33j</b> was designed to reduce the lipophilicity of the aniline moiety. Although the <i>in vitro</i> potency in both the biochemical (280 nM) and cell (1922 nM) assays was attenuated, it demonstrated the potential benefit through further optimization to identify more preferred heteroaryl groups as there was a favorable impact on aqueous solubility (190 μM). Indeed, further design of heteroaryl replacements led to pyrazoles <b>33k</b> and <b>33l</b> that provided very good <i>in vitro</i> potency (cell IC<sub>50</sub> 3 nM and 1 nM, respectively). While the initial pyrazole analogues <b>33k</b> and <b>33l</b> provided no inhibition in the mouse CNV model, they did have markedly improved aqueous solubility (833 and 682 μM, respectively). Further design and optimization led to the discovery that the cyclopropylmethyl analogue <b>33m</b> provided 64% inhibition. The close structural similarities among these analogues again provide a dramatic demonstration of the subtle effects realized only with <i>in vivo</i> SAR. Pyrazole <b>33m</b> had good aqueous solubility (252 μM) and minimal hERG activity with an IC<sub>50</sub> > 30,000 nM. This was an important finding as it demonstrated the ability to reduce hERG activity without alteration of the amine basicity.</div><div class="NLM_p">Combining the methyl substituted 6,6-bicyclic pyrimidine with the cyclopropylmethyl pyrazole as in <b>33n</b> gave good potency in the cellular assay (0.9 nM), efficacy in the mouse (67% inhibition), good aqueous solubility (450 μM), and minimal hERG activity (IC<sub>50</sub> 27,400 nM). In this case, as shown above, the opposite enantiomer <b>33p</b> and the 6,5-bicyclic analogue <b>33o</b> showed reduced efficacy <i>in vivo</i> despite similar potency <i>in vitro</i>.</div><div class="NLM_p">Further exploration of aniline replacements revealed that the isoxazole (e.g., <b>33q</b> and <b>33r</b> with 83% and 96% inhibition, respectively) provided even greater efficacy than the corresponding pyrazole analogues; however, they also had greater hERG activity. It was also found that the 3-aminoisoxazole analogues (e.g., <b>33s</b>) were more active <i>in vivo</i> than the isomeric 5-aminoisoxazoles (e.g., <b>33t</b>). Similar to the pyrazole analogues, inclusion of the methyl group in 6,5-pyrimidine did not give a favorable increase in activity (<b>33u</b>), which was again in contrast to the 6,6-bicyclic pyrimidines. Modification of the isoxazole substitution from <i>t</i>-butyl to cyclopropyl <b>33v</b> or isopropyl <b>33w</b> provided maximal inhibition in the mouse model (98 and 96% inhibition, respectively). Isoxazole <b>33v</b> also showed minimal hERG activity with an IC<sub>50</sub> > 30,000 nM in combination with good aqueous solubility (110 μM).</div><div class="NLM_p">Dose–response studies in the mouse and rat were conducted for the preferred compounds identified from the mouse <i>in vivo</i> single dose screen (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). In the mouse laser CNV model, the isoxazole derivative <b>33v</b> provided the greatest efficacy on a per dose basis with an ED<sub>90</sub> of 4.8 mg/kg, while its corresponding aniline analogue <b>33g</b> provided an ED<sub>90</sub> of 31 mg/kg. In contrast, the pyrazole analogue <b>33n</b> was found to have a higher ED<sub>90</sub> (19.6 mg/kg) than its corresponding aniline derivative <b>33c</b> in the mouse CNV. Both the nonmethylated <b>33m</b> and the methylated <b>33n</b> provided a similar dose–response in the mouse model. Further characterization of <b>33n</b>, <b>33v</b>, and <b>33m</b> in the rat laser CNV model again demonstrated that on a per dose basis <b>33v</b> was more efficacious than either <b>33m</b> or <b>33n</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Dose–Response Inhibition of Laser Induced Choroidal Neovascularization for Selected VEGFR-2 Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">mouse<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center">rat<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">ED<sub>50</sub> (mg/kg)</th><th class="colsep0 rowsep0" align="center">ED<sub>90</sub> (mg/kg)</th><th class="colsep0 rowsep0" align="center">ED<sub>50</sub> (mg/kg)</th><th class="colsep0 rowsep0" align="center">ED<sub>90</sub> (mg/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33c</b></td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left">8.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33g</b></td><td class="colsep0 rowsep0" align="left">6.9</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33n</b></td><td class="colsep0 rowsep0" align="left">3.4</td><td class="colsep0 rowsep0" align="left">19.6</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">14.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33v</b></td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33m</b></td><td class="colsep0 rowsep0" align="left">7.8</td><td class="colsep0 rowsep0" align="left">25.3</td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="left">13.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Compounds dosed q.d. orally as 0.5% MC/0.1% Tween 80, WFI 7 days.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Compounds dosed q.d. orally as 0.5% CMC/0.1% Tween 80, WFI 14 days.</p></div></div></div><div class="NLM_p">As stated above, our key objective was to identify VEGFR-2 inhibitors that provided good efficacy in the mouse and rat laser CNV models following oral dosing and demonstrated distribution to and retention in the ocular tissues relative to the plasma. Discrete oral PK studies in Brown Norway rats were conducted with preferred compounds. Exposure in plasma, retina, and posterior eye cup (retinal pigment epithelium/choroid sclera complex = posterior eye cup) were assessed at 7 time points after dosing between 0 and 24 h. In <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>, the dose normalized (DN) exposures for 3 compounds are detailed. It can readily be seen that <b>33v</b> has significantly higher plasma exposure (DNC<sub>max</sub> and DNAUC) than either <b>33n</b> or <b>33m</b>. In the retina, <b>33n</b> and <b>33v</b> had similar exposure, while <b>33m</b> was measurably lower. In the PEC, there was even greater contrast among the three compounds with the exposure decreasing in order from <b>33v</b> > <b>33n</b> > <b>33m</b>. The data from the ocular tissues indicate a strong preference for the retention of each of the compounds in those tissues versus retention in the plasma. This is most easily noted by comparison of the plasma/retina/PEC dose normalized concentrations at 24 h (<b>33n</b>, 1.6/122/1067 nM; <b>33v</b>, 6/65/3334 nM; <b>33m</b>, 0.7/13/102 nM). The above data demonstrate that it is possible to identify compounds with preferential distribution to the ocular tissues and reduced plasma exposure. The advantage of such distribution in mitigating systemic side effects will only be borne out in toxicology studies as it was not expected that our efficacy models would address this. However, it is worth noting that the approved VEGFR-2 inhibitor pazopanib, described above, has been reported to provide 93% inhibition of laser-induced CNV in the mouse model when dosed orally at 100 mg/kg twice daily and that dose when given for 7 d produced a plasma exposure of ∼13 μM at 16 h post the last dose.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">The i.v./p.o. PK parameters of <b>33n</b>, <b>33v</b>, and <b>33m</b> provide further details regarding systemic exposure and clearance (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). In accord with the ocular PK study above, <b>33m</b> shows a higher rate of clearance from the plasma (165 mL/min/kg), while <b>33v</b> provided much lower clearance (6 mL/min/kg). All three of these compounds were found to have good plasma exposure following oral dosing (F% > 50). The plasma and ocular PK data highlight the limitation of optimizing compounds with limited <i>in vivo</i> efficacy measurements or an over reliance on <i>in vivo</i> PK as <b>33m</b> would not have been preferred either from plasma or ocular PK, yet the compound is efficacious at reducing laser-induced CNV.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Dose Normalized (DN) Exposure in Selected Tissues from Brown Norway Rats for Selected VEGFR-2 Inhibitors <b>33n</b>, <b>33m</b>, and <b>33v</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">tissue</th><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">DNAUC<sub>PO 0–24h</sub> (nM·h/mg/kg)</th><th class="colsep0 rowsep0" align="center">DNC<sub>Max</sub> (nM/mg/kg)</th><th class="colsep0 rowsep0" align="center">DNC<sub>24h</sub> (nM/mg/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">plasma</td><td class="colsep0 rowsep0" align="left"><b>33n</b></td><td class="colsep0 rowsep0" align="left">598</td><td class="colsep0 rowsep0" align="left">68</td><td class="colsep0 rowsep0" align="left">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33v</b></td><td class="colsep0 rowsep0" align="left">15014</td><td class="colsep0 rowsep0" align="left">3225</td><td class="colsep0 rowsep0" align="left">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33m</b></td><td class="colsep0 rowsep0" align="left">166</td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">retina</td><td class="colsep0 rowsep0" align="left"><b>33n</b></td><td class="colsep0 rowsep0" align="left">3215</td><td class="colsep0 rowsep0" align="left">170</td><td class="colsep0 rowsep0" align="left">122</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33v</b></td><td class="colsep0 rowsep0" align="left">2692</td><td class="colsep0 rowsep0" align="left">337</td><td class="colsep0 rowsep0" align="left">65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33m</b></td><td class="colsep0 rowsep0" align="left">310</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">PEC</td><td class="colsep0 rowsep0" align="left"><b>33n</b></td><td class="colsep0 rowsep0" align="left">22266</td><td class="colsep0 rowsep0" align="left">1067</td><td class="colsep0 rowsep0" align="left">1067</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33v</b></td><td class="colsep0 rowsep0" align="left">92954</td><td class="colsep0 rowsep0" align="left">5293</td><td class="colsep0 rowsep0" align="left">3344</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33m</b></td><td class="colsep0 rowsep0" align="left">2386</td><td class="colsep0 rowsep0" align="left">110</td><td class="colsep0 rowsep0" align="left">102</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Each compound was dosed orally as a suspension of 0.5% MC/0.1% Tween 80, WFI at the following doses: 6 mg/kg (ED<sub>50</sub> = 3.0 mg/kg) (33n); 6 mg/kg (ED<sub>50</sub> = 2.7 mg/kg) (33m); and 2 mg/kg (ED<sub>50</sub>= 0.7 mg/kg) (33v). PEC = posterior eye cup (retinal pigment epithelium/choroid/sclera complex).</p></div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. PK-ADME Parameters for Selected VEGFR-2 Inhibitors.<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center"><b>33n</b><a class="ref internalNav" href="#t6fn5" aria-label="b">b</a>,<a class="ref internalNav" href="#t6fn2" aria-label="d">d</a>,<a class="ref internalNav" href="#t6fn4" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center"><b>33v</b><a class="ref internalNav" href="#t6fn5" aria-label="b">b</a><a class="ref internalNav" href="#t6fn3" aria-label="e">e</a>,<a class="ref internalNav" href="#t6fn4" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center"><b>33m</b><a class="ref internalNav" href="#t6fn6" aria-label="c">c</a>,<a class="ref internalNav" href="#t6fn2" aria-label="d">d</a>,<a class="ref internalNav" href="#t6fn4" aria-label="f">f</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>PO 0–8h</sub> (μM·h)</td><td class="colsep0 rowsep0" align="left">2488</td><td class="colsep0 rowsep0" align="left">29393</td><td class="colsep0 rowsep0" align="left">1121</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">165</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Vdss (L/kg)</td><td class="colsep0 rowsep0" align="left">5.6</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (nM)</td><td class="colsep0 rowsep0" align="left">514</td><td class="colsep0 rowsep0" align="left">11003</td><td class="colsep0 rowsep0" align="left">505</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">F (%)</td><td class="colsep0 rowsep0" align="left">81</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">51</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Brown Norway rat PK. Animals were dosed i.v. at 1 mg/kg, <i>n</i> = 2.</p></div><div class="footnote" id="t6fn5"><sup>b</sup><p class="last">Animals were dosed p.o. at 3 mg/kg, <i>n</i> = 3.</p></div><div class="footnote" id="t6fn6"><sup>c</sup><p class="last">Animals were dosed p.o. at 10 mg/kg, <i>n</i> = 3.</p></div><div class="footnote" id="t6fn2"><sup>d</sup><p class="last">i.v. dose: 10% NMP, 15% PG, 4% cremophorEL, and PBS.</p></div><div class="footnote" id="t6fn3"><sup>e</sup><p class="last">i.v. dose: 10% NMP, 30% PEG 300, and 60% WFI.</p></div><div class="footnote" id="t6fn4"><sup>f</sup><p class="last">p.o. dose: 0.5% MC/0.1% Tween 80. WFI PK parameters are derived from p.o. dosing and are reported as the mean ± SD.</p></div></div></div><div class="NLM_p last">In a selectivity panel consisting of 62 kinases, <b>33n</b> and <b>33v</b> were found to have activity <1 μM against several related kinases [IC<sub>50</sub> (μM) <b>33n</b>, Ret 0.066, PDGFRα 0.15, and c-Kit 0.6; <b>33v</b>, Ret 0.50, PDGFRα 0.15 μM]. This is consistent with the observed <i>in vivo</i> efficacy being primarily driven by VEGFR-2 inhibition.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76083" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76083" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Predicting ocular efficacy based on <i>in vitro</i> potency and <i>in vivo</i> exposure remains a challenge in ocular drug discovery. This is in part evidenced by the high number of potent VEGFR-2 inhibitors described herein, which provide little or no efficacy in the mouse laser CNV model. The challenge is more clearly illustrated by molecules <b>33m</b>, <b>33n</b>, and <b>33v</b>, which provide similar <i>in vivo</i> efficacy despite substantially different tissue distribution profiles. The reasons for these disconnects are not fully understood at this time. We believe melanin binding plays a key role not only in the preferential distribution of the compound to the ocular tissue but also in the differing correlations between ocular exposure and efficacy in the CNV models. In part, the answer may come from melanin binding studies that adequately provide the kinetic binding profiles of the molecules. Differential kinase selectivity may provide another hypothesis to explain the exposure–efficacy disconnect, although data collected against a kinase panel indicate that the molecules are reasonably selective for VEGFR-2 and have similar broad profiles.</div><div class="NLM_p last">Despite the inability to <i>a priori</i> predict ocular efficacy based on plasma PK and potency, our use of relatively high-throughput <i>in vivo</i> screening in a mouse laser CNV model facilitated the generation of clear and actionable <i>in vivo</i> SAR. Through optimization of one particular series of VEGFR-2 inhibitors, described herein, multiple promising compounds were identified that effectively reduced choroidal neovascularization and provided preferential distribution to the ocular tissues. The observations made with <b>33m</b>, <b>33n</b>, and <b>33v</b> are a clear demonstration of the ability to identify VEGFR-2 inhibitors with markedly higher ocular exposure than that in the plasma. Selective distribution to the target tissue of interest, the eye in this case, may provide an advantage in minimizing systemic side effects. This is of particular interest as the on-target systemic toxicity of VEGFR-2 inhibitors has been well established and thus may be a barrier to systemic use of such therapy in the treatment of AMD. This data may support the potential clinical utility of systemically administered VEGFR-2 inhibitors with preferential ocular distribution as a therapy for wet AMD. A similar strategy may be applicable to other disease indications that would benefit from local drug distribution to limit systemic toxicity.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24134" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24134" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Chemistry: General</h3><div class="NLM_p">NMR spectra were recorded on a Bruker Avance II 400 MHz spectrometer. All chemical shifts are reported in parts per million (δ) relative to tetramethylsilane. The following abbreviations are used to denote signal patterns: s = singlet, d = doublet, t = triplet, m = multiplet, and br = broad. Flash chromatography was conducted using grade 60 230–400 mesh silica gel from Fisher Chemical (S825-1) or by utilizing the CombiFlash Companion from Teledyne Isco, Inc. and RediSep Rf disposable normal phase silica gel columns (4–300 g). Thin layer chromatography was performed using 2.5 × 7.5 cm glass-backed TLC Silica Gel 60 F<sub>254</sub> plates from EMD Chemicals, Inc. (15341-1) and visualized by UV light. HPLC purifications were performed on a Gilson preparative HPLC system controlled by Unipoint software using X-Bridge Phenyl, C8, C18, or RP18 30 × 50 mm columns with 5 μm particle size. The purity of all compounds was ≥95%, unless otherwise noted. Low-resolution mass spectra were recorded using an Agilent 1100 series LC-MS spectrometer.</div><div id="sec6_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> 5-(6-Benzyloxymethyl-pyrimidin-4-yloxy)-1<i>H</i>-indole (<b>4</b>)</h4><div class="NLM_p last">5-Hydroxy indole <b>2</b> (5 g, 37.6 mmol) was added in one portion to a solution of 4-(benzyloxymethyl)-6-chloropyrimidine <b>3</b> (8.81 g, 37.6 mmol) and DBU (5.66 mL, 37.6 mmol) in ACN (107 mL) at room temperature. This was stirred overnight for 20 h. The reaction was concentrated and purified via FCC (12–100% EtOAc/heptane) to obtain the title compound (9.37 g, 28.3 mmol, 75% yield). MS (ESI) <i>m</i>/<i>z</i> 447.0 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.11–11.44 (m, 1 H), 8.58–8.82 (m, 1 H), 7.41–7.51 (m, 2 H), 7.34–7.39 (m, 1 H), 7.21–7.32 (m, 5 H), 6.88–6.94 (m, 2 H), 6.42–6.50 (m, 1 H), 4.52–4.64 (m, 4 H).</div></div><div id="sec6_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 5-(6-Hydroxymethyl-pyrimidin-4-yloxy)-indole-1-carboxylic Acid (4-Fluoro-3-trifluoromethyl-phenyl)-amide (<b>5</b>)</h4><div class="NLM_p">To NaH (255 mg, 6.37 mmol) in 40 mL of DMF at 0 °C under nitrogen was added a solution of 5-(6-(benzyloxymethyl)pyrimidin-4-yloxy)-1<i>H</i>-indole (960 mg, 2.90 mmol) in 5 mL of DMF and stirred at 0 °C for 0.5 h. The reaction was then cooled to −50 °C, followed by the addition of 1-fluoro-4-isocyanato-2-(trifluoromethyl)benzene (0.454 mL, 3.19 mmol) in 5 mL of DMF. The cold bath was removed,and the reaction allowed to warm to RT. After 3 h, the reaction was quenched with NH<sub>4</sub>Cl, extracted 2× EtOAc, and the combined organics washed with H<sub>2</sub>O (3×), brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was then purified via FCC (1–50% EtOAc/CH<sub>2</sub>Cl<sub>2</sub>) to obtain 5-((6-((benzyloxy)methyl)pyrimidin-4-yl)oxy)-<i>N</i>-(4-fluoro-3-(trifluoromethyl)phenyl)-1<i>H</i>-indole-1-carboxamide (1.36 g, 2.54 mmol, 88% yield). MS (ESI) <i>m</i>/<i>z</i> 537.0 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.40 (s, 1 H), 8.69 (s, 1 H), 8.30 (d, <i>J</i> = 8.84 Hz, 1 H), 8.07–8.19 (m, 2 H), 7.96–8.06 (m, 1 H), 7.58 (t, <i>J</i> = 9.85 Hz, 1 H), 7.52 (d, <i>J</i> = 2.27 Hz, 1 H), 7.24–7.40 (m, 5 H), 7.17 (dd, <i>J</i> = 8.97, 2.40 Hz, 1 H), 7.02 (s, 1 H), 6.82 (d, <i>J</i> = 3.79 Hz, 1 H), 4.61 (d, <i>J</i> = 8.84 Hz, 4 H).</div><div class="NLM_p last">A solution of 5-((6-((benzyloxy)methyl)pyrimidin-4-yl)oxy)-<i>N</i>-(4-fluoro-3-(trifluoromethyl)phenyl)-1<i>H</i>-indole-1-carboxamide (1.48 g, 2.76 mmol) in TFA (15 mL) was heated at 100 °C for 4 h before concentrating and absorbing onto silica to purify via FCC 10–100% EtOAc/CH<sub>2</sub>Cl<sub>2</sub> 10CV, then 100% EtOAc to provide the title compound <b>5</b> (0.915 g, 2.052 mmol, 74% yield). MS (ESI) <i>m</i>/<i>z</i> 447.0 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.40 (s, 1 H), 8.65 (d, <i>J</i> = 1.01 Hz, 1 H), 8.29 (d, <i>J</i> = 9.09 Hz, 1 H), 8.09–8.12 (m, 2H), 8.99–8.04 (m, 1 H), 7.58 (t, <i>J</i> = 9.60 Hz, 1 H), 7.51 (d, <i>J</i> = 2.53 Hz, 1 H), 7.16 (dd, <i>J</i> = 8.84, 2.53 Hz, 1 H), 6.99 (d, <i>J</i> = 1.01 Hz, 1 H), 6.82 (d, <i>J</i> = 3.79 Hz, 1 H), 5.61 (t, <i>J</i> = 5.05 Hz, 1 H), 4.52 (d, <i>J</i> = 5.05 Hz, 2 H).</div></div><div id="sec6_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 5-(6-Methylaminomethyl-pyrimidin-4-yloxy)-indole-1-carboxylic Acid (4-Fluoro-3-trifluoromethyl-phenyl)-amide (<b>6b</b>)</h4><div class="NLM_p">To a solution of 5-(6-hydroxymethyl-pyrimidin-4-yloxy)-indole-1-carboxylic acid (4-fluoro-3-trifluoromethyl-phenyl)-amide <b>5</b> (260 mg, 0.6 mmol), methanesulfonic anhydride (240 mg, 1.4 mmol), and THF (15 mL) was added pyridine (0.2 mL). The mixture was stirred at rt for 0.5 h before being filtered. The filtrate was used in the next step without purification. MS (ESI) <i>m</i>/<i>z</i> 525.0 (M + 1).</div><div class="NLM_p last">To a solution of 5-(6-methanesulfonylmethyl-pyrimidin-4-yloxy)-indole-1-carboxylic acid (4-fluoro-3-trifluoromethyl-phenyl)-amide ((270 mg, 0.515 mmol) was added methyl amine (8 mL, 2.0 M in methanol). The mixture was stirred at room temperature for 16 h, then concentrated under reduced pressure. The residue was diluted with EtOAc and washed with water and brine. The organic layer was removed, dried, and concentrated. The residue was then separated by FCC (MeOH with 1% NH<sub>4</sub>OH/DCM from 0% to 10%) to give the title compound <b>6b</b> (127 mg, 0.276 mmol, 54%). MS (ESI) <i>m</i>/<i>z</i> 460.1 (M + 1); <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.65 (d, <i>J</i> = 1.01 Hz, 1 H), 8.35 (d, <i>J</i> = 8.84 Hz, 1 H), 8.04 (dd, <i>J</i> = 6.19, 2.65 Hz, 1 H), 7.90–7.94 (m, 2 H), 7.41 (d, <i>J</i> = 2.27 Hz, 1 H), 7.35 (t, <i>J</i> = 9.60 Hz, 1 H), 7.11 (dd, <i>J</i> = 8.97, 2.40 Hz, 1 H), 7.00 (s, 1 H), 6.74 (d, <i>J</i> = 3.79 Hz, 1 H), 3.82 (s, 2 H), 2.43 (s, 3 H).</div></div><div id="sec6_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 5-(6-Methylaminomethyl-pyrimidin-4-yloxy)-indole-1-carboxylic Acid (3-Trifluoromethyl-phenyl)-amide (<b>6a</b>)</h4><div class="NLM_p last">Prepared as described for <b>6b</b>. MS (ESI) <i>m</i>/<i>z</i> 442.1 (M + 1); <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.64 (s, 1 H), 8.34 (d, <i>J</i> = 9.09 Hz, 1 H), 8.05 (s, 1 H), 7.93 (d, <i>J</i> = 3.79 Hz, 1 H), 7.89 (d, <i>J</i> = 8.08 Hz, 1 H), 7.56 (t, <i>J</i> = 7.96 Hz, 1 H), 7.40–7.46 (m, 2 H), 7.10 (dd, <i>J</i> = 8.97, 2.40 Hz, 1 H), 6.99 (s, 1 H), 6.73 (d, <i>J</i> = 3.79 Hz, 1 H), 3.77 (s, 2 H), 2.40 (s, 3 H).</div></div><div id="sec6_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 4-Chloro-5,8-dihydro-6<i>H</i>-pyrido[3,4-<i>d</i>]pyrimidine-7-carboxylic Acid <i>tert</i>-Butyl Ester (<b>8</b>)</h4><div class="NLM_p">7-Benzyl-5,6,7,8-tetrahydro-3<i>H</i>-pyrido[3,4-<i>d</i>]pyrimidin-4-one<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (36.9 g, 153 mmol) and BOC anhydride (40.1 g, 184 mmol) were taken up in MeOH (600 mL). The vessel was purged with argon, and palladium on carbon (10% w/w; wet) (5.0 g) was added. The contents were then stirred under a hydrogen atmosphere (1 atm) for 18 h. At that time, the suspension was filtered over Celite, and the resulting solution was concentrated to give the title compound, which was taken to the next step without further purification. MS (ESI) <i>m</i>/<i>z</i> 252.0 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.41 (s, 1H), 8.04 (s, 1H), 4.22 (s, 2H), 3.51 (app t, <i>J</i> = 5.7 Hz, 2H), 2.40 (app t, <i>J</i> = 5.7 Hz, 2H), 1.42 (s, 9H).</div><div class="NLM_p last">Triphenylphosphine (17.3 g, 66.1 mmol) was added to a solution of 4-oxo-4,5,6,8-tetrahydro-3<i>H</i>-pyrido[3,4-<i>d</i>]pyrimidine-7-carboxylic acid <i>tert</i>-butyl ester (8.30 g, 33.0 mmol), CCl<sub>4</sub> (9.6 mL, 99 mmol), and 1,2-dichloroethane (250 mL). The solution was heated at 70 °C for 2.5 h. The solution was concentrated <i>in vacuo</i> to about 50 mL. The contents of the flask were then filtered over a silica gel plug eluting with 60% EtOAc/heptane. The residue following concentration was then further separated via flash chromatography (10–30% EtOAc/heptane) to give the title compound <b>8</b> (7.09 g, 26.3 mmol, 80%). MS (ESI) <i>m</i>/<i>z</i> 270.0 and 272.0 (M + 1); <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.79 (s, 1 H), 4.65 (s, 2 H), 3.74 (t, <i>J</i> = 5.8 Hz, 2 H), 2.87 (t, <i>J</i> = 5.8 Hz, 2 H), 1.49 (s, 9 H).</div></div><div id="sec6_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>tert</i>-Butyl 4-chloro-7,8-dihydropyrido[4,3-<i>d</i>]pyrimidine-6(5<i>H</i>)-carboxylate (<b>10</b>)</h4><div class="NLM_p last">Prepared as described for <b>8</b>. MS (ESI) <i>m</i>/<i>z</i> 270.0 and 271.9 (M + 1); <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.79 (s, 1H), 4.58 (s, 2H), 3.76 (t, <i>J</i> = 5.9 Hz, 2H), 2.97 (t, <i>J</i> = 5.8 Hz, 2H), 1.50 (s, 9H).</div></div><div id="sec6_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 4-[Benzyl-(1-ethoxycarbonyl-ethyl)-amino]-butyric Acid Methyl Ester (<b>13</b>)</h4><div class="NLM_p">Ethyl alanine hydrochloride (5.5 g, 36.8 mmol), benzaldehyde (7.9 mL, 77.8 mmol), TEA (10.8 mL, 77.8 mmol), and NaBH(OAc)<sub>3</sub> (16.5 g, 77.8 mmol) were taken up in 1,2-DCE (200 mL) and stirred at rt for 4 h. The reaction was then partitioned between DCM and saturated aqueous NaHCO<sub>3</sub>. The organic layer was removed, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i>. The crude residue was used without further purification. MS (ESI) <i>m</i>/<i>z</i> 208.2 (M + 1).</div><div class="NLM_p last">2-Benzylamino-propionic acid ethyl ester (1.4 g, 6.7 mmol), methyl oxo-butanoate (1.7 g, 13.5 mmol), TEA (1.9 mL, 13.5 mmol), and NaBH(OAc)<sub>3</sub> (2.9 g, 13.5 mmol) were taken up in 1,2-DCE (35 mL) and stirred at rt for 4 h. The reaction was partitioned between DCM and saturated aqueous NaHCO<sub>3</sub>. The organic layer was removed, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i>. The crude residue was used without further purification. MS (ESI) <i>m</i>/<i>z</i> 308.3 (M + 1).</div></div><div id="sec6_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 1-Benzyl-2-methyl-3-oxo-piperidine-4-carboxylic Acid Methyl Ester (<b>14</b>)</h4><div class="NLM_p last">A mixture of 4-[benzyl-(1-ethoxycarbonyl-ethyl)-amino]-butyric acid methyl ester (1.5 g, 4.9 mmol), potassium <i>tert-</i>butoxide (906 mg, 8.9 mmol), and toluene (100 mL) was stirred at rt for 3 h. The mixture was then partitioned between DCM and saturated aqueous NH<sub>4</sub>Cl. The organic layer was removed, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude residue was used without further purification. MS (ESI) <i>m</i>/<i>z</i> 262.2 (M + 1).</div></div><div id="sec6_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 4-Chloro-8-methyl-5,8-dihydro-6<i>H</i>-pyrido[3,4-<i>d</i>]pyrimidine-7-carboxylic Acid <i>tert</i>-Butyl Ester (<b>15</b>)</h4><div class="NLM_p last">Prepared as described for <b>8</b>. MS (ESI) <i>m</i>/<i>z</i> 284.2 (M + H); <sup>1</sup>H NMR (400 MHz, methylene chloride-<i>d</i><sub>2</sub>) δ 8.67 (s, 1H), 5.24–5.23 (m, 2H), 5.05 (s, 1H), 4.26 (s, 1H), 2.97 (s, 1H), 1.42 (d, <i>J</i> = 6.9 Hz, 3H), 1.39 (s, 9H).</div></div><div id="sec6_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Ethyl 4-((2-Ethoxy-2-oxoethyl)((<i>S</i>)-1-phenylethyl)amino)pentanoate (<b>18</b>)</h4><div class="NLM_p">To a solution of (<i>S</i>)-1-phenylethanamine (25.0 g, 206 mmol) and NaBH(OAc)<sub>3</sub> (65.6 g, 309 mmol) in 1,2-DCE (500 mL) was added ethyl levulinate (29.4 mL, 206 mmol). The reaction was stirred at room temperature for 16 h. The mixture was then partitioned between DCM and saturated aqueous NaHCO<sub>3</sub>. The organic layer was removed, and the aqueous layer was extracted further with DCM (2×). The combined organic layers were then dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude ethyl 4-((<i>S</i>)-1-phenyl-ethyl)amino)pentanoate was used without further purification. MS (ESI) <i>m</i>/<i>z</i> 250.2 (M + 1).</div><div class="NLM_p last">To a solution of ethyl 4-((<i>S</i>)-1-phenylethylamino)pentanoate (51.4 g, 206 mmol) and NaBH(OAc)<sub>3</sub> (65.5 g, 309 mmol) in 1,2-DCE (500 mL) was added ethyl glyoxylate (84 g, 412 mmol, 50% toluene solution). The reaction was stirred at room temperature for 18 h. The mixture was then partitioned between DCM and saturated aqueous NaHCO<sub>3</sub>. The organic layer was removed, and the aqueous layer was extracted further with DCM (2×). The combined organic layers were then dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude diastereomeric mixture of ethyl 4-((2-ethoxy-2-oxoethyl)((<i>S</i>)-1-phenylethyl)amino)pentanoate (<b>18</b>) was used without further purification. MS (ESI) <i>m</i>/<i>z</i> 336.4 (M + 1).</div></div><div id="sec6_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (2<i>S</i>)-Ethyl 2-Methyl-5-oxo-1-((<i>S</i>)-1-phenylethyl)piperidine-4-carboxylate (<b>19</b>) and (2<i>R</i>)-Ethyl 2-methyl-5-oxo-1-((<i>S</i>)-1-phenylethyl)piperidine-4-carboxylate (<b>20</b>)</h4><div class="NLM_p last">To a solution of ethyl 4-((2-ethoxy-2-oxoethyl)((<i>S</i>)-1-phenylethyl)amino)pentanoate (44.5 g, 133 mmol) in toluene (500 mL) was added KO<i>t</i>Bu (37.2 g, 332 mmol). After stirring for 3 h at room temperature, the mixture was then partitioned between DCM and saturated aqueous NH<sub>4</sub>Cl. The organic layer was removed, and the aqueous layer was extracted further with DCM (2×). The combined organic layers were then dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and then concentrated under reduced pressure. The crude residue was purified via FCC (2.5% EtOAc/heptane) to give both of the title diastereomers (<b>19</b>, 20.6 g, 54%; <b>20</b>, 7.5 g, 19%). Analytical data for <b>19</b>: MS (ESI) <i>m</i>/<i>z</i> 290.2 (M + 1); <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 11.81 (s, 1 H), 7.18–7.37 (m, 5 H), 4.16–4.27 (m, 2 H), 3.70 (q, <i>J</i> = 6.6 Hz, 1 H), 3.27–3.38 (m, 1 H), 2.82–3.13 (m, 2 H), 2.53 (dd, <i>J</i> = 15.5, 5.2 Hz, 1 H), 2.10 (dd, <i>J</i> = 15.5, 3.7 Hz, 1 H), 1.33 (d, <i>J</i> = 6.6 Hz, 3 H), 1.30 (t, <i>J</i> = 7.1 Hz, 3 H), 1.05 (d, <i>J</i> = 6.6 Hz, 3 H). Analytical data for <b>20</b>: MS (ESI) <i>m</i>/<i>z</i> 290.2 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.94 (s, 1 H), 7.19–7.36 (m, 5 H), 4.13–4.29 (m, 2 H), 3.63 (q, <i>J</i> = 6.6 Hz, 1 H), 3.09–3.52 (m, 2 H), 2.94–3.05 (m, 1 H), 2.34–2.47 (m, 1 H), 1.94 (d, <i>J</i> = 15.4 Hz, 1 H), 1.34 (d, <i>J</i> = 6.6 Hz, 3 H), 1.28 (t, <i>J</i> = 7.2 Hz, 3 H), 0.90 (d, <i>J</i> = 6.8 Hz, 3 H).</div></div><div id="sec6_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<i>S</i>)-<i>tert</i>-Butyl 4-Chloro-6-methyl-5,6-dihydropyrido[3,4-<i>d</i>]pyrimidine-7(8<i>H</i>)-carboxylate (<b>21</b>)</h4><div class="NLM_p">A combination of (2<i>S</i>)-ethyl 2-methyl-5-oxo-1-((<i>S</i>)-1-phenylethyl)piperidine-4-carboxylate <b>19</b> (20.6 g, 71.2 mmol), formamidine acetate (11.1 g, 107 mmol), and EtOH (250 mL) was treated with NaOEt solution (57.7 g, 178 mmol, 21% w/w EtOH solution) and then heated at 90 °C for 4 h. At that point, the solvent was removed under reduced pressure, and the residue was taken up in DCM and washed with sat aq NH<sub>4</sub>Cl. The aqueous layer was further extracted with DCM, and the combined organic layers were then dried over sodium sulfate, filtered, and concentrated to give (<i>S</i>)-6-methyl-7-((<i>S</i>)-1-phenylethyl)-5,6,7,8-tetrahydropyrido[3,4-<i>d</i>]pyrimidin-4(3<i>H</i>)-one, which was taken to the next step without further purification. MS (ESI) <i>m</i>/<i>z</i> 270.1 (M + 1).</div><div class="NLM_p">To a mixture of (<i>S</i>)-6-methyl-7-((<i>S</i>)-1-phenylethyl)-5,6,7,8-tetrahydropyrido[3,4-<i>d</i>]pyrimidin-4(3<i>H</i>)-one (20.0 g, 74.3 mmol), ammonium formate (23.4 g, 371 mmol) and BOC-anhydride (48.6 g, 223 mmol), in EtOH (300 mL), was added 20% Pd(OH)<sub>2</sub>/C (7.82 g, 50% wet), and the reaction was heated at reflux for 1 h. The mixture was then filtered through a Celite pad, and the filterate was concentrated. The residue was purified via FCC (0–5% MeOH/DCM) to give (<i>S</i>)-<i>tert</i>-butyl 6-methyl-4-oxo-3,4,5,6-tetrahydropyrido[3,4-<i>d</i>]pyrimidine-7(8<i>H</i>)-carboxylate (15.7 g, 80%). MS (ESI) <i>m</i>/<i>z</i> 266.1 (M + H); <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 12.70 (s, 1H), 8.09 (s, 1H), 4.85–4.65 (m, 2H), 4.03 (d, <i>J</i> = 19.8 Hz, 1H), 2.70 (dd, <i>J</i> = 17.2, 6.0 Hz, 1H), 2.59 (d, <i>J</i> = 17.2 Hz, 1H), 1.49 (s, 9H), 1.10 (d, <i>J</i> = 6.9 Hz, 3H).</div><div class="NLM_p last">A solution of (<i>S</i>)-<i>tert</i>-butyl 6-methyl-4-oxo-3,4,5,6-tetrahydropyrido[3,4-<i>d</i>]pyrimidine-7(8<i>H</i>)-carboxylate, (15.1 g, 57.1 mmol), triphenylphosphine (29.9 g, 114 mmol), and carbon tetrachloride (16.5 mL, 171 mmol) in 1,2-DCE (300 mL) was heated at 70 °C for 3 h. At that time, the solution was concentrated <i>in vacuo</i>, and the residue was separated via FCC (5–60% EtOAc/heptane) to give (<i>S</i>)-<i>tert</i>-Butyl 4-chloro-6-methyl-5,6-dihydropyrido[3,4-<i>d</i>]pyrimidine-7(8<i>H</i>)-carboxylate (<b>21</b>) (8.22 g, 51%). MS (ESI) <i>m</i>/<i>z</i> 284.1 (M + H). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.78 (s, 1H), 4.96 (d, <i>J</i> = 19.7 Hz, 1H), 4.84 (s, 1H), 4.25 (d, <i>J</i> = 19.7 Hz, 1H), 2.99 (dd, <i>J</i> = 17.1, 5.9 Hz, 1H), 2.74 (d, <i>J</i> = 17.1 Hz, 1H), 1.48 (s, 9H), 1.11 (d, <i>J</i> = 7.0 Hz, 3H).</div></div><div id="sec6_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>R</i>)-<i>tert</i>-Butyl 4-Chloro-6-methyl-5,6-dihydropyrido[3,4-<i>d</i>]pyrimidine-7(8<i>H</i>)-carboxylate (<b>22</b>)</h4><div class="NLM_p last">Prepared as described for <b>21</b>. MS (ESI) <i>m</i>/<i>z</i> 284.0 (M + H); <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.81 (s, 1 H) 4.99 (d, <i>J</i> = 19.70 Hz, 1 H) 4.86 (br. s., 1 H) 4.27 (d, <i>J</i> = 19.96 Hz, 1 H) 3.01 (dd, <i>J</i> = 17.18, 6.06 Hz, 1 H) 2.76 (d, <i>J</i> = 17.18 Hz, 1 H) 1.41–1.56 (m, 9 H) 1.13 (d, <i>J</i> = 6.82 Hz, 3 H).</div></div><div id="sec6_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 4-Oxo-3,4,5,7-tetrahydro-pyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid <i>tert</i>-Butyl Ester (<b>24</b>)</h4><div class="NLM_p last">To a solution of 4-oxo-pyrrolidine-1,3-dicarboxylic acid 1-<i>tert</i>-butyl ester 3-ethyl ester (46 g, 179 mmol) in EtOH (1.5 L), formamidine hydrochloride (112 g, 1073 mmol) was added, followed by NaOEt (203 g, 626 mmol). The reaction was heated at 90 °C for 2 h. The reaction mixture was then evaporated, and a saturated solution of ammonium chloride (300 mL) was added followed by DCM (1 L). The layers were separated, and the aqueous layer was extracted further with DCM. The organics were combined, dried, and evaporated to give the crude product. The title compound was purified using silica gel FCC (gradient elution 100% DCM to 94% DCM/6% MeOH) (10 g, 24% yield). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i>) δ 8.18 (s, 1 H) 4.47–4.54 (m, 4 H) 1.45–1.56 (m, 8 H) 1.41 (s, 1 H) MS (ESI) <i>m</i>/<i>z</i> 238.2 (M + 1).</div></div><div id="sec6_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 5-Methyl-4-oxo-3,4,5,7-tetrahydro-pyrrolo[3,4<i>-d</i>]pyrimidine-6-carboxylic Acid <i>tert</i>-Butyl Ester (<b>28</b>)</h4><div class="NLM_p last">To a suspension of NaH (9.72 g, 243 mmol, 60% in mineral oil) in toluene (100 mL), ethyl 2-(<i>tert</i>-butoxycarbonylamino)acetate (38 g, 187 mmol) was added at 0 °C. The reaction was stirred for 5 h at the same temperature. At that point, ethyl but-2-enoate (25.6 g, 224 mmol) was added, and the reaction allowed to warm up to rt and stirred for a further 2 h. Ethanol (30 mL) was added, and the reaction was then evaporated. The crude 1-<i>tert</i>-butyl 3-ethyl 2-methyl-4-oxopyrrolidine-1,3<i>-</i>dicarboxylate was dissolved in EtOH (1500 mL), then formamidine acetate (343 g, 119 mmol) was added followed by sodium ethoxide (47.2 g, 694 mmol). The reaction was left stirring at 90 °C for 8 h. The solvent was then removed, and to the crude material, a saturated solution of NH<sub>4</sub>Cl (200 mL) was added followed by DCM (1 L). The water layer was extracted two times with DCM. The organics were dried and evaporated. The crude product was separated by FCC (DCM/MeOH 100:0 to 90:10) to give the title compound (10 g, 21%). MS (ESI) <i>m</i>/<i>z</i> 252.2 (M + 1); <sup>1</sup>H NMR (400 MHz, MeOD) δ 8.17 (s, 1 H) 4.85–4.92 (m, 1 H) 4.40–4.52 (m, 1 H) 4.02–4.19 (m, 1 H) 1.49–1.51 (m, 12 H).</div></div><div id="sec6_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 4-(1<i>H</i>-Indol-5-yloxy)-5,7-dihydro-pyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid <i>tert</i>-Butyl Ester (<b>30a</b>)</h4><div class="NLM_p last">To a solution of 4-oxo-3,4,5,7-tetrahydro-pyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic acid <i>tert</i>-butyl ester (74 mg, 0.31 mmol) in acetonitrile (3 mL), BOP (179 mg, 0.405 mmol) was added followed by DBU (0.094 mL, 0.624 mmol). After 20 min, 5-hydroxyindole (83 mg, 0.624 mmol) was added. The reaction was left stirring at rt for 3 h. The reaction mixture was evaporated, and the crude product was purified using silica gel FCC (gradient elution: 100% heptane to 60% heptane/40% ethyl acetate) to give the title compound <b>30a</b> (70 mg, 64% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.22 (br. s., 1 H) 8.62 (d, <i>J</i> = 4.04 Hz, 1 H) 7.41–7.44 (m, 2 H) 7.35 (d, <i>J</i> = 2.27 Hz, 1 H) 6.92 (d, <i>J</i> = 8.84 Hz, 1 H) 6.44 (t, <i>J</i> = 2.15 Hz, 1 H) 4.56–4.61 (m, 3 H) 4.51 (br. s., 1 H) 1.44–1.51 (m, 9 H) MS (ESI) <i>m</i>/<i>z</i> 353.1 (M + 1).</div></div><div id="sec6_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>S</i>)-4-(1<i>H-</i>Indol-5-yloxy)-6-methyl-5,8-dihydro-6<i>H-</i>pyrido[3,4<i>-d</i>]pyrimidine-7-carboxylic Acid <i>tert</i>-Butyl Ester (<b>30b</b>)</h4><div class="NLM_p last">DBU (2.34 mL, 15.5 mmol) was added to a solution of 5-hydroxyindole (2.17 g, 16.3 mmol) and (<i>S</i>)-<i>tert</i>-Butyl 4-chloro-6-methyl-5,6-dihydropyrido[3,4-<i>d</i>]pyrimidine-7(8<i>H</i>)-carboxylate (<b>21</b>) (2.20 g, 7.75 mmol) in acetonitrile (50 mL) under an argon atmosphere. The reaction was heated at 80 °C for 2.5 h. At that time, the solution was allowed to cool to rt, and the excess solvent was evaporated. The residue was then separated via flash chromatography (30–100% EtOAc) to give the title compound <b>30b</b> (2.66 g, 90%). MS (ESI) <i>m</i>/<i>z</i> 381.3 (M + 1); <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.53 (s, 1H), 8.22 (s, 1H), 7.43 (d, <i>J</i> = 8.7 Hz, 1H), 7.39 (d, <i>J</i> = 2.2 Hz, 1H), 6.97 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H), 6.56 (t, <i>J</i> = 2.3 Hz, 1H), 4.95 (d, <i>J</i> = 18.5 Hz, 1H), 4.91–4.82 (m, 1H), 4.24 (d, <i>J</i> = 19.1 Hz, 1H), 3.02 (dd, <i>J</i> = 16.9, 6.4 Hz, 1H), 2.85 (d, <i>J</i> = 16.9 Hz, 1H), 1.51 (s, 9H), 1.20 (d, <i>J</i> = 6.9 Hz, 3H).</div></div><div id="sec6_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 3-(1-Methyl-cyclopropyl)-5-phenoxycarbonylamino-pyrazole-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>32a</b>)</h4><div class="NLM_p last">To a solution of 5-amino-3-(1-methyl-cyclopropyl)-pyrazole-1-carboxylic acid <i>tert</i>-butyl ester<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (3.90 g, 16.4 mmol) and phenyl chloroformate (3.11 mL, 24.6 mmol) in DCM (150 mL) was added 2,6-lutidine (5.74 mL, 49.3 mmol). After 18 h, the solution was diluted with DCM (100 mL) and washed with 1 M HCl (250 mL). The organic layer was then dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated to provide the title compound (5.07 g, 86% yield). MS (ESI) <i>m</i>/<i>z</i> 358.0 (M + 1); <sup>1</sup>H NMR (400 MHz, dichloromethane-<i>d</i><sub>2</sub>) δ 9.76 (br. s., 1 H) 7.38–7.45 (m, 2 H) 7.24–7.30 (m, 1 H) 7.16–7.22 (m, 2 H) 6.33 (s, 1 H) 1.57–1.74 (m, 9 H) 1.42 (s, 3 H) 0.89–1.06 (m, 2 H) 0.56–0.84 (m, 2 H).</div></div><div id="sec6_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 5-((<i>S</i>)-6-Methyl-5,6,7,8-tetrahydro-pyrido[3,4<i>-d</i>]pyrimidin-4-yloxy)-indole-1-carboxylic Acid [5-(1-Methyl-cyclopropyl)-2<i>H-</i>pyrazol-3-yl]-amide (<b>33n</b>)</h4><div class="NLM_p">Sodium hydride (2.27 g, 56.8 mmol; 60% in oil) was added to a solution of (<i>S</i>)-4-(1<i>H-</i>indol-5-yloxy)-6-methyl-5,8<i>-d</i>ihydro-6<i>H-</i>pyrido[3,4<i>-d</i>]pyrimidine-7-carboxylic acid <i>tert</i>-butyl ester (7.20 g, 18.9 mmol) and 3-(1-methyl-cyclopropyl)-5-phenoxycarbonylamino-pyrazole-1-carboxylic acid <i>tert</i>-butyl ester (8.12 g, 22.7 mmol) in THF (250 mL) at 0 °C under argon. After 2 h, the reaction was quenched by slow addition to a stirred solution of saturated aqueous NH<sub>4</sub>Cl (1 L), the resulting slurry was then extracted with DCM (3 × 700 mL), and the combined organic layers were dried over sodium sulfate, filtered, and concentrated. The residue was separated directly via FCC (20–50% EtOAc/heptane) to give (<i>S</i>)-4-{1-[2-<i>tert</i>-butoxycarbonyl-5-(1-methyl-cyclopropyl)-2<i>H-</i>pyrazol-3-ylcarbamoyl]-1<i>H-</i>indol-5-yloxy}-6-methyl-5,8<i>-d</i>ihydro-6<i>H-</i>pyrido[3,4<i>-d</i>]pyrimidine-7-carboxylic acid <i>tert</i>-butyl ester (6.10 g, 50%). MS (ESI) <i>m</i>/<i>z</i> 644.2 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.38 (s, 1H), 8.50 (s, 1H), 8.26 (d, <i>J</i> = 9.0 Hz, 1H), 7.92 (d, <i>J</i> = 3.7 Hz, 1H), 7.49 (d, <i>J</i> = 2.4 Hz, 1H), 7.16 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 6.82 (d, <i>J</i> = 3.7 Hz, 1H), 6.37 (s, 1H), 4.79–4.66 (m, 2H), 4.22 (d, <i>J</i> = 20.4 Hz, 1H), 2.95 (dd, <i>J</i> = 17.1, 6.7 Hz, 1H), 2.79 (d, <i>J</i> = 16.8 Hz, 1H), 1.46 (s, 9H), 1.45 (s, 9H), 1.41 (s, 3H), 1.12 (d, <i>J</i> = 6.9 Hz, 3H), 0.96 (q, <i>J</i> = 4.0 Hz, 2H), 0.82–0.77 (m, 2H).</div><div class="NLM_p last">A solution of (<i>S</i>)-4-{1-[2-<i>tert</i>-butoxycarbonyl-5-(1-methyl-cyclopropyl)-2<i>H-</i>pyrazol-3-ylcarbamoyl]-1<i>H-</i>indol-5-yloxy}-6-methyl-5,8<i>-d</i>ihydro-6<i>H-</i>pyrido[3,4<i>-d</i>]pyrimidine-7-carboxylic acid <i>tert</i>-butyl ester (6.10 g, 9.48 mmol) in DCM (50 mL) was cooled to 0 °C, and TFA (15 mL) was added slowly. After 20 min, the ice bath was removed and the contents allowed to reach room temperature. After 2 h at that temperature, the solvent was removed under reduced pressure. The residue was taken up in water (250 mL) and acetonitrile (25 mL) and stirred. Aqueous NH<sub>4</sub>OH (28%) was then added until pH 9. The slurry was stirred for 15 min before the solid was collected and filtered. The solid was slurried a second time in dilute aqueous NH<sub>4</sub>OH and the solid collected by filtration. The solid was then dried to give the title compound <b>33n</b> (3.87 g, 92%). MS (ESI) <i>m</i>/<i>z</i> 444.1 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.13 (br. S., 1 H), 10.55 (s, 1 H), 8.40 (s, 1 H), 8.29 (d, <i>J</i> = 8.8 Hz, 1 H), 8.16 (d, <i>J</i> = 3.5 Hz, 1 H), 7.40 (d, <i>J</i> = 2.3 Hz, 1 H), 7.08 (dd, <i>J</i> = 9.1, 2.3 Hz, 1 H), 6.70 (d, <i>J</i> = 3.8 Hz, 1 H), 6.30 (s, 1 H), 3.76–3.98 (m, 2 H), 2.92–3.05 (m, 1 H), 2.85 (dd, <i>J</i> = 16.5, 3.4 Hz, 1 H), 2.27–2.40 (m, 1 H), 1.41 (s, 3 H), 1.22 (d, <i>J</i> = 6.3 Hz, 3 H), 0.89–0.97 (m, 2 H), 0.73–0.82 (m, 2 H).</div></div><div id="sec6_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 5-(6-Hydroxymethyl-pyrimidin-4-yloxy)-indole-1-carboxylic Acid (3-Trifluoromethyl-phenyl)-amide (<b>5a</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 429.1 (M + 1); <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.61 (d, <i>J</i> = 1.01 Hz, 1 H), 8.37 (d, <i>J</i> = 8.84 Hz, 1 H), 8.07 (s, 1 H), 7.96 (d, <i>J</i> = 3.79 Hz, 1 H), 7.90 (dd, <i>J</i> = 7.96, 1.39 Hz, 1 H), 7.58 (t, <i>J</i> = 7.96 Hz, 1 H), 7.45 (s, 1 H), 7.43 (d, <i>J</i> = 2.27 Hz, 1 H), 7.13 (dd, <i>J</i> = 8.97, 2.40 Hz, 1 H), 7.08 (d, <i>J</i> = 1.01 Hz, 1 H), 6.76 (d, <i>J</i> = 3.79 Hz, 1 H), 4.63 (s, 2 H).</div></div><div id="sec6_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 5-((6-((Methylamino)methyl)pyrimidin-4-yl)oxy)-<i>N</i>-(3-(trifluoromethyl)phenyl)-1<i>H</i>-indole-1-carboxamide (<b>6a</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 442.1 (M + 1); <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.64 (s, 1 H), 8.34 (d, <i>J</i> = 9.09 Hz, 1 H), 8.05 (s, 1 H), 7.93 (d, <i>J</i> = 3.79 Hz, 1 H), 7.89 (d, <i>J</i> = 8.08 Hz, 1 H), 7.56 (t, <i>J</i> = 7.96 Hz, 1 H), 7.40–7.46 (m, 2 H), 7.10 (dd, <i>J</i> = 8.97, 2.40 Hz, 1 H), 6.99 (s, 1 H), 6.73 (d, <i>J</i> = 3.79 Hz, 1 H), 3.77 (s, 2 H), 2.40 (s, 3 H).</div></div><div id="sec6_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>-(4-Fluoro-3-(trifluoromethyl)phenyl)-5-((6-((methylamino)methyl)pyrimidin-4-yl)oxy)-1<i>H</i>-indole-1-carboxamide (<b>6b</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 460.1 (M + 1); <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.65 (d, <i>J</i> = 1.01 Hz, 1 H), 8.35 (d, <i>J</i> = 8.84 Hz, 1 H), 8.04 (dd, <i>J</i> = 6.19, 2.65 Hz, 1 H), 7.90–7.94 (m, 2 H), 7.41 (d, <i>J</i> = 2.27 Hz, 1 H), 7.35 (t, <i>J</i> = 9.60 Hz, 1 H), 7.11 (dd, <i>J</i> = 8.97, 2.40 Hz, 1 H), 7.00 (s, 1 H), 6.74 (d, <i>J</i> = 3.79 Hz, 1 H), 3.82 (s, 2 H), 2.43 (s, 3 H).</div></div><div id="sec6_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 5-((5,6,7,8-Tetrahydropyrido[3,4-<i>d</i>]pyrimidin-4-yl)oxy)-<i>N</i>-(3-(trifluoromethyl)phenyl)-1<i>H</i>-indole-1-carboxamide (<b>33a</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 454.0 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.43 (s, 1 H), 8.54 (s, 1 H), 8.30 (d, <i>J</i> = 8.8 Hz, 1 H), 8.15 (d, <i>J</i> = 3.5 Hz, 1 H), 8.11 (s, 1 H), 7.98 (d, <i>J</i> = 8.3 Hz, 1 H), 7.65 (t, <i>J</i> = 8.0 Hz, 1 H), 7.44–7.53 (m, 2 H), 7.14 (dd, <i>J</i> = 9.0, 2.4 Hz, 1 H), 6.81 (d, <i>J</i> = 3.8 Hz, 1 H), 4.26 (s, 2 H), 3.45 (t, <i>J</i> = 5.9 Hz, 2 H), 3.00 (t, <i>J</i> = 5.8 Hz, 2 H).</div></div><div id="sec6_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 5-((5,6,7,8-Tetrahydropyrido[4,3-<i>d</i>]pyrimidin-4-yl)oxy)-<i>N</i>-(3-(trifluoromethyl)phenyl)-1<i>H</i>-indole-1-carboxamide (<b>33b</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 454.0 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.38 (s, 1 H), 8.46 (s, 1 H), 8.27 (d, <i>J</i> = 9.1 Hz, 1 H), 8.12 (d, <i>J</i> = 3.8 Hz, 1 H), 8.10 (s, 1 H), 7.97 (d, <i>J</i> = 8.1 Hz, 1 H), 7.65 (t, <i>J</i> = 8.0 Hz, 1 H), 7.50 (d, <i>J</i> = 7.3 Hz, 1 H), 7.46 (s, 1 H), 7.12 (dd, <i>J</i> = 9.0, 2.4 Hz, 1 H), 6.80 (d, <i>J</i> = 3.5 Hz, 1 H), 3.92–4.09 (m, 2 H), 3.17 (t, <i>J</i> = 5.7 Hz, 2 H), 2.81 (t, <i>J</i> = 5.7 Hz, 2 H).</div></div><div id="sec6_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>S</i>)<i>-</i>5-((6-Methyl-5,6,7,8-tetrahydropyrido[3,4-<i>d</i>]pyrimidin-4-yl)oxy)-<i>N</i>-(3-(trifluoromethyl)phenyl)-1<i>H</i>-indole-1-carboxamide (<b>33c</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 468.2 (M + 1); <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.37 (s, 1 H) 8.32 (d, <i>J</i> = 8.84 Hz, 1 H) 8.05 (s, 1 H) 7.92 (d, <i>J</i> = 3.79 Hz, 1 H) 7.89 (d, <i>J</i> = 8.59 Hz, 1 H) 7.56 (t, <i>J</i> = 7.96 Hz, 1 H) 7.44 (d, <i>J</i> = 7.83 Hz, 1 H) 7.39 (d, <i>J</i> = 2.27 Hz, 1 H) 7.09 (dd, <i>J</i> = 8.97, 2.40 Hz, 1 H) 6.73 (d, <i>J</i> = 3.79 Hz, 1 H) 3.89–4.09 (m, 2 H) 3.05–3.16 (m, 1 H) 2.99 (dd, <i>J</i> = 17.18, 3.79 Hz, 1 H) 2.47 (dd, <i>J</i> = 17.18, 10.36 Hz, 1 H) 1.34 (d, <i>J</i> = 6.57 Hz, 3 H).</div></div><div id="sec6_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>R</i>)<i>-</i>5-((6-Methyl-5,6,7,8-tetrahydropyrido[3,4-<i>d</i>]pyrimidin-4-yl)oxy)-<i>N</i>-(3-(trifluoromethyl)phenyl)-1<i>H</i>-indole-1-carboxamide (<b>33d</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 468.2 (M + 1); <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.37 (s, 1 H) 8.32 (d, <i>J</i> = 8.84 Hz, 1 H) 8.05 (s, 1 H) 7.92 (d, <i>J</i> = 3.79 Hz, 1 H) 7.89 (d, <i>J</i> = 8.59 Hz, 1 H) 7.56 (t, <i>J</i> = 7.96 Hz, 1 H) 7.44 (d, <i>J</i> = 7.83 Hz, 1 H) 7.39 (d, <i>J</i> = 2.27 Hz, 1 H) 7.09 (dd, <i>J</i> = 8.97, 2.40 Hz, 1 H) 6.73 (d, <i>J</i> = 3.79 Hz, 1 H) 3.89–4.09 (m, 2 H) 3.05–3.16 (m, 1 H) 2.99 (dd, <i>J</i> = 17.18, 3.79 Hz, 1 H) 2.47 (dd, <i>J</i> = 17.18, 10.36 Hz, 1 H) 1.34 (d, <i>J</i> = 6.57 Hz, 3 H).</div></div><div id="sec6_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 5-((7-Acetyl-5,6,7,8-tetrahydropyrido[3,4-<i>d</i>]pyrimidin-4-yl)oxy)-<i>N</i>-(3-(trifluoromethyl)phenyl)-1<i>H</i>-indole-1-carboxamide (<b>33e</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 496.0 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.38 (s, 1 H), 8.45–8.53 (m, 1 H), 8.27 (d, <i>J</i> = 9.1 Hz, 1 H), 8.12 (d, <i>J</i> = 3.8 Hz, 1 H), 8.10 (s, 1 H), 7.97 (d, <i>J</i> = 8.8 Hz, 1 H), 7.65 (t, <i>J</i> = 8.1 Hz, 1 H), 7.50 (d, <i>J</i> = 7.8 Hz, 1 H), 7.47 (d, <i>J</i> = 2.3 Hz, 1 H), 7.14 (dd, <i>J</i> = 9.0, 2.4 Hz, 1 H), 6.80 (d, <i>J</i> = 3.5 Hz, 1 H), 4.63 (s, 2 H), 3.81 (t, <i>J</i> = 5.9 Hz, 2 H), 2.93 (t, <i>J</i> = 5.7 Hz, 2 H), 2.16 (s, 3 H).</div></div><div id="sec6_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 5-((7-Ethyl-5,6,7,8-tetrahydropyrido[3,4-<i>d</i>]pyrimidin-4-yl)oxy)-<i>N</i>-(3-(trifluoromethyl)phenyl)-1<i>H</i>-indole-1-carboxamide (<b>33f</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 482.2 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.38 (br. S., 1 H), 8.42 (s, 1 H), 8.28 (d, <i>J</i> = 9.1 Hz, 1 H), 8.11 (d, <i>J</i> = 3.8 Hz, 1 H), 8.10 (s, 1 H), 7.96 (d, <i>J</i> = 9.1 Hz, 1 H), 7.63 (t, <i>J</i> = 8.0 Hz, 1 H), 7.48 (d, <i>J</i> = 7.8 Hz, 1 H), 7.46 (d, <i>J</i> = 2.5 Hz, 1 H), 7.13 (dd, <i>J</i> = 9.0, 2.4 Hz, 1 H), 6.78 (d, <i>J</i> = 3.8 Hz, 1 H), 3.57 (s, 2 H), 2.74–2.87 (m, 4 H), 2.59 (q, <i>J</i> = 7.2 Hz, 2 H), 1.12 (t, <i>J</i> = 7.2 Hz, 3 H).</div></div><div id="sec6_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 5-((6,7-Dihydro-5<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-4-yl)oxy)-<i>N</i>-(3-(trifluoromethyl)phenyl)-1<i>H</i>-indole-1-carboxamide (<b>33g</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 440.9 (M + 1); <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.55 (s, 1 H) 8.33 (d, <i>J</i> = 8.84 Hz, 1 H) 8.06 (br. S., 1 H) 7.89 (d, <i>J</i> = 8.34 Hz, 1 H) 7.94 (d, <i>J</i> = 3.54 Hz, 1 H) 7.57 (t, <i>J</i> = 7.96 Hz, 1 H) 7.41–7.46 (m, 2 H) 7.13 (dd, <i>J</i> = 9.09, 2.27 Hz, 1 H) 6.74 (d, <i>J</i> = 3.03 Hz, 1 H) 4.26 (d, <i>J</i> = 12.13 Hz, 4 H).</div></div><div id="sec6_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (<i>S</i>)-5-(5-Methyl-6,7<i>-d</i>ihydro-5<i>H-</i>pyrrolo[3,4<i>-d</i>]pyrimidin-4-yloxy)-indole-1-carboxylic Acid (3-trifluoromethyl-phenyl)-amide (<b>33h</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 454.9 (M + 1); <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.47 (d, <i>J</i> = 1.77 Hz, 1 H) 8.28 (dd, <i>J</i> = 9.09, 1.77 Hz, 1 H) 8.02 (s, 1 H) 7.85 (dd, <i>J</i> = 3.66, 2.40 Hz, 2 H) 7.49 (t, <i>J</i> = 7.83 Hz, 1 H) 7.36 (d, <i>J</i> = 2.02 Hz, 1 H) 7.38 (d, <i>J</i> = 8.59 Hz, 1 H) 7.06 (dd, <i>J</i> = 8.84, 2.27 Hz, 1 H) 6.65 (d, <i>J</i> = 2.53 Hz, 1 H) 4.63 (d, <i>J</i> = 6.06 Hz, 1 H) 4.15–4.23 (m, 1 H) 4.05–4.12 (m, 1 H) 1.55 (d, <i>J</i> = 6.57 Hz, 3 H).</div></div><div id="sec6_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (<i>R</i>)-5-(5-Methyl-6,7<i>-d</i>ihydro-5<i>H-</i>pyrrolo[3,4<i>-d</i>]pyrimidin-4-yloxy)-indole-1-carboxylic Acid (3-trifluoromethyl-phenyl)-amide (<b>33i</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 454.9 (M + 1); <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.48 (s, 1 H) 8.30 (d, <i>J</i> = 9.09 Hz, 1 H) 8.03 (s, 1 H) 7.87 (d, <i>J</i> = 3.54 Hz, 2 H) 7.52 (t, <i>J</i> = 8.08 Hz, 1 H) 7.38 (d, <i>J</i> = 2.27 Hz, 2 H) 7.07 (dd, <i>J</i> = 8.84, 2.27 Hz, 1 H) 6.67 (d, <i>J</i> = 3.79 Hz, 1 H) 4.66 (q, <i>J</i> = 6.57 Hz, 1 H) 4.12–4.22 (m, 2 H) 1.56 (d, <i>J</i> = 6.57 Hz, 3 H).</div></div><div id="sec6_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 5-(5,6,7,8-Tetrahydro-pyrido[3,4<i>-d</i>]pyrimidin-4-yloxy)-indole-1-carboxylic Acid (5-Methyl-pyridin-3-yl)-amide (<b>33j</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 401.1 (M + 1); <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 8.64 (d, <i>J</i> = 2.0 Hz, 1 H), 8.37 (s, 1 H), 8.33 (d, <i>J</i> = 8.8 Hz, 1 H), 8.18 (d, <i>J</i> = 1.0 Hz, 1 H), 8.03 (s, 1 H), 7.92 (d, <i>J</i> = 3.5 Hz, 1 H), 7.40 (d, <i>J</i> = 2.3 Hz, 1 H), 7.10 (dd, <i>J</i> = 9.1, 2.3 Hz, 1 H), 6.74 (d, <i>J</i> = 3.0 Hz, 1 H), 3.95 (s, 2 H), 3.18 (t, <i>J</i> = 5.9 Hz, 2 H), 2.88 (t, <i>J</i> = 5.8 Hz, 2 H), 2.41 (s, 3 H).</div></div><div id="sec6_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 5-(5,6,7,8-Tetrahydro-pyrido[3,4<i>-d</i>]pyrimidin-4-yloxy)-indole-1-carboxylic Acid (5-Isopropyl-1<i>H-</i>pyrazol-3-yl)-amide (<b>33k</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 418.2 (M + 1); <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.21 (br. S., 1 H), 10.56 (s, 1 H), 8.39 (s, 1 H), 8.29 (d, <i>J</i> = 9.1 Hz, 1 H), 8.16 (d, <i>J</i> = 3.5 Hz, 1 H), 7.41 (d, <i>J</i> = 2.3 Hz, 1 H), 7.08 (dd, <i>J</i> = 9.1, 2.3 Hz, 1 H), 6.70 (d, <i>J</i> = 3.5 Hz, 1 H), 6.34 (s, 1 H), 3.81 (s, 2 H), 2.87–3.07 (m, 3 H), 2.72 (t, <i>J</i> = 5.6 Hz, 2 H), 1.25 (d, <i>J</i> = 6.8 Hz, 6 H).</div></div><div id="sec6_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 5-(5,6,7,8-Tetrahydro-pyrido[3,4<i>-d</i>]pyrimidin-4-yloxy)-indole-1-carboxylic Acid (5-<i>tert</i>-Butyl-2<i>H-</i>pyrazol-3-yl)-amide (<b>33l</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 432.1 (M + 1); <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 8.37 (s, 1 H), 8.32 (d, <i>J</i> = 8.8 Hz, 1 H), 7.88 (d, <i>J</i> = 3.5 Hz, 1 H), 7.38 (d, <i>J</i> = 2.3 Hz, 1 H), 7.08 (dd, <i>J</i> = 9.1, 2.3 Hz, 1 H), 6.71 (d, <i>J</i> = 3.8 Hz, 1 H), 6.37 (s, 1 H), 3.96 (s, 2 H), 3.19 (t, <i>J</i> = 5.9 Hz, 2 H), 2.89 (t, <i>J</i> = 5.7 Hz, 2 H), 1.36 (s, 9 H).</div></div><div id="sec6_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 5-(5,6,7,8-Tetrahydro-pyrido[3,4<i>-d</i>]pyrimidin-4-yloxy)-indole-1-carboxylic Acid [5-(1-Methyl-cyclopropyl)-2<i>H-</i>pyrazol-3-yl]-amide (<b>33m</b>)</h4><div class="NLM_p last">HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>23</sub>N<sub>7</sub>O<sub>2</sub> (M + 1) 430.1993, found 430.1992; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.13 (br. S., 1 H), 10.55 (s, 1 H), 8.40 (s, 1 H), 8.29 (d, <i>J</i> = 8.8 Hz, 1 H), 8.16 (d, <i>J</i> = 3.8 Hz, 1 H), 7.41 (d, <i>J</i> = 2.3 Hz, 1 H), 7.08 (dd, <i>J</i> = 9.0, 2.4 Hz, 1 H), 6.70 (d, <i>J</i> = 3.5 Hz, 1 H), 6.29 (s, 1 H), 3.84 (s, 2 H), 3.05 (t, <i>J</i> = 5.8 Hz, 2 H), 2.69–2.78 (m, 2 H), 1.41 (s, 3 H), 1.25 (br. S., 2 H), 0.89–0.97 (m, 2 H); <sup>13</sup>C NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 166.9, 165.7, 154.3, 149.1, 148.7, 147.5, 146.5, 132.9, 130.2, 126.4, 118.0, 115.7, 115.4, 113.2, 106.2, 93.8, 49.4, 41.9, 22.6, 22.0, 15.6, 12.6.</div></div><div id="sec6_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 5-((<i>S</i>)-6-Methyl-5,6,7,8-tetrahydro-pyrido[3,4<i>-d</i>]pyrimidin-4-yloxy)-indole-1-carboxylic Acid [5-(1-Methyl-cyclopropyl)-2<i>H-</i>pyrazol-3-yl]-amide (<b>33n</b>)</h4><div class="NLM_p last">HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>24</sub>H<sub>25</sub>N<sub>7</sub>O<sub>2</sub> (M + 1) 444.2149, found 444.2143; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.13 (br. S., 1 H), 10.55 (s, 1 H), 8.40 (s, 1 H), 8.29 (d, <i>J</i> = 8.8 Hz, 1 H), 8.16 (d, <i>J</i> = 3.5 Hz, 1 H), 7.40 (d, <i>J</i> = 2.3 Hz, 1 H), 7.08 (dd, <i>J</i> = 9.1, 2.3 Hz, 1 H), 6.70 (d, <i>J</i> = 3.8 Hz, 1 H), 6.30 (s, 1 H), 3.76–3.98 (m, 2 H), 2.92–3.05 (m, 1 H), 2.85 (dd, <i>J</i> = 16.5, 3.4 Hz, 1 H), 2.27–2.40 (m, 1 H), 1.41 (s, 3 H), 1.22 (d, <i>J</i> = 6.3 Hz, 3 H), 0.89–0.97 (m, 2 H), 0.73–0.82 (m, 2 H); <sup>13</sup>C NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 166.8, 165.1, 154.4, 149.1, 148.7, 147.5, 146.5, 132.9, 130.2, 126.4, 118.0, 115.7, 115.1, 113.2, 106.3, 93.8, 49.4, 47.7, 29.6, 22.6, 21.5, 15.6, 12.6.</div></div><div id="sec6_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 5-(6,7-Dihydro-5<i>H-</i>pyrrolo[3,4 d]pyrimidin-4-yloxy)-indole-1-carboxylic Acid [5-(1-methyl-cyclopropyl)-2<i>H-</i>pyrazol-3-yl]-amide (<b>33o</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 416.2 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO<i>-</i>d<sub>6</sub>) δ 12.13 (s, 1H) 10.57 (s, 1 H) 8.55 (s, 1 H) 8.29 (d, <i>J</i> = 9.09 Hz, 1 H) 8.17 (d, <i>J</i> = 3.79 Hz, 1 H) 7.44 (d, <i>J</i> = 2.27 Hz, 1 H) 7.11 (dd, <i>J</i> = 9.09, 2.53 Hz, 1 H) 6.71 (d, <i>J</i> = 3.54 Hz, 1 H) 6.29 (s, 1 H) 4.09 (d, <i>J</i> = 12.63 Hz, 4 H) 1.41 (s, 3 H) 0.91–0.93 (m, 2 H) 0.74–0.78 (m, 2 H).</div></div><div id="sec6_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 5-(<i>R</i>)-6-Methyl-5,6,7,8-tetrahydro-pyrido[3,4<i>-d</i>]pyrimidin-4-yloxy)-indole-1-carboxylic Acid [5-(1-methyl-cyclopropyl)-2<i>H-</i>pyrazol-3-yl]-amide (<b>33p</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 444.1 (M + 1); <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.51 (s, 1 H), 8.34 (d, <i>J</i> = 9.0 Hz, 1 H), 7.90 (d, <i>J</i> = 3.8 Hz, 1 H), 7.41 (d, <i>J</i> = 2.1 Hz, 1 H), 7.10 (dd, <i>J</i> = 9.0, 2.3 Hz, 1 H), 6.72 (d, <i>J</i> = 3.7 Hz, 1 H), 6.28 (s, 1 H), 3.73–3.88 (m, 1 H), 2.86 (dd, <i>J</i> = 17.9, 10.7 Hz, 1 H), 1.59 (d, <i>J</i> = 6.4 Hz, 3 H), 1.46 (s, 3 H), 0.92–1.03 (m, 2 H), 0.75–0.88 (m, 2 H).</div></div><div id="sec6_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 5-(5,6,7,8-Tetrahydro-pyrido[3,4<i>-d</i>]pyrimidin-4-yloxy)-indole-1-carboxylic Acid (5-<i>tert</i>-Butyl-isoxazol-3-yl)-amide (<b>33q</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 432.9 (M + 1); <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.37 (s, 1 H) 8.33 (d, <i>J</i> = 8.84 Hz, 1 H) 7.88 (d, <i>J</i> = 3.79 Hz, 1 H) 7.38 (d, <i>J</i> = 2.02 Hz, 1 H) 7.10 (dd, <i>J</i> = 8.84, 2.27 Hz, 1 H) 6.72 (d, <i>J</i> = 3.79 Hz, 1 H) 6.65 (s, 1 H) 3.94 (s, 2 H) 3.17 (t, <i>J</i> = 5.94 Hz, 2 H) 2.87 (t, <i>J</i> = 5.68 Hz, 2 H) 1.38 (s, 9 H).</div></div><div id="sec6_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 5-((<i>S</i>)-6-Methyl-5,6,7,8-tetrahydro-pyrido[3,4<i>-d</i>]pyrimidin-4-yloxy)-indole-1-carboxylic Acid (5-<i>tert</i>-Butyl-isoxazol-3-yl)-amide (<b>33r</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 447.2 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.40 (s, 1 H) 8.29 (d, <i>J</i> = 9.09 Hz, 1 H) 8.15 (d, <i>J</i> = 3.28 Hz, 1 H) 7.43 (d, <i>J</i> = 1.26 Hz, 1 H) 7.11 (dd, <i>J</i> = 8.72, 1.39 Hz, 1 H) 6.75 (d, <i>J</i> = 3.03 Hz, 1 H) 6.68 (s, 1 H) 3.79–3.98 (m, 2 H) 2.91–3.05 (m, 1 H) 2.85 (d, <i>J</i> = 16.17 Hz, 1 H) 2.34 (dd, <i>J</i> = 16.17, 9.60 Hz, 1 H) 1.34 (s, 9 H) 1.21 (d, <i>J</i> = 6.32 Hz, 3 H).</div></div><div id="sec6_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 5-(6,7<i>-</i>Dihydro-5<i>H-</i>pyrrolo[3,4<i>-d</i>]pyrimidin-4-yloxy)-indole-1-carboxylic Acid (5-<i>tert</i>-Butyl-isoxazol-3-yl)-amide (<b>33s</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 419.2 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO<i>-d</i><sub>6</sub>) δ 8.56 (s, 1 H) 8.29 (d, <i>J</i> = 8.84 Hz, 1 H) 8.17 (d, <i>J</i> = 3.79 Hz, 1 H) 7.47 (d, <i>J</i> = 2.27 Hz, 1 H) 7.15 (dd, <i>J</i> = 8.97, 2.40 Hz, 1 H) 6.76 (d, <i>J</i> = 3.28 Hz, 1 H) 6.68 (s, 1 H) 4.07–4.14 (m, 4 H) 1.34 (s, 9 H).</div></div><div id="sec6_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 6,7-Dihydro-5<i>H-</i>pyrrolo[3,4<i>-d</i>] pyrimidin-4-yloxy)-indole-1-carboxylic acid (3-<i>tert</i>-butyl-isoxazol-5-yl)-amide (<b>33t</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 419.9 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO<i>-d</i><sub>6</sub>) δ 8.61 (s, 1 H) 8.42 (d, <i>J</i> = 9.09 Hz, 1 H) 8.11 (d, <i>J</i> = 3.79 Hz, 1 H) 7.44 (d, <i>J</i> = 2.27 Hz, 1 H) 7.11 (dd, <i>J</i> = 9.22, 2.40 Hz, 1 H) 6.67 (d, <i>J</i> = 3.54 Hz, 1 H) 6.22 (s, 1 H) 4.25 (br. S., 4 H) 1.28 (s, 9 H).</div></div><div id="sec6_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (<i>S</i>)-5-(Methyl-6,7-dihydro-5<i>H-</i>pyrrolo[3,4<i>-d</i>]pyrimidin-4-yloxy)-indole-1-carboxylic Acid (5-<i>tert</i>-Butyl-isoxazol-3-yl)-amide (<b>33u</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 433.0 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO<i>-d</i><sub>6</sub>) δ 8.54 (s, 1 H) 8.30 (d, <i>J</i> = 9.09 Hz, 1 H) 8.16 (d, <i>J</i> = 3.79 Hz, 1 H) 7.46 (d, <i>J</i> = 2.27 Hz, 1 H) 7.14 (dd, <i>J</i> = 8.97, 2.40 Hz, 1 H) 6.76 (d, <i>J</i> = 3.79 Hz, 1 H) 6.68 (s, 1 H) 4.62 (d, <i>J</i> = 6.57 Hz, 1 H) 4.12 (d, <i>J</i> = 2.27 Hz, 1 H) 4.08 (d, <i>J</i> = 1.52 Hz, 1 H) 1.44 (d, <i>J</i> = 6.57 Hz, 3 H) 1.34 (s, 9 H).</div></div><div id="sec6_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 5-(6,7<i>-</i>Dihydro-5<i>H-</i>pyrrolo[3,4<i>-d</i>] pyrimidin-4-yloxy)-indole-1-carboxylic Acid (5-Cyclopropyl-isoxazol-3-yl)-amide (<b>33v</b>)</h4><div class="NLM_p last">HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>18</sub>N<sub>6</sub>O<sub>3</sub> (M + 1) 403.1520, found 403.1520; <sup>1</sup>H NMR (400 MHz, DMSO<i>-d</i><sub>6</sub>) δ 8.55 (s, 1 H) 8.29 (d, <i>J</i> = 9.09 Hz, 1 H) 8.16 (d, <i>J</i> = 3.79 Hz, 1 H) 7.46 (d, <i>J</i> = 2.27 Hz, 1 H) 7.14 (dd, <i>J</i> = 8.97, 2.40 Hz, 1 H) 6.75 (d, <i>J</i> = 3.28 Hz, 1 H) 6.65 (s, 1 H) 4.04–4.16 (m, 4 H) 2.07–2.26 (m, 1 H) 1.01–1.15 (m, 2 H) 0.87–0.98 (m, 2 H); <sup>13</sup>C NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 175.2, 174.6, 164.4, 158.7, 157.3, 149.1, 147.7, 133.1, 130.6, 126.7, 118.5, 118.4, 116.0, 113.5, 107.2, 93.9, 52.8, 487.9, 8.2, 8.0.</div></div><div id="sec6_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 5-(6,7<i>-</i>Dihydro-5<i>H-</i>pyrrolo[3,4<i>-d</i>] pyrimidin-4-yloxy)-indole-1-carboxylic Acid (5-Isopropyl-isoxazol-3-yl)-amide (<b>33w</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 405.1 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO<i>-d</i><sub>6</sub>) δ 8.56 (s, 1 H) 8.29 (d, <i>J</i> = 8.84 Hz, 1 H) 8.17 (d, <i>J</i> = 3.79 Hz, 1H) 7.47 (d, <i>J</i> = 2.27 Hz, 1 H) 7.15 (dd, <i>J</i> = 8.97, 2.40 Hz, 1 H) 6.76 (d, <i>J</i> = 3.79 Hz, 1 H) 6.69 (s, 1 H) 4.00–4.20 (m, 4 H) 3.11 (m, 1 H) 1.29 (d, <i>J</i> = 7.07 Hz, 6 H).</div></div><div id="sec6_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 5-(6,7<i>-</i>Dihydro-5<i>H-</i>pyrrolo[3,4<i>-d</i>] pyrimidin-4-yloxy)-indole-1-carboxylic Acid [5-(1-Methyl-cyclopropyl)-isoxazol-3-yl]-amide (<b>33x</b>)</h4><div class="NLM_p last">MS (ESI) <i>m</i>/<i>z</i> 417.1 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO<i>-d</i><sub>6</sub>) δ 8.56 (s, 1 H) 8.29 (d, <i>J</i> = 8.84 Hz, 1 H) 8.16 (d, <i>J</i> = 3.79 Hz, 1 H) 7.47 (d, <i>J</i> = 2.53 Hz, 1 H) 7.15 (dd, <i>J</i> = 8.97, 2.40 Hz, 1 H) 6.76 (d, <i>J</i> = 3.28 Hz, 1 H) 6.67 (s, 1 H) 4.01–4.19 (m, 4 H + 1 N–H) 1.46 (s, 3 H) 1.07–1.21 (m, 2 H) 0.86–1.02 (m, 2 H).</div></div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Mouse Laser-Induced Choroidal Neovascularization (CNV) Model</h3><div class="NLM_p">The animal research presented in this article was approved by the Novartis Institutes for Biomedical Research IACUC Committee. We used female C57/BL6 mice that were typically 8–10 weeks old. Mice used in an experiment arrived at our research facility in a single shipment. Experimental interventions for a cohort of animals were started on the same day. Mice were treated by oral gavage with compound starting 1 h before laser treatment (Day 0) and continuing once a day through Day 6 after laser treatment. Experimental groups were dosed with either vehicle (0.5% methylcellulose and 0.2% Tween 80) or compound in vehicle (0.5% methylcellulose and 0.2% Tween 80) at 10 mg/kg. Each group consisted of 10 mice, with 3 laser burns to each eye yielding 60 data per group.</div><div id="sec700" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Laser Photocoagulation</h4><div class="NLM_p last">Mouse pupils were dilated with one drop (volume 40 μL) of 1% cyclopentolate. Just before anesthesia, pupil dilation was maximized with an additional drop of phenylephrine (usually 10% but occasionally 2.5% depending upon availability). Mice were then anaesthetized with an intraperitoneal (i.p.) injection of a mixture of ketamine and xylazine at doses up to100 mg/kg and 10 mg/kg, respectively. Prior to laser pulse application, each eye was anesthetized with topical 0.5% proparacaine. Lubricating eyedrops (Genteals Novartis) on a glass coverslip were applied to the cornea, and the retina was viewed through a slit lamp microscope. Three laser pulses were applied to the fundus around the optic nerve of each eye, six laser pulses in total for each mouse. The pulses were from a green laser (wavelength = 532 nm; Oculight GLx) and had a duration of 30 ms, a power of 120 mW, and a spot size of 100 μm. A successful laser burn generated a yellow vaporization bubble which correlated with a rupture of Bruch’s membrane. If a vaporization bubble did not form, one additional laser pulse would be administered to the same spot. For each eye, a maximum of four shots were allowed. An additional fourth shot was required in fewer than 3% of eyes. After the application of laser burns to both eyes, antibiotic ointment (0.5% Erythromycin, Tobramycin, or Neomycin ophthalmic ointment depending on availability and cost) was applied to both eyes.</div></div><div id="sec701" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Harvest and Photography of CNV Lesions</h4><div class="NLM_p last">Unless indicated, studies were completed 7 days after laser photocoagulation. On the final study day, 0.1 mL of a 5 mg/mL solution of FITC concanavalin-A (Vector Laboratories) was injected intravenously (i.v.) to fluorescently label the vascular endothelium. Animals were sacrificed 15–30 min later with inhaled carbon dioxide. Eyes were enucleated and fixed in 4% paraformaldehyde for approximately 60 min at room temperature and then transferred to vials of PBS. Posterior eye cups were dissected from the eyes. The RPE-choroidal-sclera complexes were separated from the neural retina and mounted on microscope slides, at which time each eye was given a randomization code to mask the examiners. Fluorescent images of each CNV lesion were photographed with an Axiocam MR3 camera on an Axio Image M1 microscope (Zeiss). CNV area was quantified using a semiautomated analysis program (Axiovision software, version 4.5, Zeiss) that outlined the fluorescent blood vessels. Image capture, CNV area measurement, and exclusions (see below) were performed on masked microscope slides.</div></div><div id="sec702" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Measurements of Neovascular Lesions</h4><div class="NLM_p">Most eyes generated three data points corresponding to the area of each of the three laser-induced CNV lesions. A cohort of 10 mice with both eyes treated would optimally provide 60 data points. However, a lesion would be necessarily excluded for any of the following reasons: (1) there was choroidal hemorrhage encroaching on the lesion; (2) the lesion was of irregular shape indicating an asymmetrical laser burn; (3) the lesion had fused with another lesion; (4) the lesion had a size indicating that it was an outlier lesion, as defined below; or (5) the lesion was the only lesion in an eye (i.e., if 2 of the 3 lesions in an eye were excluded, then all lesions in that eye were excluded).</div><div class="NLM_p">An outlier lesion fell into one of the following three categories: (1) “too big”, i.e., it was over 10,000 μ<sup>2</sup> in area, and it was more than 5 times larger than the next biggest lesions in the eye (for reference, the mean area of CNV in a control group typically ranged from 10,000 to 20,000 μ<sup>2</sup>); (2) “too small”, i.e., it was less than 1/5 the area of the other next smallest lesion in the eye; this criterion applied only if at least one lesion in the eye was over 5,000 μ<sup>2</sup>; (3) “too different”, i.e., after all of the lesions in a specific treatment group were measured, the lesion’s area was 5-fold greater than the mean for that group; this criterion applied only for lesions that were ≥5,000 μ<sup>2</sup>.</div><div class="NLM_p last">Other reasons that lesions were excluded or not measured include: (1) the death of a mouse before the end of an experiment; (2) the failure of the i.v. injection of the vascular label; (3) the laser could not be applied due to media opacities (e.g., a pre-existing corneal scar or cataract); in this case, the fellow eye could still be included; (4) there was damage to the CNV lesion during tissue processing (if any part of the CNV was cut or not discernible, it was not included); and (5) a CNV lesion could not be located during the imaging of an eyecup.</div></div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Rat Laser-Induced Choroidal Neovascularization (CNV) Model</h3><div class="NLM_p last">We used male Brown Norway rats that were typically 12 weeks old (range of age 7–14 weeks). Rats were purchased from Harlan, and the rats used in a single experiment arrived at our research facility in a single shipment and were age-matched. Experimental interventions for a cohort of animals were started on the same day. Laser application for an individual experiment was by a single scientist. Cages were randomly assigned to treatment groups with rats sharing a cage receiving the same treatment.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Laser Photocoagulation</h3><div class="NLM_p last">Rat pupils were dilated with one drop (volume ∼40 μL) of 1% cyclopentolate. Just before anesthesia, pupil dilation was maximized with an additional drop of phenylephrine (usually 10% but occasionally 2.5% depending upon availability). Rats were then anaesthetized with an intraperitoneal (i.p.) injection of a mixture of ketamine and xylazine at doses of 40–80 mg/kg and 5–10 mg/kg, respectively. Prior to laser pulse application, each eye was anesthetized with topical 0.5% proparacaine. Lubricating eyedrops (Genteal Alcon Laboratories, Fort Worth, TX) on a glass coverslip were applied to the cornea, and the retina was viewed through a slit lamp microscope. Each laser pulse was applied approximately 1 mm from the optic nerve; single pulses in each of four separate locations were applied to each eye for a total of eight laser photocoagulation sites for each mouse. The pulses were from a green laser (wavelength = 532 nm; Oculight GLx Mountain View, CA) and had a duration of 30 ms, a power of 190 mW, and a spot size of 200 μm. A successful laser pulse generated a yellow vaporization bubble which correlated with a rupture of Bruch’s membrane (evaluated histologically in control rats sacrificed 6 h after lasering; data not shown). In cases when a vaporization bubble did not form (<1% of laser pulses), one additional laser pulse could be administered to the same spot. For each eye, a maximum of five laser pulses were allowed to generate 4 lesions. After the application of laser burns to both eyes, antibiotic ointment (Tobramycin or Neomycin ophthalmic ointment depending on availability and cost) was applied to both eyes.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Tissue Processing, Imaging, and CNV Area Quantification</h3><div class="NLM_p last">Analysis of neovascularization was completed on tissues harvested 11, 12, or 14 days after laser photocoagulation depending on the dosing paradigm of the experiment. For an individual experiment, all rats were euthanized on the same day after alser photocoagulation. On the final study day, 0.2 mL of a 12.5 mg/mL solution of a 2,000 kDa FITC dextran (Sigma) was injected intravenously (i.v.) to fluorescently label the vascular endothelium. Animals were euthanized 15–30 min later with inhaled carbon dioxide. Eyes were enucleated and fixed in 4% paraformaldehyde (Vector Laboratories, Burlingame, CA) for approximately 60 min at room temperature, and then, the fixative was replaced with PBS. Each eye was assigned a randomized number to mask the samples for the remainder of the analysis. Posterior segments were isolated, and retinas were removed. The posterior eye cups which included the retinal pigment epithelium (RPE), the choroid, and the sclera were flat-mounted onto microscope slides after making 3 or 4 radial cuts. Fluorescent images of each CNV lesion were photographed with an Axiocam MR3 camera on an Axio Image M1 microscope (Carl Zeiss Microscopy, Thornwood, NY). CNV area was quantified using a semiautomated analysis program (Axiovision software, version 4.5, Carl Zeiss Microscopy) that outlined the fluorescent blood vessels. Image capture, CNV area measurement, and exclusions (see below) were performed on randomized samples or data by scientists masked to the treatment group.</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Compound Administration</h3><div class="NLM_p last">Test articles were administered via oral gavage, starting approximately 1 h before lasering, unless described otherwise.</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Application of Exclusion Criteria</h3><div class="NLM_p">Each eye typically generates 4 data points corresponding to the area of 4 individual CNV lesions. In a typical study, a cohort of 10 rats per group would optimally provide 80 data points. However, a lesion would be excluded for any of the following reasons: (1) there was choroidal hemorrhage encroaching on the lesion; (2) the lesion was linear instead of circular, a consequence of a deflected (“split”) laser impact; (3) the lesion had fused with another lesion; (4) the lesion had a size indicating that it was an outlier lesion as defined below; or (5) the lesion was the only lesion in an eye (i.e., if 3 of the 4 lesions in an eye were excluded, then all lesions in that eye were excluded).</div><div class="NLM_p">An outlier lesion fell into one of the following three categories: (1) “too big”, i.e., it was over 10,000 μ<sup>2</sup> in area and was more than 5 times larger than the next biggest lesion in the eye (for reference, the mean area of CNV in a control group typically ranged from 10,000 to 20,000 μ<sup>2</sup>); (2) “too small”, i.e., it was less than 1/5 the area of the next smallest lesion in the eye; this criterion applied only if at least one lesion in the eye was over 5,000 μ<sup>2</sup>; (3) “too different”, i.e., after all of the lesions in a specific treatment group were measured, the lesion’s area was 5-fold greater than the mean for that group; this criterion applied only for lesions that were ≥5,000 μ<sup>2</sup>.</div><div class="NLM_p last">Other reasons that lesions were excluded or not measured include: (1) the death of a rat before the end of an experiment; (2) the failure of the i.v. injection of the vascular label; (3) media opacities precluding accurate laser application (e.g., a pre-existing corneal scar or cataract); in this case, the fellow eye could still be included; (4) damage to the CNV lesion during tissue processing (i.e., poor quality of the tissue during processing so that the lesion could not be fully delineated); (5) inability to locate a CNV lesion during the imaging of an eyecup.</div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Ocular PK in Brown Norway Rats Following Administration of a Single Oral Dose</h3><div class="NLM_p">Three month old Brown Norway rats were administered orally with an active agent as shown in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a> at the dosing concentration and formulation specified. Ocular tissues and plasma were collected from 2 rats per active agent at 6, 24, 48, 72, 96, 120, and 144 h after dosing. The ocular tissues collected were the retina and the posterior eye cup. Each time point had drug levels measured in 4 individual retinas, 4 individual posterior eye cups, and 2 individual plasma samples.</div><div class="NLM_p last">Ocular tissues were homogenized and plasma proteins precipitated, and the drug concentration was analyzed by LC-MS/MS. Exposures in the retina, posterior eye cup (PEC), and plasma for the compounds were dose normalized and are listed in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a> as area under the curve measurements (AUC), <i>C</i><sub>max</sub>, and <i>C</i><sub>24 h</sub>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01227" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36543" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36543" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erik L. Meredith</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, Novartis Institutes
for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8ce9fee5e7a2e1e9fee9e8e5f8e4cce2e3faedfef8e5ffa2efe3e1"><span class="__cf_email__" data-cfemail="3a5f48535114575f485f5e534e527a54554c5b484e534914595557">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nello Mainolfi</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, Novartis Institutes
for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen Poor</span> - <span class="hlFld-Affiliation affiliation">Ophthalmology, Novartis Institutes for BioMedical Research, 500 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yubin Qiu</span> - <span class="hlFld-Affiliation affiliation">Ophthalmology, Novartis Institutes for BioMedical Research, 500 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karl Miranda</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, Novartis Institutes
for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Powers</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, Novartis Institutes
for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donglei Liu</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, Novartis Institutes
for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fupeng Ma</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, Novartis Institutes
for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Catherine Solovay</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, Novartis Institutes
for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chang Rao</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, Novartis Institutes
for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leland Johnson</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, Novartis Institutes
for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nan Ji</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, Novartis Institutes
for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gerald Artman</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, Novartis Institutes
for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leo Hardegger</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, Novartis Institutes
for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shawn Hanks</span> - <span class="hlFld-Affiliation affiliation">Ophthalmology, Novartis Institutes for BioMedical Research, 500 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Siyuan Shen</span> - <span class="hlFld-Affiliation affiliation">Ophthalmology, Novartis Institutes for BioMedical Research, 500 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amber Woolfenden</span> - <span class="hlFld-Affiliation affiliation">Ophthalmology, Novartis Institutes for BioMedical Research, 500 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth Fassbender</span> - <span class="hlFld-Affiliation affiliation">Ophthalmology, Novartis Institutes for BioMedical Research, 500 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeremy M. Sivak</span> - <span class="hlFld-Affiliation affiliation">Ophthalmology, Novartis Institutes for BioMedical Research, 500 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yiqin Zhang</span> - <span class="hlFld-Affiliation affiliation">Ophthalmology, Novartis Institutes for BioMedical Research, 500 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Debby Long</span> - <span class="hlFld-Affiliation affiliation">Ophthalmology, Novartis Institutes for BioMedical Research, 500 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rosemarie Cepeda</span> - <span class="hlFld-Affiliation affiliation">Ophthalmology, Novartis Institutes for BioMedical Research, 500 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fang Liu</span> - <span class="hlFld-Affiliation affiliation">Ophthalmology, Novartis Institutes for BioMedical Research, 500 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vinayak P. Hosagrahara</span> - <span class="hlFld-Affiliation affiliation">Metabolism
and Pharmacokinetics, Novartis Institutes
for BioMedical Research, 250 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wendy Lee</span> - <span class="hlFld-Affiliation affiliation">Metabolism
and Pharmacokinetics, Novartis Institutes
for BioMedical Research, 250 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Tarsa</span> - <span class="hlFld-Affiliation affiliation">Chemical
and Pharmaceutical Profiling, Novartis Institutes
for BioMedical Research, 500 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen Anderson</span> - <span class="hlFld-Affiliation affiliation">Ophthalmology, Novartis Institutes for BioMedical Research, 500 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason Elliott</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, Novartis Institutes
for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce Jaffee</span> - <span class="hlFld-Affiliation affiliation">Ophthalmology, Novartis Institutes for BioMedical Research, 500 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2362e5348-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i81">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85767" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85767" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We acknowledge the contribution of the Novartis Institute for Biomedical Research Analytical Sciences group and the Novartis Institute for Biomedical Research Metabolism and Pharmacokinetics group for support in generating the analytical details for the compounds described herein.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i82" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i82"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i83" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i83"> Abbreviations Used</h2><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">VEGF</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor</p></td></tr><tr><td class="NLM_term">AMD</td><td class="NLM_def"><p class="first last">age-related macular degeneration</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption distribution metabolism excretion</p></td></tr><tr><td class="NLM_term">CNV</td><td class="NLM_def"><p class="first last">choroidal neovascularization</p></td></tr><tr><td class="NLM_term">PEC</td><td class="NLM_def"><p class="first last">posterior eye cup</p></td></tr><tr><td class="NLM_term">p.o.</td><td class="NLM_def"><p class="first last">oral</p></td></tr><tr><td class="NLM_term">i.v.</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">i.v.t.</td><td class="NLM_def"><p class="first last">intravitreal</p></td></tr><tr><td class="NLM_term">ETDRS</td><td class="NLM_def"><p class="first last">Early Treatment of Diabetic Retinopathy Study</p></td></tr><tr><td class="NLM_term">WFI</td><td class="NLM_def"><p class="first last">water for injection</p></td></tr><tr><td class="NLM_term">MC</td><td class="NLM_def"><p class="first last">methylcellulose</p></td></tr><tr><td class="NLM_term">CMC</td><td class="NLM_def"><p class="first last">carboxymethylcellulose</p></td></tr><tr><td class="NLM_term">DN</td><td class="NLM_def"><p class="first last">dose normalized</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68602" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68602" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 29 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">CATT Research Group</span><span> </span><span class="NLM_article-title">Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">364</span><span class="NLM_x">, </span> <span class="NLM_fpage">1897</span><span class="NLM_x">–</span> <span class="NLM_lpage">1908</span><span class="refDoi"> DOI: 10.1056/NEJMoa1102673</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1056%2FNEJMoa1102673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=21526923" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2011&pages=1897-1908&author=CATT+Research+Group&title=Ranibizumab+and+Bevacizumab+for+Neovascular+Age-Related+Macular+Degeneration&doi=10.1056%2FNEJMoa1102673"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1102673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1102673%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DRanibizumab%2520and%2520Bevacizumab%2520for%2520Neovascular%2520Age-Related%2520Macular%2520Degeneration%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D364%26spage%3D1897%26epage%3D1908%26doi%3D10.1056%2FNEJMoa1102673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Brown, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michels, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soubrane, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heier, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span> </span><span class="NLM_article-title">Ranibizumab versus verteporfin for neovascular age-related macular degeneration</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">1432</span><span class="NLM_x">–</span> <span class="NLM_lpage">1444</span><span class="refDoi"> DOI: 10.1056/NEJMoa062655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1056%2FNEJMoa062655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=17021319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVGgtrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=1432-1444&author=D.+M.+Brownauthor=P.+K.+Kaiserauthor=M.+Michelsauthor=G.+Soubraneauthor=J.+S.+Heierauthor=R.+Y.+Kimauthor=J.+P.+Syauthor=S.+Schneider&title=Ranibizumab+versus+verteporfin+for+neovascular+age-related+macular+degeneration&doi=10.1056%2FNEJMoa062655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Ranibizumab versus verteporfin for neovascular age-related macular degeneration</span></div><div class="casAuthors">Brown, David M.; Kaiser, Peter K.; Michels, Mark; Soubrane, Gisele; Heier, Effrey S.; Kim, Robert Y.; Sy, Judy P.; Schneider, Susan</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1432-1444</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: We compared ranibizumab - a recombinant, humanized, monoclonal antibody Fab that neutralizes all active forms of vascular endothelial growth factor A - with photodynamic therapy with verteporfin in the treatment of predominantly classic neovascular age-related macular degeneration.  METHODS: During the first year of this 2-yr, multicenter, double-blind study, we randomly assigned patients in a 1:1:1 ratio to receive monthly intravitreal injections of ranibizumab (0.3 mg or 0.5 mg) plus sham verteporfin therapy or monthly sham injections plus active verteporfin therapy.  The primary end point was the proportion of patients losing fewer than 15 letters from baseline visual acuity at 12 mo.  RESULTS: Of the 423 patients enrolled, 94.3% of those given 0.3 mg of ranibizumab and 96.4% of those given 0.5 mg lost fewer than 15 letters, as compared with 64.3% of those in the verteporfin group (P < 0.001 for each comparison).  Visual acuity i.m.- proved by 15 letters or more in 35.7% of the 0.3-mg group and 40.3% of the 0.5-mg group, as compared with 5.6% of the verteporfin group (P < 0.001 for each comparison).  Mean visual acuity increased by 8.5 letters in the 0.3-mg group and 11.3 letters in the 0.5-mg group, as compared with a decrease of 9.5 letters in the verteporfin group (P < 0.001 for each comparison).  Among 140 patients treated with 0.5 mg of ranibizumab, presumed endophthalmitis occurred in 2 patients (1.4%) and serious uveitis in 1 (0.7%).  CONCLUSIONS: Ranibizumab was superior to verteporfin as intravitreal treatment of predominantly classic neovascular age-related macular degeneration, with low rates of serious ocular adverse events.  Treatment improved visual acuity on av. at 1 yr.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu19lFQmxb77Vg90H21EOLACvtfcHk0linyE2xNDZZ_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVGgtrrI&md5=1acef0cfe4198d3aac6f7bffb048307b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa062655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa062655%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BM.%26aulast%3DKaiser%26aufirst%3DP.%2BK.%26aulast%3DMichels%26aufirst%3DM.%26aulast%3DSoubrane%26aufirst%3DG.%26aulast%3DHeier%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DR.%2BY.%26aulast%3DSy%26aufirst%3DJ.%2BP.%26aulast%3DSchneider%26aufirst%3DS.%26atitle%3DRanibizumab%2520versus%2520verteporfin%2520for%2520neovascular%2520age-related%2520macular%2520degeneration%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D1432%26epage%3D1444%26doi%3D10.1056%2FNEJMoa062655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis-Smyth, T.</span><span> </span><span class="NLM_article-title">The biology of vascular endothelial growth factor</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1210/edrv.18.1.0287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1210%2Fedrv.18.1.0287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=9034784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A528%3ADyaK2sXhsFCiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=4-25&issue=1&author=N.+Ferraraauthor=T.+Davis-Smyth&title=The+biology+of+vascular+endothelial+growth+factor&doi=10.1210%2Fedrv.18.1.0287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The biology of vascular endothelial growth factor</span></div><div class="casAuthors">Ferrara, Napoleone; Davis-Smyth, Terri</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-25</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review, with 250 refs., on: biol. activities of vascular endothelial growth factor (VEGF); organization of the VEGF gene; properties of the VEGF isoforms; regulation of VEGF gene expression; the VEGF receptors; VEGF-related mols.; role of VEGF and its receptors in physiol. angiogenesis; role of VEGF in pathol. angiogenesis; and therapeutic applications of VEGF-induced angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5imhPXJtxxrVg90H21EOLACvtfcHk0ljayOhvz4MT_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsFCiu7s%253D&md5=22796890fbe49a721d330447396aea8b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1210%2Fedrv.18.1.0287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fedrv.18.1.0287%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DDavis-Smyth%26aufirst%3DT.%26atitle%3DThe%2520biology%2520of%2520vascular%2520endothelial%2520growth%2520factor%26jtitle%3DEndocr.%2520Rev.%26date%3D1997%26volume%3D18%26issue%3D1%26spage%3D4%26epage%3D25%26doi%3D10.1210%2Fedrv.18.1.0287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Bates, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curry, F. E.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor increases microvascular permeability via a Ca<sup>2+</sup>-dependent pathway</span> <span class="citation_source-journal">Am. J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x"> (</span><span class="NLM_issue">2 Pt 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">H687</span><span class="NLM_x">–</span> <span class="NLM_lpage">694</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1997&pages=H687-694&issue=2+Pt+2&author=D.+O.+Batesauthor=F.+E.+Curry&title=Vascular+endothelial+growth+factor+increases+microvascular+permeability+via+a+Ca2%2B-dependent+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBates%26aufirst%3DD.%2BO.%26aulast%3DCurry%26aufirst%3DF.%2BE.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520increases%2520microvascular%2520permeability%2520via%2520a%2520Ca2%252B-dependent%2520pathway%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D1997%26volume%3D273%26issue%3D2%2520Pt%25202%26spage%3DH687%26epage%3D694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mieler, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPherson, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holz, E. R.</span><span> </span><span class="NLM_article-title">Intravitreal triamcinolone does not alter basal vascular endothelial growth factor mRNA expression in rat retina</span> <span class="citation_source-journal">Vision Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span><span class="refDoi"> DOI: 10.1016/j.visres.2003.09.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1016%2Fj.visres.2003.09.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=14659961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlOisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=349-356&issue=4&author=H.+Gaoauthor=X.+Qiaoauthor=R.+Gaoauthor=W.+F.+Mielerauthor=A.+R.+McPhersonauthor=E.+R.+Holz&title=Intravitreal+triamcinolone+does+not+alter+basal+vascular+endothelial+growth+factor+mRNA+expression+in+rat+retina&doi=10.1016%2Fj.visres.2003.09.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Intravitreal triamcinolone does not alter basal vascular endothelial growth factor mRNA expression in rat retina</span></div><div class="casAuthors">Gao, Hua; Qiao, Xiaoxi; Gao, Rui; Mieler, William F.; McPherson, Alice R.; Holz, Eric R.</div><div class="citationInfo"><span class="NLM_cas:title">Vision Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">349-356</span>CODEN:
                <span class="NLM_cas:coden">VISRAM</span>;
        ISSN:<span class="NLM_cas:issn">0042-6989</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Intravitreal triamcinolone inhibits choroidal neovascularization.  To investigate if vascular endothelial growth factor (VEGF) is affected, we examd. VEGF expression after intravitreal triamcinolone administration in rat retina.  Using in situ hybridization, we have found dense clustered VEGF mRNA signals in the retinal pigment epithelium, moderate patchy signals in the inner nuclear layer, and pos. labeling in a sub-population of ganglion cells.  Densitometry and northern blot anal. revealed no significant alteration of VEGF mRNA expression pattern and level 3-21 days after triamcinolone injection.  Our data indicate that intravitreal triamcinolone does not affect basal VEGF mRNA expression in normal adult rat retina.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor9silt2aS4LVg90H21EOLACvtfcHk0ljayOhvz4MT_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlOisro%253D&md5=7659ed8439a3e68d9fde4c4be13ececc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.visres.2003.09.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.visres.2003.09.027%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DH.%26aulast%3DQiao%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DR.%26aulast%3DMieler%26aufirst%3DW.%2BF.%26aulast%3DMcPherson%26aufirst%3DA.%2BR.%26aulast%3DHolz%26aufirst%3DE.%2BR.%26atitle%3DIntravitreal%2520triamcinolone%2520does%2520not%2520alter%2520basal%2520vascular%2520endothelial%2520growth%2520factor%2520mRNA%2520expression%2520in%2520rat%2520retina%26jtitle%3DVision%2520Res.%26date%3D2004%26volume%3D44%26issue%3D4%26spage%3D349%26epage%3D356%26doi%3D10.1016%2Fj.visres.2003.09.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Lopez, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippy, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thach, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinton, D. R.</span><span> </span><span class="NLM_article-title">Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes</span> <span class="citation_source-journal">Invest. Ophthalmol. Vis. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1996&pages=855-868&issue=5&author=P.+F.+Lopezauthor=B.+D.+Sippyauthor=H.+M.+Lambertauthor=A.+B.+Thachauthor=D.+R.+Hinton&title=Transdifferentiated+retinal+pigment+epithelial+cells+are+immunoreactive+for+vascular+endothelial+growth+factor+in+surgically+excised+age-related+macular+degeneration-related+choroidal+neovascular+membranes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%26aufirst%3DP.%2BF.%26aulast%3DSippy%26aufirst%3DB.%2BD.%26aulast%3DLambert%26aufirst%3DH.%2BM.%26aulast%3DThach%26aufirst%3DA.%2BB.%26aulast%3DHinton%26aufirst%3DD.%2BR.%26atitle%3DTransdifferentiated%2520retinal%2520pigment%2520epithelial%2520cells%2520are%2520immunoreactive%2520for%2520vascular%2520endothelial%2520growth%2520factor%2520in%2520surgically%2520excised%2520age-related%2520macular%2520degeneration-related%2520choroidal%2520neovascular%2520membranes%26jtitle%3DInvest.%2520Ophthalmol.%2520Vis.%2520Sci.%26date%3D1996%26volume%3D37%26issue%3D5%26spage%3D855%26epage%3D868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Aiello, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrigg, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keyt, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jampel, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquale, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thieme, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwamoto, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aiello, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, G. L.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">331</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">1480</span><span class="NLM_x">–</span> <span class="NLM_lpage">1487</span><span class="refDoi"> DOI: 10.1056/NEJM199412013312203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1056%2FNEJM199412013312203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=7526212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A280%3ADyaK2M%252FlvFamsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=1994&pages=1480-1487&issue=22&author=L.+P.+Aielloauthor=R.+L.+Averyauthor=P.+G.+Arriggauthor=B.+A.+Keytauthor=H.+D.+Jampelauthor=S.+T.+Shahauthor=L.+R.+Pasqualeauthor=H.+Thiemeauthor=M.+A.+Iwamotoauthor=J.+E.+Parkauthor=H.+V.+Nguyenauthor=L.+M.+Aielloauthor=N.+Ferraraauthor=G.+L.+King&title=Vascular+endothelial+growth+factor+in+ocular+fluid+of+patients+with+diabetic+retinopathy+and+other+retinal+disorders&doi=10.1056%2FNEJM199412013312203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders</span></div><div class="casAuthors">Aiello L P; Avery R L; Arrigg P G; Keyt B A; Jampel H D; Shah S T; Pasquale L R; Thieme H; Iwamoto M A; Park J E</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1480-7</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND:  Retinal ischemia induces intraocular neovascularization, which often leads to glaucoma, vitreous hemorrhage, and retinal detachment, presumably by stimulating the release of angiogenic molecules.  Vascular endothelial growth factor (VEGF) is an endothelial-cell-specific angiogenic factor whose production is increased by hypoxia.  METHODS:  We measured the concentration of VEGF in 210 specimens of ocular fluid obtained from 164 patients undergoing intraocular surgery, using both radioimmuno-assays and radioreceptor assays.  Vitreous proliferative potential was measured with in vitro assays of the growth of retinal endothelial cells and with VEGF-neutralizing antibody.  RESULTS:  VEGF was detected in 69 of 136 ocular-fluid samples from patients with diabetic retinopathy, 29 of 38 samples from patients with neovascularization of the iris, and 3 of 4 samples from patients with ischemic occlusion of the central retinal vein, as compared with 2 of 31 samples from patients with no neovascular disorders (P < 0.001, P < 0.001, and P = 0.006, respectively).  The mean (+/- SD) VEGF concentration in 70 samples of ocular fluid from patients with active proliferative diabetic retinopathy (3.6 +/- 6.3 ng per milliliter) was higher than that in 25 samples from patients with nonproliferative diabetic retinopathy (0.1 +/- 0.1 ng per milliliter, P = 0.008), 41 samples from patients with quiescent proliferative diabetic retinopathy (0.2 +/- 0.6 ng per milliliter, P < 0.001), or 31 samples from nondiabetic patients (0.1 +/- 0.2 ng per milliliter, P = 0.003).  Concentrations of VEGF in vitreous fluid (8.8 +/- 9.9 ng per milliliter) were higher than those in aqueous fluid (5.6 +/- 8.6 ng per milliliter, P = 0.033) in all 10 pairs of samples obtained simultaneously from the same patient; VEGF concentrations in vitreous fluid declined after successful laser photocoagulation.  VEGF stimulated the growth of retinal endothelial cells in vitro, as did vitreous fluid containing measurable VEGF.  Stimulation was inhibited by VEGF-neutralizing antibodies.  CONCLUSIONS:  Our data suggest that VEGF plays a major part in mediating active intraocular neovascularization in patients with ischemic retinal diseases, such as diabetic retinopathy and retinal-vein occlusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTuQPc8Cq5uLhWfpMXQLRstfW6udTcc2eazgVfoClnHJLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252FlvFamsA%253D%253D&md5=0711104bb524c018047b810c879aa08e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1056%2FNEJM199412013312203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199412013312203%26sid%3Dliteratum%253Aachs%26aulast%3DAiello%26aufirst%3DL.%2BP.%26aulast%3DAvery%26aufirst%3DR.%2BL.%26aulast%3DArrigg%26aufirst%3DP.%2BG.%26aulast%3DKeyt%26aufirst%3DB.%2BA.%26aulast%3DJampel%26aufirst%3DH.%2BD.%26aulast%3DShah%26aufirst%3DS.%2BT.%26aulast%3DPasquale%26aufirst%3DL.%2BR.%26aulast%3DThieme%26aufirst%3DH.%26aulast%3DIwamoto%26aufirst%3DM.%2BA.%26aulast%3DPark%26aufirst%3DJ.%2BE.%26aulast%3DNguyen%26aufirst%3DH.%2BV.%26aulast%3DAiello%26aufirst%3DL.%2BM.%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DKing%26aufirst%3DG.%2BL.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520in%2520ocular%2520fluid%2520of%2520patients%2520with%2520diabetic%2520retinopathy%2520and%2520other%2520retinal%2520disorders%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1994%26volume%3D331%26issue%3D22%26spage%3D1480%26epage%3D1487%26doi%3D10.1056%2FNEJM199412013312203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Nguyen, Q. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatlipinar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haller, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinlan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer-Galler, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor is a critical stimulus for diabetic macular edema</span> <span class="citation_source-journal">Am. J. Ophthalmol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">961</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.1016/j.ajo.2006.06.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1016%2Fj.ajo.2006.06.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=17046701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12msLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2006&pages=961-9&issue=6&author=Q.+D.+Nguyenauthor=S.+Tatlipinarauthor=S.+M.+Shahauthor=J.+A.+Hallerauthor=E.+Quinlanauthor=J.+Sungauthor=I.+Zimmer-Gallerauthor=D.+V.+Doauthor=P.+A.+Campochiaro&title=Vascular+endothelial+growth+factor+is+a+critical+stimulus+for+diabetic+macular+edema&doi=10.1016%2Fj.ajo.2006.06.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular Endothelial Growth Factor Is a Critical Stimulus for Diabetic Macular Edema</span></div><div class="casAuthors">Nguyen, Quan Dong; Tatlipinar, Sinan; Shah, Syed Mahmood; Haller, Julia A.; Quinlan, Edward; Sung, Jennifer; Zimmer-Galler, Ingrid; Do, Diana V.; Campochiaro, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Ophthalmology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">961-969</span>CODEN:
                <span class="NLM_cas:coden">AJOPAA</span>;
        ISSN:<span class="NLM_cas:issn">0002-9394</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Purpose: The role of vascular endothelial growth factor (VEGF) in diabetic macular edema (DME) was tested with ranibizumab, a specific antagonist of VEGF.  Design: A nonrandomized clin. trial.  Methods: Ten patients with chronic DME received intraocular injections of 0.5 mg of ranibizumab at baseline and at one, two, four, and six months.  The primary outcome was change in foveal thickness between baseline and seven months, and the secondary outcome measures were changes from baseline in visual acuity and macular vol.  Results: Mean values at baseline were 503 μm for foveal thickness, 9.22 mm3 for macular vol., and 28.1 letters (20/80) read on an Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity chart.  At seven months (one month after the fifth injection), the mean foveal thickness was 257 μm, which was a redn. of 246 μm (85% of the excess foveal thickness present at baseline; P = .005 by Wilcoxon signed-rank test for likelihood that this change is due to ranibizumab rather than chance).  The macular vol. was 7.47 mm3, which was a redn. of 1.75 mm3 (77% of the excess macular vol. at baseline; P = .009).  Mean visual acuity was 40.4 letters (20/40), which was an improvement of 12.3 letters (P = .005).  The injections were well-tolerated with no ocular or systemic adverse events.  Conclusion: Intraocular injections of ranibizumab significantly reduced foveal thickness and improved visual acuity in 10 patients with DME, which demonstrated that VEGF is an important therapeutic target for DME.  A randomized, controlled, double-masked trial is needed to test whether intraocular injections of ranibizumab provide long-term benefit to patients with DME.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraQ4X1zj_2PLVg90H21EOLACvtfcHk0lhdrAschvbnSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12msLfE&md5=1eaf14ff1ca9d7b98f917d48f841c1f7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.ajo.2006.06.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajo.2006.06.068%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DQ.%2BD.%26aulast%3DTatlipinar%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DS.%2BM.%26aulast%3DHaller%26aufirst%3DJ.%2BA.%26aulast%3DQuinlan%26aufirst%3DE.%26aulast%3DSung%26aufirst%3DJ.%26aulast%3DZimmer-Galler%26aufirst%3DI.%26aulast%3DDo%26aufirst%3DD.%2BV.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520is%2520a%2520critical%2520stimulus%2520for%2520diabetic%2520macular%2520edema%26jtitle%3DAm.%2520J.%2520Ophthalmol.%26date%3D2006%26volume%3D142%26issue%3D6%26spage%3D961%26epage%3D9%26doi%3D10.1016%2Fj.ajo.2006.06.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Terman, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougher-Vermazen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrion, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrov, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armellino, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gospodarowicz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böhlen, P.</span><span> </span><span class="NLM_article-title">Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">187</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1579</span><span class="NLM_x">–</span> <span class="NLM_lpage">1586</span><span class="refDoi"> DOI: 10.1016/0006-291X(92)90483-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1016%2F0006-291X%2892%2990483-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=1992&pages=1579-1586&issue=3&author=B.+I.+Termanauthor=M.+Dougher-Vermazenauthor=M.+E.+Carrionauthor=D.+Dimitrovauthor=D.+C.+Armellinoauthor=D.+Gospodarowiczauthor=P.+B%C3%B6hlen&title=Identification+of+the+KDR+tyrosine+kinase+as+a+receptor+for+vascular+endothelial+cell+growth+factor&doi=10.1016%2F0006-291X%2892%2990483-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2892%2990483-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252892%252990483-2%26sid%3Dliteratum%253Aachs%26aulast%3DTerman%26aufirst%3DB.%2BI.%26aulast%3DDougher-Vermazen%26aufirst%3DM.%26aulast%3DCarrion%26aufirst%3DM.%2BE.%26aulast%3DDimitrov%26aufirst%3DD.%26aulast%3DArmellino%26aufirst%3DD.%2BC.%26aulast%3DGospodarowicz%26aufirst%3DD.%26aulast%3DB%25C3%25B6hlen%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520the%2520KDR%2520tyrosine%2520kinase%2520as%2520a%2520receptor%2520for%2520vascular%2520endothelial%2520cell%2520growth%2520factor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1992%26volume%3D187%26issue%3D3%26spage%3D1579%26epage%3D1586%26doi%3D10.1016%2F0006-291X%2892%2990483-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Shalaby, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gertsenstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuh, A. C.</span><span> </span><span class="NLM_article-title">Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x"> (</span><span class="NLM_issue">6535</span><span class="NLM_x">) </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span><span class="refDoi"> DOI: 10.1038/376062a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1038%2F376062a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=1995&pages=62-66&issue=6535&author=F.+Shalabyauthor=J.+Rossantauthor=T.+P.+Yamaguchiauthor=M.+Gertsensteinauthor=X.+F.+Wuauthor=M.+L.+Breitmanauthor=A.+C.+Schuh&title=Failure+of+blood-island+formation+and+vasculogenesis+in+Flk-1-deficient+mice&doi=10.1038%2F376062a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F376062a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F376062a0%26sid%3Dliteratum%253Aachs%26aulast%3DShalaby%26aufirst%3DF.%26aulast%3DRossant%26aufirst%3DJ.%26aulast%3DYamaguchi%26aufirst%3DT.%2BP.%26aulast%3DGertsenstein%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DX.%2BF.%26aulast%3DBreitman%26aufirst%3DM.%2BL.%26aulast%3DSchuh%26aufirst%3DA.%2BC.%26atitle%3DFailure%2520of%2520blood-island%2520formation%2520and%2520vasculogenesis%2520in%2520Flk-1-deficient%2520mice%26jtitle%3DNature%26date%3D1995%26volume%3D376%26issue%3D6535%26spage%3D62%26epage%3D66%26doi%3D10.1038%2F376062a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Matsumoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claesson-Welsh, L.</span><span> </span><span class="NLM_article-title">VEGF receptor signal transduction</span> <span class="citation_source-journal">Sci. Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2001</span><span class="NLM_x"> (</span><span class="NLM_issue">112</span><span class="NLM_x">) </span> <span class="NLM_fpage">re21</span><span class="refDoi"> DOI: 10.1126/stke.2001.112.re21</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1126%2Fstke.2001.112.re21" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2001&publication_year=2001&pages=re21&issue=112&author=T.+Matsumotoauthor=L.+Claesson-Welsh&title=VEGF+receptor+signal+transduction&doi=10.1126%2Fstke.2001.112.re21"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fstke.2001.112.re21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fstke.2001.112.re21%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DT.%26aulast%3DClaesson-Welsh%26aufirst%3DL.%26atitle%3DVEGF%2520receptor%2520signal%2520transduction%26jtitle%3DSci.%2520Signaling%26date%3D2001%26volume%3D2001%26issue%3D112%26spage%3Dre21%26doi%3D10.1126%2Fstke.2001.112.re21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Keefe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okera, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stringer, A.</span><span> </span><span class="NLM_article-title">Noncardiac vascular toxicities of vascular endothelial growth factor inhibitors in advanced cancer: a review</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">432</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span><span class="refDoi"> DOI: 10.1634/theoncologist.2010-0271</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1634%2Ftheoncologist.2010-0271" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=432-444&issue=4&author=D.+Keefeauthor=J.+Bowenauthor=R.+Gibsonauthor=T.+Tanauthor=M.+Okeraauthor=A.+Stringer&title=Noncardiac+vascular+toxicities+of+vascular+endothelial+growth+factor+inhibitors+in+advanced+cancer%3A+a+review&doi=10.1634%2Ftheoncologist.2010-0271"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.2010-0271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.2010-0271%26sid%3Dliteratum%253Aachs%26aulast%3DKeefe%26aufirst%3DD.%26aulast%3DBowen%26aufirst%3DJ.%26aulast%3DGibson%26aufirst%3DR.%26aulast%3DTan%26aufirst%3DT.%26aulast%3DOkera%26aufirst%3DM.%26aulast%3DStringer%26aufirst%3DA.%26atitle%3DNoncardiac%2520vascular%2520toxicities%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520inhibitors%2520in%2520advanced%2520cancer%253A%2520a%2520review%26jtitle%3DOncologist%26date%3D2011%26volume%3D16%26issue%3D4%26spage%3D432%26epage%3D444%26doi%3D10.1634%2Ftheoncologist.2010-0271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Boyer, S. J.</span><span> </span><span class="NLM_article-title">Small molecule inhibitors of KDR (VEGFR-2)kinase: an overview of structure activity relationships</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span><span class="refDoi"> DOI: 10.2174/1568026023393273</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.2174%2F1568026023393273" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=12171566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtVOitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=973-1000&author=S.+J.+Boyer&title=Small+molecule+inhibitors+of+KDR+%28VEGFR-2%29kinase%3A+an+overview+of+structure+activity+relationships&doi=10.2174%2F1568026023393273"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitors of KDR (VEGFR-2) kinase: an overview of structure activity relationships</span></div><div class="casAuthors">Boyer, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">973-1000</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The Kinase insert Domain contg. Receptor (KDR), alternatively referred to as VEGFR-2, is a receptor for Vascular Endothelial Growth Factors (VEGFs) and functions as a key regulator of angiogenesis, the process by which new capillaries are created from preexisting blood vessels.  The induction of angiogenesis, or the "angiogenic switch," is a crit. step in tumor progression, and inhibitors of KDR have been demonstrated both to induce tumor regression and reduce metastatic potential in preclin. models.  In the last few years, medicinal chemists have expanded the kinase selectivity profile of known inhibitor classes to include KDR, and also identified novel classes of KDR inhibitors.  This review presents structure activity relationships (SAR) of small mol. inhibitors of KDR, with an emphasis on the pharmacophore elements of the scaffolds employed.  Binding hypotheses based on x-ray crystallog. analyses will also be described.  Addnl., the efficacy of representative compds. in in vitro and in vivo models of tumor progression and angiogenesis are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8iX5xdLgktLVg90H21EOLACvtfcHk0ljpQW3Ly6IOSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtVOitbw%253D&md5=4c4445eac589bded1baed3140b918be8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F1568026023393273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026023393273%26sid%3Dliteratum%253Aachs%26aulast%3DBoyer%26aufirst%3DS.%2BJ.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520KDR%2520%2528VEGFR-2%2529kinase%253A%2520an%2520overview%2520of%2520structure%2520activity%2520relationships%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2002%26volume%3D2%26spage%3D973%26epage%3D1000%26doi%3D10.2174%2F1568026023393273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Schenone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondavalli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span> </span><span class="NLM_article-title">Antiangiogenic agents: an update on small molecule VEGFR inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2495</span><span class="NLM_x">–</span> <span class="NLM_lpage">2516</span><span class="refDoi"> DOI: 10.2174/092986707782023622</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.2174%2F092986707782023622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=17979703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=2495-2516&author=S.+Schenoneauthor=F.+Bondavalliauthor=M.+Botta&title=Antiangiogenic+agents%3A+an+update+on+small+molecule+VEGFR+inhibitors&doi=10.2174%2F092986707782023622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Antiangiogenic agents: an update on small molecule VEGFR inhibitors</span></div><div class="casAuthors">Schenone, S.; Bondavalli, F.; Botta, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2495-2516</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Angiogenesis is a tightly regulated process that leads to the formation of new blood vessels sprouting from pre-existing microvasculature and occurs in limited physiol. conditions or under pathol. situations such as retinopathies, arthritis, endometriosis and cancer.  Blockade of angiogenesis is an attractive approach for the treatment of such diseases.  Particularly in malignancies, antiangiogenic therapy should be less toxic in comparison with conventional treatments such as chemotherapy, as angiogenesis is a process relatively restricted to the growing tumor.  Vascular endothelial growth factor (VEGF) is one of the most important inducers of angiogenesis and exerts its cellular effects mainly by interacting with two high-affinity transmembrane tyrosine kinase receptors: VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1).  It has been proven that inhibition of VEGF receptor activity reduces angiogenesis.  For these reasons, the inhibition of VEGF or its receptor signaling system is an attractive target for therapeutic intervention.  The most studied and developed inhibitors are monoclonal antibodies that neutralize VEGF, ribozymes, and small mol. VEGFR kinase inhibitors.  Many important reviews dealing with VEGF-induced angiogenesis and its inhibition through the block of VEGF receptors have been reported, esp. from a biol. point of view.  Here, we will review small synthetic VEGFR inhibitors that have appeared in literature in the last few years, focusing our attention on their medicinal chem. in terms of chem. structure, mechanisms of action and structure-activity relationships.  In fact, there have been an increased no. of tyrosine kinase inhibitors in the most recent literature reports; their biol. profile is extremely interesting and could be of great importance to medicinal chemists working in this area in improving their efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7o_mKLGN1mLVg90H21EOLACvtfcHk0ljpQW3Ly6IOSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrbN&md5=1cb7ea6cf7867e796f2333e5d304220c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F092986707782023622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986707782023622%26sid%3Dliteratum%253Aachs%26aulast%3DSchenone%26aufirst%3DS.%26aulast%3DBondavalli%26aufirst%3DF.%26aulast%3DBotta%26aufirst%3DM.%26atitle%3DAntiangiogenic%2520agents%253A%2520an%2520update%2520on%2520small%2520molecule%2520VEGFR%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2007%26volume%3D14%26spage%3D2495%26epage%3D2516%26doi%3D10.2174%2F092986707782023622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Musumeci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brullo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenone, S.</span><span> </span><span class="NLM_article-title">Vascular Endothelial Growth Factor (VEGF) Receptors: Drugs and New Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10797</span><span class="NLM_x">–</span> <span class="NLM_lpage">10822</span><div class="note"><p class="first last">and references therein.</p></div><span class="refDoi"> DOI: 10.1021/jm301085w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301085w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10797-10822&author=F.+Musumeciauthor=M.+Radiauthor=C.+Brulloauthor=S.+Schenone&title=Vascular+Endothelial+Growth+Factor+%28VEGF%29+Receptors%3A+Drugs+and+New+Inhibitors&doi=10.1021%2Fjm301085w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm301085w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301085w%26sid%3Dliteratum%253Aachs%26aulast%3DMusumeci%26aufirst%3DF.%26aulast%3DRadi%26aufirst%3DM.%26aulast%3DBrullo%26aufirst%3DC.%26aulast%3DSchenone%26aufirst%3DS.%26atitle%3DVascular%2520Endothelial%2520Growth%2520Factor%2520%2528VEGF%2529%2520Receptors%253A%2520Drugs%2520and%2520New%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10797%26epage%3D10822%26doi%3D10.1021%2Fjm301085w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Diago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulido, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collett, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Link, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, E. H.,  Jr.</span><span> </span><span class="NLM_article-title">Ranibizumab combined with low-dose sorafenib for exudative age-related macular degeneration</span> <span class="citation_source-journal">Mayo Clin. Proc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span><span class="refDoi"> DOI: 10.4065/83.2.231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.4065%2F83.2.231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=18241635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252FosF2itg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2008&pages=231-234&author=T.+Diagoauthor=J.+S.+Pulidoauthor=J.+R.+Molinaauthor=L.+C.+Collettauthor=T.+P.+Linkauthor=E.+H.+Ryan&title=Ranibizumab+combined+with+low-dose+sorafenib+for+exudative+age-related+macular+degeneration&doi=10.4065%2F83.2.231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Ranibizumab combined with low-dose sorafenib for exudative age-related macular degeneration</span></div><div class="casAuthors">Diago Teresa; Pulido Jose S; Molina Julian R; Collett Lucienne C; Link Thomas P; Ryan Edwin H Jr</div><div class="citationInfo"><span class="NLM_cas:title">Mayo Clinic proceedings</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">231-4</span>
        ISSN:<span class="NLM_cas:issn">0025-6196</span>.
    </div><div class="casAbstract">Angiogenesis is a common factor in the pathogenesis of cancer and in exudative age-related macular degeneration (AMD).  Therefore, angiogenesis inhibition has been developed as a therapeutic strategy.  We report 2 cases of recurrent exudative AMD in which oral sorafenib, a tyrosine kinase inhibitor approved for cancer, was added to intravitreal ranibizumab, an antibody to vascular endothelial growth factor.  These 2 patients were followed up by determination of visual acuity, fluorescein angiography, fundoscopy, and optical coherence tomography.  The visual acuity of 1 patient improved from 20/70 to 20/60 while he was receiving sorafenib therapy; that of the other did not.  Marked improvement was noted in both patients on optical coherence tomography.  Additionally, both patients appeared to receive some benefit when low-dose oral sorafenib was used as monotherapy after its initial addition to ranibizumab therapy.  Randomized trials of adding sorafenib to standard therapy for patients with neovascular AMD should be considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQChMnlkUBCzlVwdslNBF-tfW6udTcc2eYxt5OTl62Pp7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252FosF2itg%253D%253D&md5=3239159c9a781c2f097e04fd848632d5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.4065%2F83.2.231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4065%252F83.2.231%26sid%3Dliteratum%253Aachs%26aulast%3DDiago%26aufirst%3DT.%26aulast%3DPulido%26aufirst%3DJ.%2BS.%26aulast%3DMolina%26aufirst%3DJ.%2BR.%26aulast%3DCollett%26aufirst%3DL.%2BC.%26aulast%3DLink%26aufirst%3DT.%2BP.%26aulast%3DRyan%26aufirst%3DE.%2BH.%26atitle%3DRanibizumab%2520combined%2520with%2520low-dose%2520sorafenib%2520for%2520exudative%2520age-related%2520macular%2520degeneration%26jtitle%3DMayo%2520Clin.%2520Proc.%26date%3D2008%26volume%3D83%26spage%3D231%26epage%3D234%26doi%3D10.4065%2F83.2.231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Kernt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staehler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stief, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kampik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, A. S.</span><span> </span><span class="NLM_article-title">Resolution of macular oedema in occult choroidal neovascularization under oral Sorafenib treatment</span> <span class="citation_source-journal">Acta Ophthalmol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">456</span><span class="NLM_x">–</span> <span class="NLM_lpage">458</span><span class="refDoi"> DOI: 10.1111/j.1600-0420.2007.01014.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1111%2Fj.1600-0420.2007.01014.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=17908257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A280%3ADC%252BD1czjt1GqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2008&pages=456-458&author=M.+Kerntauthor=M.+Staehlerauthor=C.+Stiefauthor=A.+Kampikauthor=A.+S.+Neubauer&title=Resolution+of+macular+oedema+in+occult+choroidal+neovascularization+under+oral+Sorafenib+treatment&doi=10.1111%2Fj.1600-0420.2007.01014.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Resolution of macular oedema in occult choroidal neovascularization under oral Sorafenib treatment</span></div><div class="casAuthors">Kernt Marcus; Staehler Michael; Stief Christian; Kampik Anselm; Neubauer Aljoscha S</div><div class="citationInfo"><span class="NLM_cas:title">Acta ophthalmologica</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">456-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  To report on the effect of oral nexavar (Sorafenib) treatment in one patient with neovascular age-related macular degeneration (AMD) and advanced renal cell cancer (RCC).  METHODS:  After two intravitreal injections of bevacizumab (1.25 mg) for occult choroidal neovascularization (CNV) in AMD, the patient was started on oral Sorafenib (400 mg twice daily) treatment for RCC.  RESULTS:  Visual acuity (VA) was 20/80 in the left eye and optical coherence tomography (OCT) demonstrated persistent central thickening to 251 microm after bevacizumab.  After 6 weeks of oral Sorafenib treatment, VA had increased to 20/70 and a significant decrease in retinal thickness to 208 microm was observed on OCT.  The patient remained stable during a further 3 months of follow-up.  CONCLUSIONS:  Resolution of macular oedema and stabilization of VA under oral treatment with the multikinase inhibitor Sorafenib was observed.  This observation warrants further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnUQ4l905ipUQ0lWbKiCflfW6udTcc2eYxt5OTl62Pp7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czjt1GqtQ%253D%253D&md5=6061764af0d0c95036c65325c75b4c6a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0420.2007.01014.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0420.2007.01014.x%26sid%3Dliteratum%253Aachs%26aulast%3DKernt%26aufirst%3DM.%26aulast%3DStaehler%26aufirst%3DM.%26aulast%3DStief%26aufirst%3DC.%26aulast%3DKampik%26aufirst%3DA.%26aulast%3DNeubauer%26aufirst%3DA.%2BS.%26atitle%3DResolution%2520of%2520macular%2520oedema%2520in%2520occult%2520choroidal%2520neovascularization%2520under%2520oral%2520Sorafenib%2520treatment%26jtitle%3DActa%2520Ophthalmol.%26date%3D2008%26volume%3D86%26spage%3D456%26epage%3D458%26doi%3D10.1111%2Fj.1600-0420.2007.01014.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Amparo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadrai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso-Bartolozzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shikari, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciolino, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chodosh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurkunas, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaumberg, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dana, R.</span><span> </span><span class="NLM_article-title">Safety and Efficacy of the Multitargeted Receptor Kinase Inhibitor Pazopanib in the Treatment of Corneal Neovascularization</span> <span class="citation_source-journal">Invest. Ophthalmol. Visual Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">544</span><span class="refDoi"> DOI: 10.1167/iovs.12-11032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1167%2Fiovs.12-11032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=537-544&author=F.+Amparoauthor=Z.+Sadraiauthor=Y.+Jinauthor=B.+Alfonso-Bartolozziauthor=H.+Wangauthor=H.+Shikariauthor=J.+B.+Ciolinoauthor=J.+Chodoshauthor=U.+Jurkunasauthor=D.+A.+Schaumbergauthor=R.+Dana&title=Safety+and+Efficacy+of+the+Multitargeted+Receptor+Kinase+Inhibitor+Pazopanib+in+the+Treatment+of+Corneal+Neovascularization&doi=10.1167%2Fiovs.12-11032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1167%2Fiovs.12-11032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.12-11032%26sid%3Dliteratum%253Aachs%26aulast%3DAmparo%26aufirst%3DF.%26aulast%3DSadrai%26aufirst%3DZ.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DAlfonso-Bartolozzi%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DShikari%26aufirst%3DH.%26aulast%3DCiolino%26aufirst%3DJ.%2BB.%26aulast%3DChodosh%26aufirst%3DJ.%26aulast%3DJurkunas%26aufirst%3DU.%26aulast%3DSchaumberg%26aufirst%3DD.%2BA.%26aulast%3DDana%26aufirst%3DR.%26atitle%3DSafety%2520and%2520Efficacy%2520of%2520the%2520Multitargeted%2520Receptor%2520Kinase%2520Inhibitor%2520Pazopanib%2520in%2520the%2520Treatment%2520of%2520Corneal%2520Neovascularization%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2013%26volume%3D54%26spage%3D537%26epage%3D544%26doi%3D10.1167%2Fiovs.12-11032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kwak, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A.</span><span> </span><span class="NLM_article-title">VEGF is major stimulator in model of choroidal neovascularization</span> <span class="citation_source-journal">Invest. Ophthalmol. Vis. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">3158</span><span class="NLM_x">–</span> <span class="NLM_lpage">3164</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=3158-3164&author=N.+Kwakauthor=N.+Okamotoauthor=J.+M.+Woodauthor=P.+A.+Campochiaro&title=VEGF+is+major+stimulator+in+model+of+choroidal+neovascularization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKwak%26aufirst%3DN.%26aulast%3DOkamoto%26aufirst%3DN.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26atitle%3DVEGF%2520is%2520major%2520stimulator%2520in%2520model%2520of%2520choroidal%2520neovascularization%26jtitle%3DInvest.%2520Ophthalmol.%2520Vis.%2520Sci.%26date%3D2000%26volume%3D41%26spage%3D3158%26epage%3D3164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Bold, G.; Capraro, H.-G.; Caravatti, G.; Floersheimer, A.; Furet, P.; Manley, P.; Vaupel, A.; Pissot Soldermann, C.; Gessier, F.; Schnell, C.; Littlewood-Evans, A. J.; Kapa, P. K.; Bajwa, J. S.; Jiang, X.</span> Preparation of Bicyclic Amides as Kinase Inhibitors. PCT Int. Appl. WO 2006059234,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bold%2C+G.%3B+Capraro%2C+H.-G.%3B+Caravatti%2C+G.%3B+Floersheimer%2C+A.%3B+Furet%2C+P.%3B+Manley%2C+P.%3B+Vaupel%2C+A.%3B+Pissot+Soldermann%2C+C.%3B+Gessier%2C+F.%3B+Schnell%2C+C.%3B+Littlewood-Evans%2C+A.+J.%3B+Kapa%2C+P.+K.%3B+Bajwa%2C+J.+S.%3B+Jiang%2C+X.+Preparation+of+Bicyclic+Amides+as+Kinase+Inhibitors.+PCT+Int.+Appl.+WO+2006059234%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBold%26aufirst%3DG.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Bold, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaupel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x"> Heterobicyclic Carboxamidesas Protein Kinase Inhibitors and Their Preparation, PharmaceuticalCompositions and Use in the Treatment of Proliferative Diseases. PCTInt. Appl. </span>WO 2008009487,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bold%2C+G.%3B+Vaupel%2C+A.%3B+Lang%2C+M.+Heterobicyclic+Carboxamidesas+Protein+Kinase+Inhibitors+and+Their+Preparation%2C+PharmaceuticalCompositions+and+Use+in+the+Treatment+of+Proliferative+Diseases.+PCTInt.+Appl.+WO+2008009487%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBold%26aufirst%3DG.%26aulast%3DVaupel%26aufirst%3DA.%26aulast%3DLang%26aufirst%3DM.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Wan, Z.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wacharasindhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levins, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabei, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span> </span><span class="NLM_article-title">The Scope and Mechanism of Phosphonium-Mediated S<sub>N</sub>Ar Reactions in Heterocyclic Amides and Ureas</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">10194</span><span class="NLM_x">–</span> <span class="NLM_lpage">10210</span><span class="refDoi"> DOI: 10.1021/jo7020373</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo7020373" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=10194-10210&issue=26&author=Z.-K.+Wanauthor=S.+Wacharasindhuauthor=C.+G.+Levinsauthor=M.+Linauthor=K.+Tabeiauthor=T.+S.+Mansour&title=The+Scope+and+Mechanism+of+Phosphonium-Mediated+SNAr+Reactions+in+Heterocyclic+Amides+and+Ureas&doi=10.1021%2Fjo7020373"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjo7020373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo7020373%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DZ.-K.%26aulast%3DWacharasindhu%26aufirst%3DS.%26aulast%3DLevins%26aufirst%3DC.%2BG.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DTabei%26aufirst%3DK.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26atitle%3DThe%2520Scope%2520and%2520Mechanism%2520of%2520Phosphonium-Mediated%2520SNAr%2520Reactions%2520in%2520Heterocyclic%2520Amides%2520and%2520Ureas%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26issue%3D26%26spage%3D10194%26epage%3D10210%26doi%3D10.1021%2Fjo7020373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Ji, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jendza, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainolfi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span> </span><span class="NLM_article-title">Synthesis of 1-substituted-3-aminopyrazoles</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6799</span><span class="NLM_x">–</span> <span class="NLM_lpage">6801</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2010.10.073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1016%2Fj.tetlet.2010.10.073" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=6799-6801&author=N.+Jiauthor=E.+L.+Meredithauthor=D.+Liuauthor=C.+M.+Adamsauthor=G.+D.+Artmanauthor=K.+C.+Jendzaauthor=F.+Maauthor=N.+Mainolfiauthor=J.+J.+Powersauthor=C.+Zhang&title=Synthesis+of+1-substituted-3-aminopyrazoles&doi=10.1016%2Fj.tetlet.2010.10.073"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2010.10.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2010.10.073%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DN.%26aulast%3DMeredith%26aufirst%3DE.%2BL.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DAdams%26aufirst%3DC.%2BM.%26aulast%3DArtman%26aufirst%3DG.%2BD.%26aulast%3DJendza%26aufirst%3DK.%2BC.%26aulast%3DMa%26aufirst%3DF.%26aulast%3DMainolfi%26aufirst%3DN.%26aulast%3DPowers%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DC.%26atitle%3DSynthesis%2520of%25201-substituted-3-aminopyrazoles%26jtitle%3DTetrahedron%2520Lett.%26date%3D2010%26volume%3D51%26spage%3D6799%26epage%3D6801%26doi%3D10.1016%2Fj.tetlet.2010.10.073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Johnson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jendza, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainolfi, N.</span><span> </span><span class="NLM_article-title">A Reliable Synthesis of 3-Amino-5-Alkyl and 5-Amino-3-Alkyl Isoxazoles</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span><span class="refDoi"> DOI: 10.1055/s-0032-1317935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1055%2Fs-0032-1317935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvFeru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2013&pages=171-173&author=L.+Johnsonauthor=J.+Powersauthor=M.+Maauthor=K.+Jendzaauthor=B.+Wangauthor=E.+L.+Meredithauthor=N.+Mainolfi&title=A+Reliable+Synthesis+of+3-Amino-5-Alkyl+and+5-Amino-3-Alkyl+Isoxazoles&doi=10.1055%2Fs-0032-1317935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A reliable synthesis of 3-amino-5-alkyl and 5-amino-3-alkyl isoxazoles</span></div><div class="casAuthors">Johnson, Leland; Powers, James; Ma, Fupeng; Jendza, Keith; Wang, Bing; Meredith, Erik; Mainolfi, Nello</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-173</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A reliable procedure that can be used to access a wide range of 3-amino-5-alkyl and 5-amino-3-alkyl isoxazoles was developed.  Reaction temp. and pH were key factors that detd. the regioselectivity of the two reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLV6By8DSrZbVg90H21EOLACvtfcHk0lhd_RmJjTLX3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvFeru7k%253D&md5=1137266d2fd7af5986596f3e7910c5e8</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1055%2Fs-0032-1317935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0032-1317935%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DL.%26aulast%3DPowers%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DM.%26aulast%3DJendza%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DMeredith%26aufirst%3DE.%2BL.%26aulast%3DMainolfi%26aufirst%3DN.%26atitle%3DA%2520Reliable%2520Synthesis%2520of%25203-Amino-5-Alkyl%2520and%25205-Amino-3-Alkyl%2520Isoxazoles%26jtitle%3DSynthesis%26date%3D2013%26volume%3D45%26spage%3D171%26epage%3D173%26doi%3D10.1055%2Fs-0032-1317935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jones, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbati, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Large, C. H.</span><span> </span><span class="NLM_article-title">Automated patch clamping using the QPatch</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">565</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span><span class="refDoi"> DOI: 10.1007/978-1-60327-258-2_10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1007%2F978-1-60327-258-2_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=19551364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVKhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=565&publication_year=2009&pages=209-223&author=K.+A.+Jonesauthor=N.+Garbatiauthor=H.+Zhangauthor=C.+H.+Large&title=Automated+patch+clamping+using+the+QPatch&doi=10.1007%2F978-1-60327-258-2_10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Automated patch clamping using the QPatch</span></div><div class="casAuthors">Jones, Kenneth A.; Garbati, Nicoletta; Zhang, Hong; Large, Charles H.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (Totowa, NJ, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">565</span>
        (<span class="NLM_cas:issue">High Throughput Screening</span>),
    <span class="NLM_cas:pages">209-223</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Whole-cell voltage clamp electrophysiol. using glass patch pipettes (1) is regarded as the gold std. for measurement of compd. activity on ion channels.  Despite the high quality of the data generated by this method, in its traditional format, patch clamping has limited use in drug screening due to very low throughput.  Over the years, developments in microfabrication have driven the development of planar, multi-aperture technologies that are suitable for parallel, automated patch recording techniques.  Here we present detailed methods for two common applications of the planar patch technol. using one of the com. available instruments.  The results demonstrate (a) the high quality of whole-cell recordings obtainable from cell lines expressing human Nav1.2 or hERG ion channels, (b) the advantages of the methodol. for increasing throughput, and (c) examples of how these assays support ion channel drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrCzni5ncUF7Vg90H21EOLACvtfcHk0lhd_RmJjTLX3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVKhsg%253D%253D&md5=ffd29fd4f07481819fa9668dcb8e6354</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1007%2F978-1-60327-258-2_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-60327-258-2_10%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DK.%2BA.%26aulast%3DGarbati%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLarge%26aufirst%3DC.%2BH.%26atitle%3DAutomated%2520patch%2520clamping%2520using%2520the%2520QPatch%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2009%26volume%3D565%26spage%3D209%26epage%3D223%26doi%3D10.1007%2F978-1-60327-258-2_10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kutchinsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asmild, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taboryski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vestergaard, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krzywkowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroder, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ljungstrom, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helix, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorensen, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bech, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willumsen, N. J.</span><span> </span><span class="NLM_article-title">Characterization of potassium channel modulators with QPatch automated patch-clamp technology: system characteristics and performance</span> <span class="citation_source-journal">Assay Drug Dev. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span><span class="refDoi"> DOI: 10.1089/154065803770381048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1089%2F154065803770381048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=685-693&author=J.+Kutchinskyauthor=S.+Friisauthor=M.+Asmildauthor=R.+Taboryskiauthor=S.+Pedersenauthor=R.+K.+Vestergaardauthor=R.+B.+Jacobsenauthor=K.+Krzywkowskiauthor=R.+L.+Schroderauthor=T.+Ljungstromauthor=N.+Helixauthor=C.+B.+Sorensenauthor=M.+Bechauthor=N.+J.+Willumsen&title=Characterization+of+potassium+channel+modulators+with+QPatch+automated+patch-clamp+technology%3A+system+characteristics+and+performance&doi=10.1089%2F154065803770381048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1089%2F154065803770381048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F154065803770381048%26sid%3Dliteratum%253Aachs%26aulast%3DKutchinsky%26aufirst%3DJ.%26aulast%3DFriis%26aufirst%3DS.%26aulast%3DAsmild%26aufirst%3DM.%26aulast%3DTaboryski%26aufirst%3DR.%26aulast%3DPedersen%26aufirst%3DS.%26aulast%3DVestergaard%26aufirst%3DR.%2BK.%26aulast%3DJacobsen%26aufirst%3DR.%2BB.%26aulast%3DKrzywkowski%26aufirst%3DK.%26aulast%3DSchroder%26aufirst%3DR.%2BL.%26aulast%3DLjungstrom%26aufirst%3DT.%26aulast%3DHelix%26aufirst%3DN.%26aulast%3DSorensen%26aufirst%3DC.%2BB.%26aulast%3DBech%26aufirst%3DM.%26aulast%3DWillumsen%26aufirst%3DN.%2BJ.%26atitle%3DCharacterization%2520of%2520potassium%2520channel%2520modulators%2520with%2520QPatch%2520automated%2520patch-clamp%2520technology%253A%2520system%2520characteristics%2520and%2520performance%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2003%26volume%3D1%26spage%3D685%26epage%3D693%26doi%3D10.1089%2F154065803770381048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span> </span><span class="NLM_article-title">Development of a High Throughput Equilibrium Solubility Assay Using Miniaturized Shake-Flask Method in Early Drug Discovery</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">3052</span><span class="NLM_x">–</span> <span class="NLM_lpage">3071</span><span class="refDoi"> DOI: 10.1002/jps.20913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1002%2Fjps.20913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=17722003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12jtrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=3052-3071&author=L.+Zhouauthor=L.+Yangauthor=S.+Tiltonauthor=J.+Wang&title=Development+of+a+High+Throughput+Equilibrium+Solubility+Assay+Using+Miniaturized+Shake-Flask+Method+in+Early+Drug+Discovery&doi=10.1002%2Fjps.20913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a high throughput equilibrium solubility assay using miniaturized shake-flask method in early drug discovery</span></div><div class="casAuthors">Zhou, Liping; Yang, Linhong; Tilton, Suzanne; Wang, Jianling</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3052-3071</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Increasingly, pharmaceutical and biotech companies have begun to realize the importance of obtaining soly. information in early drug discovery as it is one of the crit. parameters for lead selection and optimization.  This report introduces a high-throughput equil. soly. (HT-Eq sol) assay using a novel miniaturized shake-flask approach and streamlined HPLC anal.  The new HT-Eq sol assay, validated and optimized via a test set of 85 marketed drugs and Novartis internal compds., shows an excellent correlation to the conventional shake-flask thermodn. soly. data generated inhouse and the equil. soly. results reported in literature.  It therefore offers a fast, reliable and cost-effective screening tool for soly. assessment in early drug discovery, allowing for prioritization of drug candidates using aq. soly. in conjunction with other profiling information and efficacy data.  Our work demonstrates that presence of a small amt. of DMSO (0.5-5%) will result in significant overestimation of equil. soly. (up to 6 folds).  In addn., monitoring of drug dissoln. process using the current approach as well as the interplay between equil. soly. data and those from kinetic soly. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLEKUmI4vDMLVg90H21EOLACvtfcHk0lizK_OfgVnOyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12jtrrO&md5=e04d5b859372d08551b4a6af19e23fb5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fjps.20913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20913%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DTilton%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%2520a%2520High%2520Throughput%2520Equilibrium%2520Solubility%2520Assay%2520Using%2520Miniaturized%2520Shake-Flask%2520Method%2520in%2520Early%2520Drug%2520Discovery%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2007%26volume%3D96%26spage%3D3052%26epage%3D3071%26doi%3D10.1002%2Fjps.20913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saishin, Yo.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saishin</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A.</span><span> </span><span class="NLM_article-title">Suppression and Regression of Choroidal Neovascularization by the Multitargeted Kinase Inhibitor Pazopanib</span> <span class="citation_source-journal">Arch. Ophthalmol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">494</span><span class="NLM_x">–</span> <span class="NLM_lpage">499</span><span class="refDoi"> DOI: 10.1001/archophthalmol.2009.27</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1001%2Farchophthalmol.2009.27" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=19365030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVWgu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2009&pages=494-499&author=K.+Takahashiauthor=Yo.+Saishinauthor=+Saishinauthor=+Yuauthor=A.+G.+Kingauthor=R.+Levinauthor=P.+A.+Campochiaro&title=Suppression+and+Regression+of+Choroidal+Neovascularization+by+the+Multitargeted+Kinase+Inhibitor+Pazopanib&doi=10.1001%2Farchophthalmol.2009.27"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression and regression of choroidal neovascularization by the multitargeted kinase inhibitor pazopanib</span></div><div class="casAuthors">Takahashi, Kyoichi; Saishin, Yoshitsugu; Saishin, Yumiko; King, Andrew G.; Levin, Robert; Campochiaro, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Ophthalmology (Chicago, IL, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">494-499</span>CODEN:
                <span class="NLM_cas:coden">AROPAW</span>;
        ISSN:<span class="NLM_cas:issn">0003-9950</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">To investigate pazopanib hydrochloride, a multitargeted kinase inhibitor, for treatment of choroidal neovascularization (CNV).  Choroidal neovascularization was induced in mice by rupture of Bruch membrane with laser photocoagulation.  Mice were treated with pazopanib by gavage or periocular injection, and the area of CNV was measured.  Twice-daily gavage of pazopanib, 100 mg/kg, suppressed the development of CNV by 93%.  Treatment of established CNV between days 7 and 14 with 8, 40, or 200 mg/kg per day reduced CNV by 0%, 58%, and 71%, resp.  Substantial regression (40%) of CNV was also achieved after periocular injection of pazopanib.  A single oral dose of 4 or 100 mg/kg resulted in an area under the curve from time 0 to the last quantifiable concn. of 129.6 and 752.0 μg/h/mL, resp.  After 7 days of 4, 20, or 100 mg/kg twice a day by gavage, plasma levels were 1300, 4900, and 5800 ng/mL and levels in the retina/choroid were 4800, 28,800, and 38,000 ng/g of tissue.  Orally administered pazopanib has good bioavailability to the retina/choroid and strongly suppresses CNV in mice.  Treatment with pazopanib after CNV is established causes dose-dependent regression of CNV.  Pazopanib may be useful for treatment of CNV in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5KrkISTQQTLVg90H21EOLACvtfcHk0lizK_OfgVnOyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVWgu7Y%253D&md5=13d6c8f38b906a3668a3dc630480c819</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1001%2Farchophthalmol.2009.27&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchophthalmol.2009.27%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DSaishin%26aufirst%3DYo.%26aulast%3DSaishin%26aulast%3DYu%26aulast%3DKing%26aufirst%3DA.%2BG.%26aulast%3DLevin%26aufirst%3DR.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26atitle%3DSuppression%2520and%2520Regression%2520of%2520Choroidal%2520Neovascularization%2520by%2520the%2520Multitargeted%2520Kinase%2520Inhibitor%2520Pazopanib%26jtitle%3DArch.%2520Ophthalmol.%26date%3D2009%26volume%3D127%26spage%3D494%26epage%3D499%26doi%3D10.1001%2Farchophthalmol.2009.27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Connolly, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matchett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarma, K.</span><span> </span><span class="NLM_article-title">Process Development and Scale-up of a Selective α<sub>1</sub>-Adrenoreceptor Antagonist</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1021/op0498114</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op0498114" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2005&pages=80-87&author=T.+J.+Connollyauthor=M.+Matchettauthor=K.+Sarma&title=Process+Development+and+Scale-up+of+a+Selective+%CE%B11-Adrenoreceptor+Antagonist&doi=10.1021%2Fop0498114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fop0498114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop0498114%26sid%3Dliteratum%253Aachs%26aulast%3DConnolly%26aufirst%3DT.%2BJ.%26aulast%3DMatchett%26aufirst%3DM.%26aulast%3DSarma%26aufirst%3DK.%26atitle%3DProcess%2520Development%2520and%2520Scale-up%2520of%2520a%2520Selective%2520%25CE%25B11-Adrenoreceptor%2520Antagonist%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2005%26volume%3D9%26spage%3D80%26epage%3D87%26doi%3D10.1021%2Fop0498114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Seelen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shäfer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, A.</span><span> </span><span class="NLM_article-title">Selective ring N-protection of aminopyrazoles</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4491</span><span class="NLM_x">–</span> <span class="NLM_lpage">4493</span><span class="refDoi"> DOI: 10.1016/S0040-4039(03)00988-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1016%2FS0040-4039%2803%2900988-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=4491-4493&author=W.+Seelenauthor=M.+Sh%C3%A4ferauthor=A.+Ernst&title=Selective+ring+N-protection+of+aminopyrazoles&doi=10.1016%2FS0040-4039%2803%2900988-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2803%2900988-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252803%252900988-2%26sid%3Dliteratum%253Aachs%26aulast%3DSeelen%26aufirst%3DW.%26aulast%3DSh%25C3%25A4fer%26aufirst%3DM.%26aulast%3DErnst%26aufirst%3DA.%26atitle%3DSelective%2520ring%2520N-protection%2520of%2520aminopyrazoles%26jtitle%3DTetrahedron%2520Lett.%26date%3D2003%26volume%3D44%26spage%3D4491%26epage%3D4493%26doi%3D10.1016%2FS0040-4039%2803%2900988-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25a','cit25b'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 19 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kuei-Ju Cheng, Chien-Ming Hsieh, Kunal Nepali, <span class="NLM_string-name hlFld-ContribAuthor">Jing-Ping Liou</span>. </span><span class="cited-content_cbyCitation_article-title">Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10533-10593. <a href="https://doi.org/10.1021/acs.jmedchem.9b01033" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01033%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOcular%252BDisease%252BTherapeutics%25253A%252BDesign%252Band%252BDelivery%252Bof%252BDrugs%252Bfor%252BDiseases%252Bof%252Bthe%252BEye%26aulast%3DCheng%26aufirst%3DKuei-Ju%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D28062019%26date%3D02062020%26volume%3D63%26issue%3D19%26spage%3D10533%26epage%3D10593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nello Mainolfi, Takeru Ehara, Rajeshri G. Karki, Karen Anderson, Aengus Mac Sweeney, Sha-Mei Liao, Upendra A. Argikar, Keith Jendza, Chun Zhang, James Powers, Daniel W. Klosowski, Maura Crowley, Toshio Kawanami, Jian Ding, Myriam April, Cornelia Forster, Michael Serrano-Wu, Michael Capparelli, Rrezarta Ramqaj, Catherine Solovay, Frederic Cumin, Thomas M. Smith, Luciana Ferrara, Wendy Lee, Debby Long, Melissa Prentiss, Andrea De Erkenez, Louis Yang, Fang Liu, Holger Sellner, Finton Sirockin, Eric Valeur, Paulus Erbel, Daniela Ostermeier, Paul Ramage, Bernd Gerhartz, Anna Schubart, Stefanie Flohr, Nathalie Gradoux, Roland Feifel, Barbara Vogg, Christian Wiesmann, Jürgen Maibaum, Jörg Eder, Richard Sedrani, Richard A. Harrison, Muneto Mogi, Bruce D. Jaffee, <span class="NLM_string-name hlFld-ContribAuthor">Christopher M. Adams</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-((2S,4S)-4-Ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 5697-5722. <a href="https://doi.org/10.1021/acs.jmedchem.9b01870" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01870</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01870%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B4-%252528%2525282S%25252C4S%252529-4-Ethoxy-1-%252528%2525285-methoxy-7-methyl-1H-indol-4-yl%252529methyl%252529piperidin-2-yl%252529benzoic%252BAcid%252B%252528LNP023%252529%25252C%252Ba%252BFactor%252BB%252BInhibitor%252BSpecifically%252BDesigned%252BTo%252BBe%252BApplicable%252Bto%252BTreating%252Ba%252BDiverse%252BArray%252Bof%252BComplement%252BMediated%252BDiseases%26aulast%3DMainolfi%26aufirst%3DNello%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D11112019%26date%3D19022020%26volume%3D63%26issue%3D11%26spage%3D5697%26epage%3D5722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hua Xu, Wenhao Yin, Haoqiang Liang, Yanbo Nan, Fayang Qiu, <span class="NLM_string-name hlFld-ContribAuthor">Yehua Jin</span>. </span><span class="cited-content_cbyCitation_article-title">A Scalable Total Synthesis of Halofuginone. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2019,</strong> <em>23 </em>
                                    (5)
                                     , 990-997. <a href="https://doi.org/10.1021/acs.oprd.9b00059" title="DOI URL">https://doi.org/10.1021/acs.oprd.9b00059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.9b00059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.9b00059%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DA%252BScalable%252BTotal%252BSynthesis%252Bof%252BHalofuginone%26aulast%3DXu%26aufirst%3DHua%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D01022019%26date%3D14032019%26date%3D06032019%26volume%3D23%26issue%3D5%26spage%3D990%26epage%3D997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher M.  Adams</span>, <span class="hlFld-ContribAuthor ">Karen  Anderson</span>, <span class="hlFld-ContribAuthor ">Gerald  Artman, III</span>, <span class="hlFld-ContribAuthor ">Jean-Claude  Bizec</span>, <span class="hlFld-ContribAuthor ">Rosemarie  Cepeda</span>, <span class="hlFld-ContribAuthor ">Jason  Elliott</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Fassbender</span>, <span class="hlFld-ContribAuthor ">Malay  Ghosh</span>, <span class="hlFld-ContribAuthor ">Shawn  Hanks</span>, <span class="hlFld-ContribAuthor ">Leo A.  Hardegger</span>, <span class="hlFld-ContribAuthor ">Vinayak P.  Hosagrahara</span>, <span class="hlFld-ContribAuthor ">Bruce  Jaffee</span>, <span class="hlFld-ContribAuthor ">Keith  Jendza</span>, <span class="hlFld-ContribAuthor ">Nan  Ji</span>, <span class="hlFld-ContribAuthor ">Leland  Johnson</span>, <span class="hlFld-ContribAuthor ">Wendy  Lee</span>, <span class="hlFld-ContribAuthor ">Donglei  Liu</span>, <span class="hlFld-ContribAuthor ">Fang  Liu</span>, <span class="hlFld-ContribAuthor ">Debby  Long</span>, <span class="hlFld-ContribAuthor ">Fupeng  Ma</span>, <span class="hlFld-ContribAuthor ">Nello  Mainolfi</span>, <span class="hlFld-ContribAuthor ">Erik L.  Meredith</span>, <span class="hlFld-ContribAuthor ">Karl  Miranda</span>, <span class="hlFld-ContribAuthor ">Yao  Peng</span>, <span class="hlFld-ContribAuthor ">Stephen  Poor</span>, <span class="hlFld-ContribAuthor ">James  Powers</span>, <span class="hlFld-ContribAuthor ">Yubin  Qiu</span>, <span class="hlFld-ContribAuthor ">Chang  Rao</span>, <span class="hlFld-ContribAuthor ">Siyuan  Shen</span>, <span class="hlFld-ContribAuthor ">Jeremy M.  Sivak</span>, <span class="hlFld-ContribAuthor ">Catherine  Solovay</span>, <span class="hlFld-ContribAuthor ">Peter  Tarsa</span>, <span class="hlFld-ContribAuthor ">Amber  Woolfenden</span>, <span class="hlFld-ContribAuthor ">Chun  Zhang</span>, and <span class="hlFld-ContribAuthor ">Yiqin  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery of N-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (4)
                                     , 1622-1635. <a href="https://doi.org/10.1021/acs.jmedchem.7b01731" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01731</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01731%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252BN-%2525281-Methyl-5-%252528trifluoromethyl%252529-1H-pyrazol-3-yl%252529-5-%252528%2525286-%252B%252528%252528methylamino%252529methyl%252529pyrimidin-4-yl%252529oxy%252529-1H-indole-1-carboxamide%252B%252528Acrizanib%252529%25252C%252Ba%252BVEGFR-2%252BInhibitor%252BSpecifically%252BDesigned%252Bfor%252BTopical%252BOcular%252BDelivery%25252C%252Bas%252Ba%252BTherapy%252Bfor%252BNeovascular%252BAge-Related%252BMacular%252BDegeneration%26aulast%3DAdams%26aufirst%3DChristopher%2BM.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D28112017%26date%3D05022018%26date%3D22022018%26volume%3D61%26issue%3D4%26spage%3D1622%26epage%3D1635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhanling  Cheng</span>, <span class="hlFld-ContribAuthor ">Zhiliang  Yu</span>, <span class="hlFld-ContribAuthor ">Song  Yang</span>, <span class="hlFld-ContribAuthor ">Hong C.  Shen</span>, <span class="hlFld-ContribAuthor ">Weili  Zhao</span>, and <span class="hlFld-ContribAuthor ">Sheng  Zhong</span>  . </span><span class="cited-content_cbyCitation_article-title">C–H Bond Functionalization of Tetrahydropyridopyrimidines and Other Related Hetereocycles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (24)
                                     , 13678-13685. <a href="https://doi.org/10.1021/acs.joc.7b02382" title="DOI URL">https://doi.org/10.1021/acs.joc.7b02382</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b02382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b02382%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DC%2525E2%252580%252593H%252BBond%252BFunctionalization%252Bof%252BTetrahydropyridopyrimidines%252Band%252BOther%252BRelated%252BHetereocycles%26aulast%3DCheng%26aufirst%3DZhanling%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D29092017%26date%3D22112017%26date%3D15122017%26date%3D14112017%26volume%3D82%26issue%3D24%26spage%3D13678%26epage%3D13685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nello  Mainolfi</span>, <span class="hlFld-ContribAuthor ">Rajeshri  Karki</span>, <span class="hlFld-ContribAuthor ">Fang  Liu</span>, and <span class="hlFld-ContribAuthor ">Karen  Anderson</span>  . </span><span class="cited-content_cbyCitation_article-title">Evolution of a New Class of VEGFR-2 Inhibitors from Scaffold Morphing and Redesign. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (4)
                                     , 363-367. <a href="https://doi.org/10.1021/acsmedchemlett.5b00486" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00486</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00486%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEvolution%252Bof%252Ba%252BNew%252BClass%252Bof%252BVEGFR-2%252BInhibitors%252Bfrom%252BScaffold%252BMorphing%252Band%252BRedesign%26aulast%3DMainolfi%26aufirst%3DNello%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D14122015%26date%3D02022016%26date%3D08022016%26date%3D14042016%26date%3D02022016%26volume%3D7%26issue%3D4%26spage%3D363%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nello  Mainolfi</span>, <span class="hlFld-ContribAuthor ">James  Powers</span>, <span class="hlFld-ContribAuthor ">Erik  Meredith</span>, <span class="hlFld-ContribAuthor ">Jason  Elliott</span>, <span class="hlFld-ContribAuthor ">Karl G.  Gunderson</span>, <span class="hlFld-ContribAuthor ">Stephen  Poor</span>, <span class="hlFld-ContribAuthor ">Fang  Liu</span>, and <span class="hlFld-ContribAuthor ">Karen  Anderson</span>  . </span><span class="cited-content_cbyCitation_article-title">Core Replacements in a Potent Series of VEGFR-2 Inhibitors and Their Impact on Potency, Solubility, and hERG. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (4)
                                     , 357-362. <a href="https://doi.org/10.1021/acsmedchemlett.6b00018" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00018%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCore%252BReplacements%252Bin%252Ba%252BPotent%252BSeries%252Bof%252BVEGFR-2%252BInhibitors%252Band%252BTheir%252BImpact%252Bon%252BPotency%25252C%252BSolubility%25252C%252Band%252BhERG%26aulast%3DMainolfi%26aufirst%3DNello%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D19012016%26date%3D16032016%26date%3D01042016%26date%3D14042016%26date%3D16032016%26volume%3D7%26issue%3D4%26spage%3D357%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satoshi  Inoue</span>, <span class="hlFld-ContribAuthor ">Yoshinobu  Yamane</span>, <span class="hlFld-ContribAuthor ">Shuntaro  Tsukamoto</span>, <span class="hlFld-ContribAuthor ">Norio  Murai</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Azuma</span>, <span class="hlFld-ContribAuthor ">Satoshi  Nagao</span>, <span class="hlFld-ContribAuthor ">Kyoko  Nishibata</span>, <span class="hlFld-ContribAuthor ">Sayo  Fukushima</span>, <span class="hlFld-ContribAuthor ">Kenji  Ichikawa</span>, <span class="hlFld-ContribAuthor ">Takayuki  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Naoko  Hata Sugi</span>, <span class="hlFld-ContribAuthor ">Daisuke  Ito</span>, <span class="hlFld-ContribAuthor ">Yu  Kato</span>, <span class="hlFld-ContribAuthor ">Aya  Goto</span>, <span class="hlFld-ContribAuthor ">Dai  Kakiuchi</span>, <span class="hlFld-ContribAuthor ">Takashi  Ueno</span>, <span class="hlFld-ContribAuthor ">Junji  Matsui</span>, <span class="hlFld-ContribAuthor ">Tomohiro  Matsushima</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine derivatives as novel selective Axl inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>48 </em>, 128247. <a href="https://doi.org/10.1016/j.bmcl.2021.128247" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128247</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128247%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B5%25252C6%25252C7%25252C8-tetrahydropyrido%25255B3%25252C4-d%25255Dpyrimidine%252Bderivatives%252Bas%252Bnovel%252Bselective%252BAxl%252Binhibitors%26aulast%3DInoue%26aufirst%3DSatoshi%26date%3D2021%26volume%3D48%26spage%3D128247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eunsoo  Jung</span>, <span class="hlFld-ContribAuthor ">Woo Kwon  Jung</span>, <span class="hlFld-ContribAuthor ">Su‐Bin  Park</span>, <span class="hlFld-ContribAuthor ">Hyung Rae  Kim</span>, <span class="hlFld-ContribAuthor ">Junghyun  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Aucuba japonica
              extract inhibits retinal neovascularization in a mouse model of oxygen‐induced retinopathy, with its bioactive components preventing VEGF‐induced retinal vascular hyperpermeability. </span><span class="cited-content_cbyCitation_journal-name">Food Science & Nutrition</span><span> <strong>2020,</strong> <em>8 </em>
                                    (6)
                                     , 2895-2903. <a href="https://doi.org/10.1002/fsn3.1590" title="DOI URL">https://doi.org/10.1002/fsn3.1590</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/fsn3.1590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Ffsn3.1590%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520Science%2520%2526%2520Nutrition%26atitle%3DAucuba%252Bjaponica%252Bextract%252Binhibits%252Bretinal%252Bneovascularization%252Bin%252Ba%252Bmouse%252Bmodel%252Bof%252Boxygen%2525E2%252580%252590induced%252Bretinopathy%25252C%252Bwith%252Bits%252Bbioactive%252Bcomponents%252Bpreventing%252BVEGF%2525E2%252580%252590induced%252Bretinal%252Bvascular%252Bhyperpermeability%26aulast%3DJung%26aufirst%3DEunsoo%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D6%26spage%3D2895%26epage%3D2903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amanda  Garrido</span>, <span class="hlFld-ContribAuthor ">Alban  Lepailleur</span>, <span class="hlFld-ContribAuthor ">Serge M.  Mignani</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>. </span><span class="cited-content_cbyCitation_article-title">hERG toxicity assessment: Useful guidelines for drug design. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>195 </em>, 112290. <a href="https://doi.org/10.1016/j.ejmech.2020.112290" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112290</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112290%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DhERG%252Btoxicity%252Bassessment%25253A%252BUseful%252Bguidelines%252Bfor%252Bdrug%252Bdesign%26aulast%3DGarrido%26aufirst%3DAmanda%26date%3D2020%26volume%3D195%26spage%3D112290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valeria  Tarallo</span>, <span class="hlFld-ContribAuthor ">Emanuela  Iaccarino</span>, <span class="hlFld-ContribAuthor ">Valeria  Cicatiello</span>, <span class="hlFld-ContribAuthor ">Riccardo  Sanna</span>, <span class="hlFld-ContribAuthor ">Menotti  Ruvo</span>, <span class="hlFld-ContribAuthor ">Sandro  De Falco</span>. </span><span class="cited-content_cbyCitation_article-title">Oral Delivery of a Tetrameric Tripeptide Inhibitor of VEGFR1 Suppresses Pathological Choroid Neovascularization. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (2)
                                     , 410. <a href="https://doi.org/10.3390/ijms21020410" title="DOI URL">https://doi.org/10.3390/ijms21020410</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21020410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21020410%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DOral%252BDelivery%252Bof%252Ba%252BTetrameric%252BTripeptide%252BInhibitor%252Bof%252BVEGFR1%252BSuppresses%252BPathological%252BChoroid%252BNeovascularization%26aulast%3DTarallo%26aufirst%3DValeria%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D2%26spage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed  Monier</span>, <span class="hlFld-ContribAuthor ">Doaa  Abdel-Latif</span>, <span class="hlFld-ContribAuthor ">Ahmed  El-Mekabaty</span>, <span class="hlFld-ContribAuthor ">Başak D.  Mert</span>, <span class="hlFld-ContribAuthor ">Khaled M.  Elattar</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the Chemistry of 6-6 Bicyclic Systems: Chemistry of Pyrido[3,4- d]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Synthesis</span><span> <strong>2019,</strong> <em>16 </em>
                                    (6)
                                     , 812-854. <a href="https://doi.org/10.2174/1570179416666190704113647" title="DOI URL">https://doi.org/10.2174/1570179416666190704113647</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570179416666190704113647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570179416666190704113647%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Synthesis%26atitle%3DAdvances%252Bin%252Bthe%252BChemistry%252Bof%252B6-6%252BBicyclic%252BSystems%25253A%252BChemistry%252Bof%252BPyrido%25255B3%25252C4-%252Bd%25255Dpyrimidines%26aulast%3DMonier%26aufirst%3DMohamed%26date%3D2019%26volume%3D16%26issue%3D6%26spage%3D812%26epage%3D854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nevine M.Y.  Elsayed</span>, <span class="hlFld-ContribAuthor ">Rabah A.T.  Serya</span>, <span class="hlFld-ContribAuthor ">Mai F.  Tolba</span>, <span class="hlFld-ContribAuthor ">Marawan  Ahmed</span>, <span class="hlFld-ContribAuthor ">Khaled  Barakat</span>, <span class="hlFld-ContribAuthor ">Dalal A.  Abou El Ella</span>, <span class="hlFld-ContribAuthor ">Khaled A.M.  Abouzid</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>82 </em>, 340-359. <a href="https://doi.org/10.1016/j.bioorg.2018.10.071" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.10.071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.10.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.10.071%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bdynamics%252Bsimulation%252Bof%252Bindazole%252Bderivatives%252Bwith%252Bantiangiogenic%252Band%252Bantiproliferative%252Banticancer%252Bactivity%26aulast%3DElsayed%26aufirst%3DNevine%2BM.Y.%26date%3D2019%26volume%3D82%26spage%3D340%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanyuan  Shan</span>, <span class="hlFld-ContribAuthor ">Binghe  Wang</span>, <span class="hlFld-ContribAuthor ">Jie  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">New strategies in achieving antiangiogenic effect: Multiplex inhibitors suppressing compensatory activations of RTKs. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2018,</strong> <em>38 </em>
                                    (5)
                                     , 1674-1705. <a href="https://doi.org/10.1002/med.21517" title="DOI URL">https://doi.org/10.1002/med.21517</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21517%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DNew%252Bstrategies%252Bin%252Bachieving%252Bantiangiogenic%252Beffect%25253A%252BMultiplex%252Binhibitors%252Bsuppressing%252Bcompensatory%252Bactivations%252Bof%252BRTKs%26aulast%3DShan%26aufirst%3DYuanyuan%26date%3D2018%26date%3D2018%26volume%3D38%26issue%3D5%26spage%3D1674%26epage%3D1705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fleur M.  Ferguson</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase inhibitors: the road ahead. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2018,</strong> <em>17 </em>
                                    (5)
                                     , 353-377. <a href="https://doi.org/10.1038/nrd.2018.21" title="DOI URL">https://doi.org/10.1038/nrd.2018.21</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd.2018.21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd.2018.21%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DKinase%252Binhibitors%25253A%252Bthe%252Broad%252Bahead%26aulast%3DFerguson%26aufirst%3DFleur%2BM.%26date%3D2018%26date%3D2018%26volume%3D17%26issue%3D5%26spage%3D353%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junghyun  Kim</span>, <span class="hlFld-ContribAuthor ">Yun Mi  Lee</span>, <span class="hlFld-ContribAuthor ">Wookwon  Jung</span>, <span class="hlFld-ContribAuthor ">Su-Bin  Park</span>, <span class="hlFld-ContribAuthor ">Chan-Sik  Kim</span>, <span class="hlFld-ContribAuthor ">Jin Sook  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Aster koraiensis
              Extract and Chlorogenic Acid Inhibit Retinal Angiogenesis in a Mouse Model of Oxygen-Induced Retinopathy. </span><span class="cited-content_cbyCitation_journal-name">Evidence-Based Complementary and Alternative Medicine</span><span> <strong>2018,</strong> <em>2018 </em>, 1-8. <a href="https://doi.org/10.1155/2018/6402650" title="DOI URL">https://doi.org/10.1155/2018/6402650</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2018/6402650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2018%2F6402650%26sid%3Dliteratum%253Aachs%26jtitle%3DEvidence-Based%2520Complementary%2520and%2520Alternative%2520Medicine%26atitle%3DAster%252Bkoraiensis%252BExtract%252Band%252BChlorogenic%252BAcid%252BInhibit%252BRetinal%252BAngiogenesis%252Bin%252Ba%252BMouse%252BModel%252Bof%252BOxygen-Induced%252BRetinopathy%26aulast%3DKim%26aufirst%3DJunghyun%26date%3D2018%26volume%3D2018%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paweł  Borowiecki</span>, <span class="hlFld-ContribAuthor ">Iwona  Justyniak</span>, <span class="hlFld-ContribAuthor ">Zbigniew  Ochal</span>. </span><span class="cited-content_cbyCitation_article-title">Lipase-catalyzed kinetic resolution approach toward enantiomerically enriched 1-(β-hydroxypropyl)indoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron: Asymmetry</span><span> <strong>2017,</strong> <em>28 </em>
                                    (12)
                                     , 1717-1732. <a href="https://doi.org/10.1016/j.tetasy.2017.10.010" title="DOI URL">https://doi.org/10.1016/j.tetasy.2017.10.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetasy.2017.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetasy.2017.10.010%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%253A%2520Asymmetry%26atitle%3DLipase-catalyzed%252Bkinetic%252Bresolution%252Bapproach%252Btoward%252Benantiomerically%252Benriched%252B1-%252528%2525CE%2525B2-hydroxypropyl%252529indoles%26aulast%3DBorowiecki%26aufirst%3DPawe%25C5%2582%26date%3D2017%26volume%3D28%26issue%3D12%26spage%3D1717%26epage%3D1732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eunsoo  Jung</span>, <span class="hlFld-ContribAuthor ">Wookwon  Jung</span>, <span class="hlFld-ContribAuthor ">Su-Bin  Park</span>, <span class="hlFld-ContribAuthor ">Chan-Sik  Kim</span>, <span class="hlFld-ContribAuthor ">Jin Sook  Kim</span>, <span class="hlFld-ContribAuthor ">Junghyun  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">EGHB010, a Standardized Extract of Paeoniae Radix and Glycyrrhizae Radix, Inhibits VEGF-Induced Tube Formation In Vitro and Retinal Vascular Leakage and Choroidal Neovascularization In Vivo. </span><span class="cited-content_cbyCitation_journal-name">Evidence-Based Complementary and Alternative Medicine</span><span> <strong>2017,</strong> <em>2017 </em>, 1-7. <a href="https://doi.org/10.1155/2017/1568702" title="DOI URL">https://doi.org/10.1155/2017/1568702</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2017/1568702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2017%2F1568702%26sid%3Dliteratum%253Aachs%26jtitle%3DEvidence-Based%2520Complementary%2520and%2520Alternative%2520Medicine%26atitle%3DEGHB010%25252C%252Ba%252BStandardized%252BExtract%252Bof%252BPaeoniae%252BRadix%252Band%252BGlycyrrhizae%252BRadix%25252C%252BInhibits%252BVEGF-Induced%252BTube%252BFormation%252BIn%252BVitro%252Band%252BRetinal%252BVascular%252BLeakage%252Band%252BChoroidal%252BNeovascularization%252BIn%252BVivo%26aulast%3DJung%26aufirst%3DEunsoo%26date%3D2017%26volume%3D2017%26spage%3D1%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/medium/jm-2015-01227y_0013.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01227&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/medium/jm-2015-01227y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01227&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) DBU, CH<sub>3</sub>CN, 75%; (ii) NaH, R<sup>2</sup>NCO, DMF, −50 °C to rt, 88%; (iii) TFA, 100 °C, 74%; (iv) Ms<sub>2</sub>O, pyridine, THF; (v) CH<sub>3</sub>NH<sub>2</sub>, MeOH, 54%, 2 steps.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/medium/jm-2015-01227y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01227&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) formamidine acetate, EtONa, EtOH, reflux, 90%; (ii) Pd/C, Boc<sub>2</sub>O, MeOH/THF; (iii) CCl<sub>4</sub>, PPh<sub>3</sub>, DCE, reflux, 80%, 2 steps.</p></p></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/medium/jm-2015-01227y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01227&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) <b>11</b>, <b>12</b>, NaBH(OAc)<sub>3</sub>, TEA, DCE; (ii) ethyl oxobutanoate, NaBH(OAc)<sub>3</sub>, DCE; (iii) <i>t</i>BuOK, toluene; (iv) formamidine acetate, EtONa, EtOH, reflux, 36% 4 steps; (v) Pd/C, Boc<sub>2</sub>O, MeOH; (vi) CCl<sub>4</sub>, PPh<sub>3</sub>, DCE, reflux 57%, 2 steps.</p></p></figure><figure data-id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/medium/jm-2015-01227y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01227&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) <b>16</b>, <b>17</b>, NaBH(OAc)<sub>3</sub>, DCE; (ii) ethyl glyoxylate, NaBH(OAc)<sub>3</sub>, DCE; (iii) <i>t</i>BuOK, toluene, 50–70%, 3 steps; (iv) formamidine acetate, EtONa, EtOH, reflux, 93%; (v) Pd/C, Boc<sub>2</sub>O, EtOH, 80%, 2 steps; (vi) CCl<sub>4</sub>, PPh<sub>3</sub>, DCE, reflux, 51%.</p></p></figure><figure data-id="sch5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/medium/jm-2015-01227y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01227&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) formamidine acetate, EtONa, EtOH, reflux, 24%.</p></p></figure><figure data-id="sch6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/medium/jm-2015-01227y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01227&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NaH, toluene, 0 °C to rt; (ii) formamidine acetate, EtONa, EtOH, reflux, ∼ 20%.</p></p></figure><figure data-id="sch7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/medium/jm-2015-01227y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b01227/20151204/images/large/jm-2015-01227y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01227&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) <b>10</b>, <b>15</b>, <b>21</b>, or <b>22</b>, DBU, CH<sub>3</sub>CN, reflux, 90%; (ii) <b>24</b> or <b>28</b>, PyBop, acetonitrile, DBU, 64%; (iii) <b>25</b>, phenyl chloroformate, pyridine, 86%; (iv) <b>32</b> or R<sup>2</sup>NCO, NaH, THF, 0 °C-rt, 50%; (v) TFA, DCM, 92%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80278" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80278" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 29 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">CATT Research Group</span><span> </span><span class="NLM_article-title">Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">364</span><span class="NLM_x">, </span> <span class="NLM_fpage">1897</span><span class="NLM_x">–</span> <span class="NLM_lpage">1908</span><span class="refDoi"> DOI: 10.1056/NEJMoa1102673</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1056%2FNEJMoa1102673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=21526923" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2011&pages=1897-1908&author=CATT+Research+Group&title=Ranibizumab+and+Bevacizumab+for+Neovascular+Age-Related+Macular+Degeneration&doi=10.1056%2FNEJMoa1102673"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1102673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1102673%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DRanibizumab%2520and%2520Bevacizumab%2520for%2520Neovascular%2520Age-Related%2520Macular%2520Degeneration%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D364%26spage%3D1897%26epage%3D1908%26doi%3D10.1056%2FNEJMoa1102673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Brown, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michels, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soubrane, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heier, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span> </span><span class="NLM_article-title">Ranibizumab versus verteporfin for neovascular age-related macular degeneration</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">1432</span><span class="NLM_x">–</span> <span class="NLM_lpage">1444</span><span class="refDoi"> DOI: 10.1056/NEJMoa062655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1056%2FNEJMoa062655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=17021319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVGgtrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=1432-1444&author=D.+M.+Brownauthor=P.+K.+Kaiserauthor=M.+Michelsauthor=G.+Soubraneauthor=J.+S.+Heierauthor=R.+Y.+Kimauthor=J.+P.+Syauthor=S.+Schneider&title=Ranibizumab+versus+verteporfin+for+neovascular+age-related+macular+degeneration&doi=10.1056%2FNEJMoa062655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Ranibizumab versus verteporfin for neovascular age-related macular degeneration</span></div><div class="casAuthors">Brown, David M.; Kaiser, Peter K.; Michels, Mark; Soubrane, Gisele; Heier, Effrey S.; Kim, Robert Y.; Sy, Judy P.; Schneider, Susan</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1432-1444</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: We compared ranibizumab - a recombinant, humanized, monoclonal antibody Fab that neutralizes all active forms of vascular endothelial growth factor A - with photodynamic therapy with verteporfin in the treatment of predominantly classic neovascular age-related macular degeneration.  METHODS: During the first year of this 2-yr, multicenter, double-blind study, we randomly assigned patients in a 1:1:1 ratio to receive monthly intravitreal injections of ranibizumab (0.3 mg or 0.5 mg) plus sham verteporfin therapy or monthly sham injections plus active verteporfin therapy.  The primary end point was the proportion of patients losing fewer than 15 letters from baseline visual acuity at 12 mo.  RESULTS: Of the 423 patients enrolled, 94.3% of those given 0.3 mg of ranibizumab and 96.4% of those given 0.5 mg lost fewer than 15 letters, as compared with 64.3% of those in the verteporfin group (P < 0.001 for each comparison).  Visual acuity i.m.- proved by 15 letters or more in 35.7% of the 0.3-mg group and 40.3% of the 0.5-mg group, as compared with 5.6% of the verteporfin group (P < 0.001 for each comparison).  Mean visual acuity increased by 8.5 letters in the 0.3-mg group and 11.3 letters in the 0.5-mg group, as compared with a decrease of 9.5 letters in the verteporfin group (P < 0.001 for each comparison).  Among 140 patients treated with 0.5 mg of ranibizumab, presumed endophthalmitis occurred in 2 patients (1.4%) and serious uveitis in 1 (0.7%).  CONCLUSIONS: Ranibizumab was superior to verteporfin as intravitreal treatment of predominantly classic neovascular age-related macular degeneration, with low rates of serious ocular adverse events.  Treatment improved visual acuity on av. at 1 yr.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu19lFQmxb77Vg90H21EOLACvtfcHk0liO05zc7ZqMfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVGgtrrI&md5=1acef0cfe4198d3aac6f7bffb048307b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa062655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa062655%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BM.%26aulast%3DKaiser%26aufirst%3DP.%2BK.%26aulast%3DMichels%26aufirst%3DM.%26aulast%3DSoubrane%26aufirst%3DG.%26aulast%3DHeier%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DR.%2BY.%26aulast%3DSy%26aufirst%3DJ.%2BP.%26aulast%3DSchneider%26aufirst%3DS.%26atitle%3DRanibizumab%2520versus%2520verteporfin%2520for%2520neovascular%2520age-related%2520macular%2520degeneration%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D1432%26epage%3D1444%26doi%3D10.1056%2FNEJMoa062655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis-Smyth, T.</span><span> </span><span class="NLM_article-title">The biology of vascular endothelial growth factor</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1210/edrv.18.1.0287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1210%2Fedrv.18.1.0287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=9034784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A528%3ADyaK2sXhsFCiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=4-25&issue=1&author=N.+Ferraraauthor=T.+Davis-Smyth&title=The+biology+of+vascular+endothelial+growth+factor&doi=10.1210%2Fedrv.18.1.0287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The biology of vascular endothelial growth factor</span></div><div class="casAuthors">Ferrara, Napoleone; Davis-Smyth, Terri</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-25</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review, with 250 refs., on: biol. activities of vascular endothelial growth factor (VEGF); organization of the VEGF gene; properties of the VEGF isoforms; regulation of VEGF gene expression; the VEGF receptors; VEGF-related mols.; role of VEGF and its receptors in physiol. angiogenesis; role of VEGF in pathol. angiogenesis; and therapeutic applications of VEGF-induced angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5imhPXJtxxrVg90H21EOLACvtfcHk0liO05zc7ZqMfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsFCiu7s%253D&md5=22796890fbe49a721d330447396aea8b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1210%2Fedrv.18.1.0287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fedrv.18.1.0287%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DDavis-Smyth%26aufirst%3DT.%26atitle%3DThe%2520biology%2520of%2520vascular%2520endothelial%2520growth%2520factor%26jtitle%3DEndocr.%2520Rev.%26date%3D1997%26volume%3D18%26issue%3D1%26spage%3D4%26epage%3D25%26doi%3D10.1210%2Fedrv.18.1.0287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Bates, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curry, F. E.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor increases microvascular permeability via a Ca<sup>2+</sup>-dependent pathway</span> <span class="citation_source-journal">Am. J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x"> (</span><span class="NLM_issue">2 Pt 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">H687</span><span class="NLM_x">–</span> <span class="NLM_lpage">694</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1997&pages=H687-694&issue=2+Pt+2&author=D.+O.+Batesauthor=F.+E.+Curry&title=Vascular+endothelial+growth+factor+increases+microvascular+permeability+via+a+Ca2%2B-dependent+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBates%26aufirst%3DD.%2BO.%26aulast%3DCurry%26aufirst%3DF.%2BE.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520increases%2520microvascular%2520permeability%2520via%2520a%2520Ca2%252B-dependent%2520pathway%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D1997%26volume%3D273%26issue%3D2%2520Pt%25202%26spage%3DH687%26epage%3D694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mieler, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPherson, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holz, E. R.</span><span> </span><span class="NLM_article-title">Intravitreal triamcinolone does not alter basal vascular endothelial growth factor mRNA expression in rat retina</span> <span class="citation_source-journal">Vision Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span><span class="refDoi"> DOI: 10.1016/j.visres.2003.09.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1016%2Fj.visres.2003.09.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=14659961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlOisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=349-356&issue=4&author=H.+Gaoauthor=X.+Qiaoauthor=R.+Gaoauthor=W.+F.+Mielerauthor=A.+R.+McPhersonauthor=E.+R.+Holz&title=Intravitreal+triamcinolone+does+not+alter+basal+vascular+endothelial+growth+factor+mRNA+expression+in+rat+retina&doi=10.1016%2Fj.visres.2003.09.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Intravitreal triamcinolone does not alter basal vascular endothelial growth factor mRNA expression in rat retina</span></div><div class="casAuthors">Gao, Hua; Qiao, Xiaoxi; Gao, Rui; Mieler, William F.; McPherson, Alice R.; Holz, Eric R.</div><div class="citationInfo"><span class="NLM_cas:title">Vision Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">349-356</span>CODEN:
                <span class="NLM_cas:coden">VISRAM</span>;
        ISSN:<span class="NLM_cas:issn">0042-6989</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Intravitreal triamcinolone inhibits choroidal neovascularization.  To investigate if vascular endothelial growth factor (VEGF) is affected, we examd. VEGF expression after intravitreal triamcinolone administration in rat retina.  Using in situ hybridization, we have found dense clustered VEGF mRNA signals in the retinal pigment epithelium, moderate patchy signals in the inner nuclear layer, and pos. labeling in a sub-population of ganglion cells.  Densitometry and northern blot anal. revealed no significant alteration of VEGF mRNA expression pattern and level 3-21 days after triamcinolone injection.  Our data indicate that intravitreal triamcinolone does not affect basal VEGF mRNA expression in normal adult rat retina.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor9silt2aS4LVg90H21EOLACvtfcHk0lia2h3shFQyJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlOisro%253D&md5=7659ed8439a3e68d9fde4c4be13ececc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.visres.2003.09.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.visres.2003.09.027%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DH.%26aulast%3DQiao%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DR.%26aulast%3DMieler%26aufirst%3DW.%2BF.%26aulast%3DMcPherson%26aufirst%3DA.%2BR.%26aulast%3DHolz%26aufirst%3DE.%2BR.%26atitle%3DIntravitreal%2520triamcinolone%2520does%2520not%2520alter%2520basal%2520vascular%2520endothelial%2520growth%2520factor%2520mRNA%2520expression%2520in%2520rat%2520retina%26jtitle%3DVision%2520Res.%26date%3D2004%26volume%3D44%26issue%3D4%26spage%3D349%26epage%3D356%26doi%3D10.1016%2Fj.visres.2003.09.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Lopez, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippy, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thach, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinton, D. R.</span><span> </span><span class="NLM_article-title">Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes</span> <span class="citation_source-journal">Invest. Ophthalmol. Vis. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1996&pages=855-868&issue=5&author=P.+F.+Lopezauthor=B.+D.+Sippyauthor=H.+M.+Lambertauthor=A.+B.+Thachauthor=D.+R.+Hinton&title=Transdifferentiated+retinal+pigment+epithelial+cells+are+immunoreactive+for+vascular+endothelial+growth+factor+in+surgically+excised+age-related+macular+degeneration-related+choroidal+neovascular+membranes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%26aufirst%3DP.%2BF.%26aulast%3DSippy%26aufirst%3DB.%2BD.%26aulast%3DLambert%26aufirst%3DH.%2BM.%26aulast%3DThach%26aufirst%3DA.%2BB.%26aulast%3DHinton%26aufirst%3DD.%2BR.%26atitle%3DTransdifferentiated%2520retinal%2520pigment%2520epithelial%2520cells%2520are%2520immunoreactive%2520for%2520vascular%2520endothelial%2520growth%2520factor%2520in%2520surgically%2520excised%2520age-related%2520macular%2520degeneration-related%2520choroidal%2520neovascular%2520membranes%26jtitle%3DInvest.%2520Ophthalmol.%2520Vis.%2520Sci.%26date%3D1996%26volume%3D37%26issue%3D5%26spage%3D855%26epage%3D868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Aiello, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrigg, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keyt, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jampel, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquale, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thieme, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwamoto, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aiello, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, G. L.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">331</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">1480</span><span class="NLM_x">–</span> <span class="NLM_lpage">1487</span><span class="refDoi"> DOI: 10.1056/NEJM199412013312203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1056%2FNEJM199412013312203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=7526212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A280%3ADyaK2M%252FlvFamsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=1994&pages=1480-1487&issue=22&author=L.+P.+Aielloauthor=R.+L.+Averyauthor=P.+G.+Arriggauthor=B.+A.+Keytauthor=H.+D.+Jampelauthor=S.+T.+Shahauthor=L.+R.+Pasqualeauthor=H.+Thiemeauthor=M.+A.+Iwamotoauthor=J.+E.+Parkauthor=H.+V.+Nguyenauthor=L.+M.+Aielloauthor=N.+Ferraraauthor=G.+L.+King&title=Vascular+endothelial+growth+factor+in+ocular+fluid+of+patients+with+diabetic+retinopathy+and+other+retinal+disorders&doi=10.1056%2FNEJM199412013312203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders</span></div><div class="casAuthors">Aiello L P; Avery R L; Arrigg P G; Keyt B A; Jampel H D; Shah S T; Pasquale L R; Thieme H; Iwamoto M A; Park J E</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1480-7</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND:  Retinal ischemia induces intraocular neovascularization, which often leads to glaucoma, vitreous hemorrhage, and retinal detachment, presumably by stimulating the release of angiogenic molecules.  Vascular endothelial growth factor (VEGF) is an endothelial-cell-specific angiogenic factor whose production is increased by hypoxia.  METHODS:  We measured the concentration of VEGF in 210 specimens of ocular fluid obtained from 164 patients undergoing intraocular surgery, using both radioimmuno-assays and radioreceptor assays.  Vitreous proliferative potential was measured with in vitro assays of the growth of retinal endothelial cells and with VEGF-neutralizing antibody.  RESULTS:  VEGF was detected in 69 of 136 ocular-fluid samples from patients with diabetic retinopathy, 29 of 38 samples from patients with neovascularization of the iris, and 3 of 4 samples from patients with ischemic occlusion of the central retinal vein, as compared with 2 of 31 samples from patients with no neovascular disorders (P < 0.001, P < 0.001, and P = 0.006, respectively).  The mean (+/- SD) VEGF concentration in 70 samples of ocular fluid from patients with active proliferative diabetic retinopathy (3.6 +/- 6.3 ng per milliliter) was higher than that in 25 samples from patients with nonproliferative diabetic retinopathy (0.1 +/- 0.1 ng per milliliter, P = 0.008), 41 samples from patients with quiescent proliferative diabetic retinopathy (0.2 +/- 0.6 ng per milliliter, P < 0.001), or 31 samples from nondiabetic patients (0.1 +/- 0.2 ng per milliliter, P = 0.003).  Concentrations of VEGF in vitreous fluid (8.8 +/- 9.9 ng per milliliter) were higher than those in aqueous fluid (5.6 +/- 8.6 ng per milliliter, P = 0.033) in all 10 pairs of samples obtained simultaneously from the same patient; VEGF concentrations in vitreous fluid declined after successful laser photocoagulation.  VEGF stimulated the growth of retinal endothelial cells in vitro, as did vitreous fluid containing measurable VEGF.  Stimulation was inhibited by VEGF-neutralizing antibodies.  CONCLUSIONS:  Our data suggest that VEGF plays a major part in mediating active intraocular neovascularization in patients with ischemic retinal diseases, such as diabetic retinopathy and retinal-vein occlusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTuQPc8Cq5uLhWfpMXQLRstfW6udTcc2eaZJuEfI2yos7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252FlvFamsA%253D%253D&md5=0711104bb524c018047b810c879aa08e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1056%2FNEJM199412013312203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199412013312203%26sid%3Dliteratum%253Aachs%26aulast%3DAiello%26aufirst%3DL.%2BP.%26aulast%3DAvery%26aufirst%3DR.%2BL.%26aulast%3DArrigg%26aufirst%3DP.%2BG.%26aulast%3DKeyt%26aufirst%3DB.%2BA.%26aulast%3DJampel%26aufirst%3DH.%2BD.%26aulast%3DShah%26aufirst%3DS.%2BT.%26aulast%3DPasquale%26aufirst%3DL.%2BR.%26aulast%3DThieme%26aufirst%3DH.%26aulast%3DIwamoto%26aufirst%3DM.%2BA.%26aulast%3DPark%26aufirst%3DJ.%2BE.%26aulast%3DNguyen%26aufirst%3DH.%2BV.%26aulast%3DAiello%26aufirst%3DL.%2BM.%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DKing%26aufirst%3DG.%2BL.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520in%2520ocular%2520fluid%2520of%2520patients%2520with%2520diabetic%2520retinopathy%2520and%2520other%2520retinal%2520disorders%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1994%26volume%3D331%26issue%3D22%26spage%3D1480%26epage%3D1487%26doi%3D10.1056%2FNEJM199412013312203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Nguyen, Q. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatlipinar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haller, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinlan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer-Galler, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor is a critical stimulus for diabetic macular edema</span> <span class="citation_source-journal">Am. J. Ophthalmol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">961</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.1016/j.ajo.2006.06.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1016%2Fj.ajo.2006.06.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=17046701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12msLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2006&pages=961-9&issue=6&author=Q.+D.+Nguyenauthor=S.+Tatlipinarauthor=S.+M.+Shahauthor=J.+A.+Hallerauthor=E.+Quinlanauthor=J.+Sungauthor=I.+Zimmer-Gallerauthor=D.+V.+Doauthor=P.+A.+Campochiaro&title=Vascular+endothelial+growth+factor+is+a+critical+stimulus+for+diabetic+macular+edema&doi=10.1016%2Fj.ajo.2006.06.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular Endothelial Growth Factor Is a Critical Stimulus for Diabetic Macular Edema</span></div><div class="casAuthors">Nguyen, Quan Dong; Tatlipinar, Sinan; Shah, Syed Mahmood; Haller, Julia A.; Quinlan, Edward; Sung, Jennifer; Zimmer-Galler, Ingrid; Do, Diana V.; Campochiaro, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Ophthalmology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">961-969</span>CODEN:
                <span class="NLM_cas:coden">AJOPAA</span>;
        ISSN:<span class="NLM_cas:issn">0002-9394</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Purpose: The role of vascular endothelial growth factor (VEGF) in diabetic macular edema (DME) was tested with ranibizumab, a specific antagonist of VEGF.  Design: A nonrandomized clin. trial.  Methods: Ten patients with chronic DME received intraocular injections of 0.5 mg of ranibizumab at baseline and at one, two, four, and six months.  The primary outcome was change in foveal thickness between baseline and seven months, and the secondary outcome measures were changes from baseline in visual acuity and macular vol.  Results: Mean values at baseline were 503 μm for foveal thickness, 9.22 mm3 for macular vol., and 28.1 letters (20/80) read on an Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity chart.  At seven months (one month after the fifth injection), the mean foveal thickness was 257 μm, which was a redn. of 246 μm (85% of the excess foveal thickness present at baseline; P = .005 by Wilcoxon signed-rank test for likelihood that this change is due to ranibizumab rather than chance).  The macular vol. was 7.47 mm3, which was a redn. of 1.75 mm3 (77% of the excess macular vol. at baseline; P = .009).  Mean visual acuity was 40.4 letters (20/40), which was an improvement of 12.3 letters (P = .005).  The injections were well-tolerated with no ocular or systemic adverse events.  Conclusion: Intraocular injections of ranibizumab significantly reduced foveal thickness and improved visual acuity in 10 patients with DME, which demonstrated that VEGF is an important therapeutic target for DME.  A randomized, controlled, double-masked trial is needed to test whether intraocular injections of ranibizumab provide long-term benefit to patients with DME.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraQ4X1zj_2PLVg90H21EOLACvtfcHk0li6bsUJUtNGCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12msLfE&md5=1eaf14ff1ca9d7b98f917d48f841c1f7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.ajo.2006.06.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajo.2006.06.068%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DQ.%2BD.%26aulast%3DTatlipinar%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DS.%2BM.%26aulast%3DHaller%26aufirst%3DJ.%2BA.%26aulast%3DQuinlan%26aufirst%3DE.%26aulast%3DSung%26aufirst%3DJ.%26aulast%3DZimmer-Galler%26aufirst%3DI.%26aulast%3DDo%26aufirst%3DD.%2BV.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520is%2520a%2520critical%2520stimulus%2520for%2520diabetic%2520macular%2520edema%26jtitle%3DAm.%2520J.%2520Ophthalmol.%26date%3D2006%26volume%3D142%26issue%3D6%26spage%3D961%26epage%3D9%26doi%3D10.1016%2Fj.ajo.2006.06.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Terman, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougher-Vermazen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrion, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrov, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armellino, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gospodarowicz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böhlen, P.</span><span> </span><span class="NLM_article-title">Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">187</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1579</span><span class="NLM_x">–</span> <span class="NLM_lpage">1586</span><span class="refDoi"> DOI: 10.1016/0006-291X(92)90483-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1016%2F0006-291X%2892%2990483-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=1992&pages=1579-1586&issue=3&author=B.+I.+Termanauthor=M.+Dougher-Vermazenauthor=M.+E.+Carrionauthor=D.+Dimitrovauthor=D.+C.+Armellinoauthor=D.+Gospodarowiczauthor=P.+B%C3%B6hlen&title=Identification+of+the+KDR+tyrosine+kinase+as+a+receptor+for+vascular+endothelial+cell+growth+factor&doi=10.1016%2F0006-291X%2892%2990483-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2892%2990483-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252892%252990483-2%26sid%3Dliteratum%253Aachs%26aulast%3DTerman%26aufirst%3DB.%2BI.%26aulast%3DDougher-Vermazen%26aufirst%3DM.%26aulast%3DCarrion%26aufirst%3DM.%2BE.%26aulast%3DDimitrov%26aufirst%3DD.%26aulast%3DArmellino%26aufirst%3DD.%2BC.%26aulast%3DGospodarowicz%26aufirst%3DD.%26aulast%3DB%25C3%25B6hlen%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520the%2520KDR%2520tyrosine%2520kinase%2520as%2520a%2520receptor%2520for%2520vascular%2520endothelial%2520cell%2520growth%2520factor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1992%26volume%3D187%26issue%3D3%26spage%3D1579%26epage%3D1586%26doi%3D10.1016%2F0006-291X%2892%2990483-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Shalaby, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gertsenstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuh, A. C.</span><span> </span><span class="NLM_article-title">Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x"> (</span><span class="NLM_issue">6535</span><span class="NLM_x">) </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span><span class="refDoi"> DOI: 10.1038/376062a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1038%2F376062a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=1995&pages=62-66&issue=6535&author=F.+Shalabyauthor=J.+Rossantauthor=T.+P.+Yamaguchiauthor=M.+Gertsensteinauthor=X.+F.+Wuauthor=M.+L.+Breitmanauthor=A.+C.+Schuh&title=Failure+of+blood-island+formation+and+vasculogenesis+in+Flk-1-deficient+mice&doi=10.1038%2F376062a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F376062a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F376062a0%26sid%3Dliteratum%253Aachs%26aulast%3DShalaby%26aufirst%3DF.%26aulast%3DRossant%26aufirst%3DJ.%26aulast%3DYamaguchi%26aufirst%3DT.%2BP.%26aulast%3DGertsenstein%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DX.%2BF.%26aulast%3DBreitman%26aufirst%3DM.%2BL.%26aulast%3DSchuh%26aufirst%3DA.%2BC.%26atitle%3DFailure%2520of%2520blood-island%2520formation%2520and%2520vasculogenesis%2520in%2520Flk-1-deficient%2520mice%26jtitle%3DNature%26date%3D1995%26volume%3D376%26issue%3D6535%26spage%3D62%26epage%3D66%26doi%3D10.1038%2F376062a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Matsumoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claesson-Welsh, L.</span><span> </span><span class="NLM_article-title">VEGF receptor signal transduction</span> <span class="citation_source-journal">Sci. Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2001</span><span class="NLM_x"> (</span><span class="NLM_issue">112</span><span class="NLM_x">) </span> <span class="NLM_fpage">re21</span><span class="refDoi"> DOI: 10.1126/stke.2001.112.re21</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1126%2Fstke.2001.112.re21" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2001&publication_year=2001&pages=re21&issue=112&author=T.+Matsumotoauthor=L.+Claesson-Welsh&title=VEGF+receptor+signal+transduction&doi=10.1126%2Fstke.2001.112.re21"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fstke.2001.112.re21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fstke.2001.112.re21%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DT.%26aulast%3DClaesson-Welsh%26aufirst%3DL.%26atitle%3DVEGF%2520receptor%2520signal%2520transduction%26jtitle%3DSci.%2520Signaling%26date%3D2001%26volume%3D2001%26issue%3D112%26spage%3Dre21%26doi%3D10.1126%2Fstke.2001.112.re21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Keefe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okera, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stringer, A.</span><span> </span><span class="NLM_article-title">Noncardiac vascular toxicities of vascular endothelial growth factor inhibitors in advanced cancer: a review</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">432</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span><span class="refDoi"> DOI: 10.1634/theoncologist.2010-0271</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1634%2Ftheoncologist.2010-0271" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=432-444&issue=4&author=D.+Keefeauthor=J.+Bowenauthor=R.+Gibsonauthor=T.+Tanauthor=M.+Okeraauthor=A.+Stringer&title=Noncardiac+vascular+toxicities+of+vascular+endothelial+growth+factor+inhibitors+in+advanced+cancer%3A+a+review&doi=10.1634%2Ftheoncologist.2010-0271"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.2010-0271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.2010-0271%26sid%3Dliteratum%253Aachs%26aulast%3DKeefe%26aufirst%3DD.%26aulast%3DBowen%26aufirst%3DJ.%26aulast%3DGibson%26aufirst%3DR.%26aulast%3DTan%26aufirst%3DT.%26aulast%3DOkera%26aufirst%3DM.%26aulast%3DStringer%26aufirst%3DA.%26atitle%3DNoncardiac%2520vascular%2520toxicities%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520inhibitors%2520in%2520advanced%2520cancer%253A%2520a%2520review%26jtitle%3DOncologist%26date%3D2011%26volume%3D16%26issue%3D4%26spage%3D432%26epage%3D444%26doi%3D10.1634%2Ftheoncologist.2010-0271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Boyer, S. J.</span><span> </span><span class="NLM_article-title">Small molecule inhibitors of KDR (VEGFR-2)kinase: an overview of structure activity relationships</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span><span class="refDoi"> DOI: 10.2174/1568026023393273</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.2174%2F1568026023393273" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=12171566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtVOitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=973-1000&author=S.+J.+Boyer&title=Small+molecule+inhibitors+of+KDR+%28VEGFR-2%29kinase%3A+an+overview+of+structure+activity+relationships&doi=10.2174%2F1568026023393273"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitors of KDR (VEGFR-2) kinase: an overview of structure activity relationships</span></div><div class="casAuthors">Boyer, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">973-1000</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The Kinase insert Domain contg. Receptor (KDR), alternatively referred to as VEGFR-2, is a receptor for Vascular Endothelial Growth Factors (VEGFs) and functions as a key regulator of angiogenesis, the process by which new capillaries are created from preexisting blood vessels.  The induction of angiogenesis, or the "angiogenic switch," is a crit. step in tumor progression, and inhibitors of KDR have been demonstrated both to induce tumor regression and reduce metastatic potential in preclin. models.  In the last few years, medicinal chemists have expanded the kinase selectivity profile of known inhibitor classes to include KDR, and also identified novel classes of KDR inhibitors.  This review presents structure activity relationships (SAR) of small mol. inhibitors of KDR, with an emphasis on the pharmacophore elements of the scaffolds employed.  Binding hypotheses based on x-ray crystallog. analyses will also be described.  Addnl., the efficacy of representative compds. in in vitro and in vivo models of tumor progression and angiogenesis are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8iX5xdLgktLVg90H21EOLACvtfcHk0lgHBCNmFMMKvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtVOitbw%253D&md5=4c4445eac589bded1baed3140b918be8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F1568026023393273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026023393273%26sid%3Dliteratum%253Aachs%26aulast%3DBoyer%26aufirst%3DS.%2BJ.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520KDR%2520%2528VEGFR-2%2529kinase%253A%2520an%2520overview%2520of%2520structure%2520activity%2520relationships%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2002%26volume%3D2%26spage%3D973%26epage%3D1000%26doi%3D10.2174%2F1568026023393273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Schenone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondavalli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span> </span><span class="NLM_article-title">Antiangiogenic agents: an update on small molecule VEGFR inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2495</span><span class="NLM_x">–</span> <span class="NLM_lpage">2516</span><span class="refDoi"> DOI: 10.2174/092986707782023622</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.2174%2F092986707782023622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=17979703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=2495-2516&author=S.+Schenoneauthor=F.+Bondavalliauthor=M.+Botta&title=Antiangiogenic+agents%3A+an+update+on+small+molecule+VEGFR+inhibitors&doi=10.2174%2F092986707782023622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Antiangiogenic agents: an update on small molecule VEGFR inhibitors</span></div><div class="casAuthors">Schenone, S.; Bondavalli, F.; Botta, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2495-2516</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Angiogenesis is a tightly regulated process that leads to the formation of new blood vessels sprouting from pre-existing microvasculature and occurs in limited physiol. conditions or under pathol. situations such as retinopathies, arthritis, endometriosis and cancer.  Blockade of angiogenesis is an attractive approach for the treatment of such diseases.  Particularly in malignancies, antiangiogenic therapy should be less toxic in comparison with conventional treatments such as chemotherapy, as angiogenesis is a process relatively restricted to the growing tumor.  Vascular endothelial growth factor (VEGF) is one of the most important inducers of angiogenesis and exerts its cellular effects mainly by interacting with two high-affinity transmembrane tyrosine kinase receptors: VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1).  It has been proven that inhibition of VEGF receptor activity reduces angiogenesis.  For these reasons, the inhibition of VEGF or its receptor signaling system is an attractive target for therapeutic intervention.  The most studied and developed inhibitors are monoclonal antibodies that neutralize VEGF, ribozymes, and small mol. VEGFR kinase inhibitors.  Many important reviews dealing with VEGF-induced angiogenesis and its inhibition through the block of VEGF receptors have been reported, esp. from a biol. point of view.  Here, we will review small synthetic VEGFR inhibitors that have appeared in literature in the last few years, focusing our attention on their medicinal chem. in terms of chem. structure, mechanisms of action and structure-activity relationships.  In fact, there have been an increased no. of tyrosine kinase inhibitors in the most recent literature reports; their biol. profile is extremely interesting and could be of great importance to medicinal chemists working in this area in improving their efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7o_mKLGN1mLVg90H21EOLACvtfcHk0li3iBI08NqMIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrbN&md5=1cb7ea6cf7867e796f2333e5d304220c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F092986707782023622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986707782023622%26sid%3Dliteratum%253Aachs%26aulast%3DSchenone%26aufirst%3DS.%26aulast%3DBondavalli%26aufirst%3DF.%26aulast%3DBotta%26aufirst%3DM.%26atitle%3DAntiangiogenic%2520agents%253A%2520an%2520update%2520on%2520small%2520molecule%2520VEGFR%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2007%26volume%3D14%26spage%3D2495%26epage%3D2516%26doi%3D10.2174%2F092986707782023622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Musumeci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brullo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenone, S.</span><span> </span><span class="NLM_article-title">Vascular Endothelial Growth Factor (VEGF) Receptors: Drugs and New Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10797</span><span class="NLM_x">–</span> <span class="NLM_lpage">10822</span><div class="note"><p class="first last">and references therein.</p></div><span class="refDoi"> DOI: 10.1021/jm301085w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301085w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10797-10822&author=F.+Musumeciauthor=M.+Radiauthor=C.+Brulloauthor=S.+Schenone&title=Vascular+Endothelial+Growth+Factor+%28VEGF%29+Receptors%3A+Drugs+and+New+Inhibitors&doi=10.1021%2Fjm301085w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm301085w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301085w%26sid%3Dliteratum%253Aachs%26aulast%3DMusumeci%26aufirst%3DF.%26aulast%3DRadi%26aufirst%3DM.%26aulast%3DBrullo%26aufirst%3DC.%26aulast%3DSchenone%26aufirst%3DS.%26atitle%3DVascular%2520Endothelial%2520Growth%2520Factor%2520%2528VEGF%2529%2520Receptors%253A%2520Drugs%2520and%2520New%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10797%26epage%3D10822%26doi%3D10.1021%2Fjm301085w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Diago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulido, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collett, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Link, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, E. H.,  Jr.</span><span> </span><span class="NLM_article-title">Ranibizumab combined with low-dose sorafenib for exudative age-related macular degeneration</span> <span class="citation_source-journal">Mayo Clin. Proc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span><span class="refDoi"> DOI: 10.4065/83.2.231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.4065%2F83.2.231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=18241635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252FosF2itg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2008&pages=231-234&author=T.+Diagoauthor=J.+S.+Pulidoauthor=J.+R.+Molinaauthor=L.+C.+Collettauthor=T.+P.+Linkauthor=E.+H.+Ryan&title=Ranibizumab+combined+with+low-dose+sorafenib+for+exudative+age-related+macular+degeneration&doi=10.4065%2F83.2.231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Ranibizumab combined with low-dose sorafenib for exudative age-related macular degeneration</span></div><div class="casAuthors">Diago Teresa; Pulido Jose S; Molina Julian R; Collett Lucienne C; Link Thomas P; Ryan Edwin H Jr</div><div class="citationInfo"><span class="NLM_cas:title">Mayo Clinic proceedings</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">231-4</span>
        ISSN:<span class="NLM_cas:issn">0025-6196</span>.
    </div><div class="casAbstract">Angiogenesis is a common factor in the pathogenesis of cancer and in exudative age-related macular degeneration (AMD).  Therefore, angiogenesis inhibition has been developed as a therapeutic strategy.  We report 2 cases of recurrent exudative AMD in which oral sorafenib, a tyrosine kinase inhibitor approved for cancer, was added to intravitreal ranibizumab, an antibody to vascular endothelial growth factor.  These 2 patients were followed up by determination of visual acuity, fluorescein angiography, fundoscopy, and optical coherence tomography.  The visual acuity of 1 patient improved from 20/70 to 20/60 while he was receiving sorafenib therapy; that of the other did not.  Marked improvement was noted in both patients on optical coherence tomography.  Additionally, both patients appeared to receive some benefit when low-dose oral sorafenib was used as monotherapy after its initial addition to ranibizumab therapy.  Randomized trials of adding sorafenib to standard therapy for patients with neovascular AMD should be considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQChMnlkUBCzlVwdslNBF-tfW6udTcc2eZE6IRm67v9y7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252FosF2itg%253D%253D&md5=3239159c9a781c2f097e04fd848632d5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.4065%2F83.2.231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4065%252F83.2.231%26sid%3Dliteratum%253Aachs%26aulast%3DDiago%26aufirst%3DT.%26aulast%3DPulido%26aufirst%3DJ.%2BS.%26aulast%3DMolina%26aufirst%3DJ.%2BR.%26aulast%3DCollett%26aufirst%3DL.%2BC.%26aulast%3DLink%26aufirst%3DT.%2BP.%26aulast%3DRyan%26aufirst%3DE.%2BH.%26atitle%3DRanibizumab%2520combined%2520with%2520low-dose%2520sorafenib%2520for%2520exudative%2520age-related%2520macular%2520degeneration%26jtitle%3DMayo%2520Clin.%2520Proc.%26date%3D2008%26volume%3D83%26spage%3D231%26epage%3D234%26doi%3D10.4065%2F83.2.231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Kernt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staehler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stief, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kampik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, A. S.</span><span> </span><span class="NLM_article-title">Resolution of macular oedema in occult choroidal neovascularization under oral Sorafenib treatment</span> <span class="citation_source-journal">Acta Ophthalmol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">456</span><span class="NLM_x">–</span> <span class="NLM_lpage">458</span><span class="refDoi"> DOI: 10.1111/j.1600-0420.2007.01014.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1111%2Fj.1600-0420.2007.01014.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=17908257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A280%3ADC%252BD1czjt1GqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2008&pages=456-458&author=M.+Kerntauthor=M.+Staehlerauthor=C.+Stiefauthor=A.+Kampikauthor=A.+S.+Neubauer&title=Resolution+of+macular+oedema+in+occult+choroidal+neovascularization+under+oral+Sorafenib+treatment&doi=10.1111%2Fj.1600-0420.2007.01014.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Resolution of macular oedema in occult choroidal neovascularization under oral Sorafenib treatment</span></div><div class="casAuthors">Kernt Marcus; Staehler Michael; Stief Christian; Kampik Anselm; Neubauer Aljoscha S</div><div class="citationInfo"><span class="NLM_cas:title">Acta ophthalmologica</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">456-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  To report on the effect of oral nexavar (Sorafenib) treatment in one patient with neovascular age-related macular degeneration (AMD) and advanced renal cell cancer (RCC).  METHODS:  After two intravitreal injections of bevacizumab (1.25 mg) for occult choroidal neovascularization (CNV) in AMD, the patient was started on oral Sorafenib (400 mg twice daily) treatment for RCC.  RESULTS:  Visual acuity (VA) was 20/80 in the left eye and optical coherence tomography (OCT) demonstrated persistent central thickening to 251 microm after bevacizumab.  After 6 weeks of oral Sorafenib treatment, VA had increased to 20/70 and a significant decrease in retinal thickness to 208 microm was observed on OCT.  The patient remained stable during a further 3 months of follow-up.  CONCLUSIONS:  Resolution of macular oedema and stabilization of VA under oral treatment with the multikinase inhibitor Sorafenib was observed.  This observation warrants further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnUQ4l905ipUQ0lWbKiCflfW6udTcc2eabP-QXc3wksbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czjt1GqtQ%253D%253D&md5=6061764af0d0c95036c65325c75b4c6a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0420.2007.01014.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0420.2007.01014.x%26sid%3Dliteratum%253Aachs%26aulast%3DKernt%26aufirst%3DM.%26aulast%3DStaehler%26aufirst%3DM.%26aulast%3DStief%26aufirst%3DC.%26aulast%3DKampik%26aufirst%3DA.%26aulast%3DNeubauer%26aufirst%3DA.%2BS.%26atitle%3DResolution%2520of%2520macular%2520oedema%2520in%2520occult%2520choroidal%2520neovascularization%2520under%2520oral%2520Sorafenib%2520treatment%26jtitle%3DActa%2520Ophthalmol.%26date%3D2008%26volume%3D86%26spage%3D456%26epage%3D458%26doi%3D10.1111%2Fj.1600-0420.2007.01014.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Amparo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadrai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso-Bartolozzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shikari, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciolino, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chodosh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurkunas, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaumberg, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dana, R.</span><span> </span><span class="NLM_article-title">Safety and Efficacy of the Multitargeted Receptor Kinase Inhibitor Pazopanib in the Treatment of Corneal Neovascularization</span> <span class="citation_source-journal">Invest. Ophthalmol. Visual Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">544</span><span class="refDoi"> DOI: 10.1167/iovs.12-11032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1167%2Fiovs.12-11032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=537-544&author=F.+Amparoauthor=Z.+Sadraiauthor=Y.+Jinauthor=B.+Alfonso-Bartolozziauthor=H.+Wangauthor=H.+Shikariauthor=J.+B.+Ciolinoauthor=J.+Chodoshauthor=U.+Jurkunasauthor=D.+A.+Schaumbergauthor=R.+Dana&title=Safety+and+Efficacy+of+the+Multitargeted+Receptor+Kinase+Inhibitor+Pazopanib+in+the+Treatment+of+Corneal+Neovascularization&doi=10.1167%2Fiovs.12-11032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1167%2Fiovs.12-11032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.12-11032%26sid%3Dliteratum%253Aachs%26aulast%3DAmparo%26aufirst%3DF.%26aulast%3DSadrai%26aufirst%3DZ.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DAlfonso-Bartolozzi%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DShikari%26aufirst%3DH.%26aulast%3DCiolino%26aufirst%3DJ.%2BB.%26aulast%3DChodosh%26aufirst%3DJ.%26aulast%3DJurkunas%26aufirst%3DU.%26aulast%3DSchaumberg%26aufirst%3DD.%2BA.%26aulast%3DDana%26aufirst%3DR.%26atitle%3DSafety%2520and%2520Efficacy%2520of%2520the%2520Multitargeted%2520Receptor%2520Kinase%2520Inhibitor%2520Pazopanib%2520in%2520the%2520Treatment%2520of%2520Corneal%2520Neovascularization%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2013%26volume%3D54%26spage%3D537%26epage%3D544%26doi%3D10.1167%2Fiovs.12-11032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kwak, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A.</span><span> </span><span class="NLM_article-title">VEGF is major stimulator in model of choroidal neovascularization</span> <span class="citation_source-journal">Invest. Ophthalmol. Vis. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">3158</span><span class="NLM_x">–</span> <span class="NLM_lpage">3164</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=3158-3164&author=N.+Kwakauthor=N.+Okamotoauthor=J.+M.+Woodauthor=P.+A.+Campochiaro&title=VEGF+is+major+stimulator+in+model+of+choroidal+neovascularization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKwak%26aufirst%3DN.%26aulast%3DOkamoto%26aufirst%3DN.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26atitle%3DVEGF%2520is%2520major%2520stimulator%2520in%2520model%2520of%2520choroidal%2520neovascularization%26jtitle%3DInvest.%2520Ophthalmol.%2520Vis.%2520Sci.%26date%3D2000%26volume%3D41%26spage%3D3158%26epage%3D3164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Bold, G.; Capraro, H.-G.; Caravatti, G.; Floersheimer, A.; Furet, P.; Manley, P.; Vaupel, A.; Pissot Soldermann, C.; Gessier, F.; Schnell, C.; Littlewood-Evans, A. J.; Kapa, P. K.; Bajwa, J. S.; Jiang, X.</span> Preparation of Bicyclic Amides as Kinase Inhibitors. PCT Int. Appl. WO 2006059234,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bold%2C+G.%3B+Capraro%2C+H.-G.%3B+Caravatti%2C+G.%3B+Floersheimer%2C+A.%3B+Furet%2C+P.%3B+Manley%2C+P.%3B+Vaupel%2C+A.%3B+Pissot+Soldermann%2C+C.%3B+Gessier%2C+F.%3B+Schnell%2C+C.%3B+Littlewood-Evans%2C+A.+J.%3B+Kapa%2C+P.+K.%3B+Bajwa%2C+J.+S.%3B+Jiang%2C+X.+Preparation+of+Bicyclic+Amides+as+Kinase+Inhibitors.+PCT+Int.+Appl.+WO+2006059234%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBold%26aufirst%3DG.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Bold, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaupel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x"> Heterobicyclic Carboxamidesas Protein Kinase Inhibitors and Their Preparation, PharmaceuticalCompositions and Use in the Treatment of Proliferative Diseases. PCTInt. Appl. </span>WO 2008009487,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bold%2C+G.%3B+Vaupel%2C+A.%3B+Lang%2C+M.+Heterobicyclic+Carboxamidesas+Protein+Kinase+Inhibitors+and+Their+Preparation%2C+PharmaceuticalCompositions+and+Use+in+the+Treatment+of+Proliferative+Diseases.+PCTInt.+Appl.+WO+2008009487%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBold%26aufirst%3DG.%26aulast%3DVaupel%26aufirst%3DA.%26aulast%3DLang%26aufirst%3DM.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Wan, Z.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wacharasindhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levins, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabei, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span> </span><span class="NLM_article-title">The Scope and Mechanism of Phosphonium-Mediated S<sub>N</sub>Ar Reactions in Heterocyclic Amides and Ureas</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">10194</span><span class="NLM_x">–</span> <span class="NLM_lpage">10210</span><span class="refDoi"> DOI: 10.1021/jo7020373</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo7020373" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=10194-10210&issue=26&author=Z.-K.+Wanauthor=S.+Wacharasindhuauthor=C.+G.+Levinsauthor=M.+Linauthor=K.+Tabeiauthor=T.+S.+Mansour&title=The+Scope+and+Mechanism+of+Phosphonium-Mediated+SNAr+Reactions+in+Heterocyclic+Amides+and+Ureas&doi=10.1021%2Fjo7020373"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjo7020373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo7020373%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DZ.-K.%26aulast%3DWacharasindhu%26aufirst%3DS.%26aulast%3DLevins%26aufirst%3DC.%2BG.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DTabei%26aufirst%3DK.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26atitle%3DThe%2520Scope%2520and%2520Mechanism%2520of%2520Phosphonium-Mediated%2520SNAr%2520Reactions%2520in%2520Heterocyclic%2520Amides%2520and%2520Ureas%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26issue%3D26%26spage%3D10194%26epage%3D10210%26doi%3D10.1021%2Fjo7020373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Ji, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jendza, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainolfi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span> </span><span class="NLM_article-title">Synthesis of 1-substituted-3-aminopyrazoles</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6799</span><span class="NLM_x">–</span> <span class="NLM_lpage">6801</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2010.10.073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1016%2Fj.tetlet.2010.10.073" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=6799-6801&author=N.+Jiauthor=E.+L.+Meredithauthor=D.+Liuauthor=C.+M.+Adamsauthor=G.+D.+Artmanauthor=K.+C.+Jendzaauthor=F.+Maauthor=N.+Mainolfiauthor=J.+J.+Powersauthor=C.+Zhang&title=Synthesis+of+1-substituted-3-aminopyrazoles&doi=10.1016%2Fj.tetlet.2010.10.073"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2010.10.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2010.10.073%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DN.%26aulast%3DMeredith%26aufirst%3DE.%2BL.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DAdams%26aufirst%3DC.%2BM.%26aulast%3DArtman%26aufirst%3DG.%2BD.%26aulast%3DJendza%26aufirst%3DK.%2BC.%26aulast%3DMa%26aufirst%3DF.%26aulast%3DMainolfi%26aufirst%3DN.%26aulast%3DPowers%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DC.%26atitle%3DSynthesis%2520of%25201-substituted-3-aminopyrazoles%26jtitle%3DTetrahedron%2520Lett.%26date%3D2010%26volume%3D51%26spage%3D6799%26epage%3D6801%26doi%3D10.1016%2Fj.tetlet.2010.10.073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Johnson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jendza, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainolfi, N.</span><span> </span><span class="NLM_article-title">A Reliable Synthesis of 3-Amino-5-Alkyl and 5-Amino-3-Alkyl Isoxazoles</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span><span class="refDoi"> DOI: 10.1055/s-0032-1317935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1055%2Fs-0032-1317935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvFeru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2013&pages=171-173&author=L.+Johnsonauthor=J.+Powersauthor=M.+Maauthor=K.+Jendzaauthor=B.+Wangauthor=E.+L.+Meredithauthor=N.+Mainolfi&title=A+Reliable+Synthesis+of+3-Amino-5-Alkyl+and+5-Amino-3-Alkyl+Isoxazoles&doi=10.1055%2Fs-0032-1317935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A reliable synthesis of 3-amino-5-alkyl and 5-amino-3-alkyl isoxazoles</span></div><div class="casAuthors">Johnson, Leland; Powers, James; Ma, Fupeng; Jendza, Keith; Wang, Bing; Meredith, Erik; Mainolfi, Nello</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-173</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A reliable procedure that can be used to access a wide range of 3-amino-5-alkyl and 5-amino-3-alkyl isoxazoles was developed.  Reaction temp. and pH were key factors that detd. the regioselectivity of the two reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLV6By8DSrZbVg90H21EOLACvtfcHk0ljWuoyxzNfong"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvFeru7k%253D&md5=1137266d2fd7af5986596f3e7910c5e8</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1055%2Fs-0032-1317935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0032-1317935%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DL.%26aulast%3DPowers%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DM.%26aulast%3DJendza%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DMeredith%26aufirst%3DE.%2BL.%26aulast%3DMainolfi%26aufirst%3DN.%26atitle%3DA%2520Reliable%2520Synthesis%2520of%25203-Amino-5-Alkyl%2520and%25205-Amino-3-Alkyl%2520Isoxazoles%26jtitle%3DSynthesis%26date%3D2013%26volume%3D45%26spage%3D171%26epage%3D173%26doi%3D10.1055%2Fs-0032-1317935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jones, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbati, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Large, C. H.</span><span> </span><span class="NLM_article-title">Automated patch clamping using the QPatch</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">565</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span><span class="refDoi"> DOI: 10.1007/978-1-60327-258-2_10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1007%2F978-1-60327-258-2_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=19551364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVKhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=565&publication_year=2009&pages=209-223&author=K.+A.+Jonesauthor=N.+Garbatiauthor=H.+Zhangauthor=C.+H.+Large&title=Automated+patch+clamping+using+the+QPatch&doi=10.1007%2F978-1-60327-258-2_10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Automated patch clamping using the QPatch</span></div><div class="casAuthors">Jones, Kenneth A.; Garbati, Nicoletta; Zhang, Hong; Large, Charles H.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (Totowa, NJ, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">565</span>
        (<span class="NLM_cas:issue">High Throughput Screening</span>),
    <span class="NLM_cas:pages">209-223</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Whole-cell voltage clamp electrophysiol. using glass patch pipettes (1) is regarded as the gold std. for measurement of compd. activity on ion channels.  Despite the high quality of the data generated by this method, in its traditional format, patch clamping has limited use in drug screening due to very low throughput.  Over the years, developments in microfabrication have driven the development of planar, multi-aperture technologies that are suitable for parallel, automated patch recording techniques.  Here we present detailed methods for two common applications of the planar patch technol. using one of the com. available instruments.  The results demonstrate (a) the high quality of whole-cell recordings obtainable from cell lines expressing human Nav1.2 or hERG ion channels, (b) the advantages of the methodol. for increasing throughput, and (c) examples of how these assays support ion channel drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrCzni5ncUF7Vg90H21EOLACvtfcHk0ljWuoyxzNfong"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVKhsg%253D%253D&md5=ffd29fd4f07481819fa9668dcb8e6354</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1007%2F978-1-60327-258-2_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-60327-258-2_10%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DK.%2BA.%26aulast%3DGarbati%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLarge%26aufirst%3DC.%2BH.%26atitle%3DAutomated%2520patch%2520clamping%2520using%2520the%2520QPatch%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2009%26volume%3D565%26spage%3D209%26epage%3D223%26doi%3D10.1007%2F978-1-60327-258-2_10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kutchinsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asmild, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taboryski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vestergaard, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krzywkowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroder, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ljungstrom, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helix, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorensen, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bech, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willumsen, N. J.</span><span> </span><span class="NLM_article-title">Characterization of potassium channel modulators with QPatch automated patch-clamp technology: system characteristics and performance</span> <span class="citation_source-journal">Assay Drug Dev. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span><span class="refDoi"> DOI: 10.1089/154065803770381048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1089%2F154065803770381048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=685-693&author=J.+Kutchinskyauthor=S.+Friisauthor=M.+Asmildauthor=R.+Taboryskiauthor=S.+Pedersenauthor=R.+K.+Vestergaardauthor=R.+B.+Jacobsenauthor=K.+Krzywkowskiauthor=R.+L.+Schroderauthor=T.+Ljungstromauthor=N.+Helixauthor=C.+B.+Sorensenauthor=M.+Bechauthor=N.+J.+Willumsen&title=Characterization+of+potassium+channel+modulators+with+QPatch+automated+patch-clamp+technology%3A+system+characteristics+and+performance&doi=10.1089%2F154065803770381048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1089%2F154065803770381048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F154065803770381048%26sid%3Dliteratum%253Aachs%26aulast%3DKutchinsky%26aufirst%3DJ.%26aulast%3DFriis%26aufirst%3DS.%26aulast%3DAsmild%26aufirst%3DM.%26aulast%3DTaboryski%26aufirst%3DR.%26aulast%3DPedersen%26aufirst%3DS.%26aulast%3DVestergaard%26aufirst%3DR.%2BK.%26aulast%3DJacobsen%26aufirst%3DR.%2BB.%26aulast%3DKrzywkowski%26aufirst%3DK.%26aulast%3DSchroder%26aufirst%3DR.%2BL.%26aulast%3DLjungstrom%26aufirst%3DT.%26aulast%3DHelix%26aufirst%3DN.%26aulast%3DSorensen%26aufirst%3DC.%2BB.%26aulast%3DBech%26aufirst%3DM.%26aulast%3DWillumsen%26aufirst%3DN.%2BJ.%26atitle%3DCharacterization%2520of%2520potassium%2520channel%2520modulators%2520with%2520QPatch%2520automated%2520patch-clamp%2520technology%253A%2520system%2520characteristics%2520and%2520performance%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2003%26volume%3D1%26spage%3D685%26epage%3D693%26doi%3D10.1089%2F154065803770381048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span> </span><span class="NLM_article-title">Development of a High Throughput Equilibrium Solubility Assay Using Miniaturized Shake-Flask Method in Early Drug Discovery</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">3052</span><span class="NLM_x">–</span> <span class="NLM_lpage">3071</span><span class="refDoi"> DOI: 10.1002/jps.20913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1002%2Fjps.20913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=17722003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12jtrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=3052-3071&author=L.+Zhouauthor=L.+Yangauthor=S.+Tiltonauthor=J.+Wang&title=Development+of+a+High+Throughput+Equilibrium+Solubility+Assay+Using+Miniaturized+Shake-Flask+Method+in+Early+Drug+Discovery&doi=10.1002%2Fjps.20913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a high throughput equilibrium solubility assay using miniaturized shake-flask method in early drug discovery</span></div><div class="casAuthors">Zhou, Liping; Yang, Linhong; Tilton, Suzanne; Wang, Jianling</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3052-3071</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Increasingly, pharmaceutical and biotech companies have begun to realize the importance of obtaining soly. information in early drug discovery as it is one of the crit. parameters for lead selection and optimization.  This report introduces a high-throughput equil. soly. (HT-Eq sol) assay using a novel miniaturized shake-flask approach and streamlined HPLC anal.  The new HT-Eq sol assay, validated and optimized via a test set of 85 marketed drugs and Novartis internal compds., shows an excellent correlation to the conventional shake-flask thermodn. soly. data generated inhouse and the equil. soly. results reported in literature.  It therefore offers a fast, reliable and cost-effective screening tool for soly. assessment in early drug discovery, allowing for prioritization of drug candidates using aq. soly. in conjunction with other profiling information and efficacy data.  Our work demonstrates that presence of a small amt. of DMSO (0.5-5%) will result in significant overestimation of equil. soly. (up to 6 folds).  In addn., monitoring of drug dissoln. process using the current approach as well as the interplay between equil. soly. data and those from kinetic soly. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLEKUmI4vDMLVg90H21EOLACvtfcHk0liukN1em0l9oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12jtrrO&md5=e04d5b859372d08551b4a6af19e23fb5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fjps.20913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20913%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DTilton%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%2520a%2520High%2520Throughput%2520Equilibrium%2520Solubility%2520Assay%2520Using%2520Miniaturized%2520Shake-Flask%2520Method%2520in%2520Early%2520Drug%2520Discovery%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2007%26volume%3D96%26spage%3D3052%26epage%3D3071%26doi%3D10.1002%2Fjps.20913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saishin, Yo.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saishin</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A.</span><span> </span><span class="NLM_article-title">Suppression and Regression of Choroidal Neovascularization by the Multitargeted Kinase Inhibitor Pazopanib</span> <span class="citation_source-journal">Arch. Ophthalmol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">494</span><span class="NLM_x">–</span> <span class="NLM_lpage">499</span><span class="refDoi"> DOI: 10.1001/archophthalmol.2009.27</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1001%2Farchophthalmol.2009.27" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=19365030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVWgu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2009&pages=494-499&author=K.+Takahashiauthor=Yo.+Saishinauthor=+Saishinauthor=+Yuauthor=A.+G.+Kingauthor=R.+Levinauthor=P.+A.+Campochiaro&title=Suppression+and+Regression+of+Choroidal+Neovascularization+by+the+Multitargeted+Kinase+Inhibitor+Pazopanib&doi=10.1001%2Farchophthalmol.2009.27"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression and regression of choroidal neovascularization by the multitargeted kinase inhibitor pazopanib</span></div><div class="casAuthors">Takahashi, Kyoichi; Saishin, Yoshitsugu; Saishin, Yumiko; King, Andrew G.; Levin, Robert; Campochiaro, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Ophthalmology (Chicago, IL, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">494-499</span>CODEN:
                <span class="NLM_cas:coden">AROPAW</span>;
        ISSN:<span class="NLM_cas:issn">0003-9950</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">To investigate pazopanib hydrochloride, a multitargeted kinase inhibitor, for treatment of choroidal neovascularization (CNV).  Choroidal neovascularization was induced in mice by rupture of Bruch membrane with laser photocoagulation.  Mice were treated with pazopanib by gavage or periocular injection, and the area of CNV was measured.  Twice-daily gavage of pazopanib, 100 mg/kg, suppressed the development of CNV by 93%.  Treatment of established CNV between days 7 and 14 with 8, 40, or 200 mg/kg per day reduced CNV by 0%, 58%, and 71%, resp.  Substantial regression (40%) of CNV was also achieved after periocular injection of pazopanib.  A single oral dose of 4 or 100 mg/kg resulted in an area under the curve from time 0 to the last quantifiable concn. of 129.6 and 752.0 μg/h/mL, resp.  After 7 days of 4, 20, or 100 mg/kg twice a day by gavage, plasma levels were 1300, 4900, and 5800 ng/mL and levels in the retina/choroid were 4800, 28,800, and 38,000 ng/g of tissue.  Orally administered pazopanib has good bioavailability to the retina/choroid and strongly suppresses CNV in mice.  Treatment with pazopanib after CNV is established causes dose-dependent regression of CNV.  Pazopanib may be useful for treatment of CNV in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5KrkISTQQTLVg90H21EOLACvtfcHk0liukN1em0l9oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVWgu7Y%253D&md5=13d6c8f38b906a3668a3dc630480c819</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1001%2Farchophthalmol.2009.27&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchophthalmol.2009.27%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DSaishin%26aufirst%3DYo.%26aulast%3DSaishin%26aulast%3DYu%26aulast%3DKing%26aufirst%3DA.%2BG.%26aulast%3DLevin%26aufirst%3DR.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26atitle%3DSuppression%2520and%2520Regression%2520of%2520Choroidal%2520Neovascularization%2520by%2520the%2520Multitargeted%2520Kinase%2520Inhibitor%2520Pazopanib%26jtitle%3DArch.%2520Ophthalmol.%26date%3D2009%26volume%3D127%26spage%3D494%26epage%3D499%26doi%3D10.1001%2Farchophthalmol.2009.27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Connolly, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matchett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarma, K.</span><span> </span><span class="NLM_article-title">Process Development and Scale-up of a Selective α<sub>1</sub>-Adrenoreceptor Antagonist</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1021/op0498114</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op0498114" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2005&pages=80-87&author=T.+J.+Connollyauthor=M.+Matchettauthor=K.+Sarma&title=Process+Development+and+Scale-up+of+a+Selective+%CE%B11-Adrenoreceptor+Antagonist&doi=10.1021%2Fop0498114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fop0498114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop0498114%26sid%3Dliteratum%253Aachs%26aulast%3DConnolly%26aufirst%3DT.%2BJ.%26aulast%3DMatchett%26aufirst%3DM.%26aulast%3DSarma%26aufirst%3DK.%26atitle%3DProcess%2520Development%2520and%2520Scale-up%2520of%2520a%2520Selective%2520%25CE%25B11-Adrenoreceptor%2520Antagonist%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2005%26volume%3D9%26spage%3D80%26epage%3D87%26doi%3D10.1021%2Fop0498114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Seelen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shäfer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, A.</span><span> </span><span class="NLM_article-title">Selective ring N-protection of aminopyrazoles</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4491</span><span class="NLM_x">–</span> <span class="NLM_lpage">4493</span><span class="refDoi"> DOI: 10.1016/S0040-4039(03)00988-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;key=10.1016%2FS0040-4039%2803%2900988-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=4491-4493&author=W.+Seelenauthor=M.+Sh%C3%A4ferauthor=A.+Ernst&title=Selective+ring+N-protection+of+aminopyrazoles&doi=10.1016%2FS0040-4039%2803%2900988-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2803%2900988-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252803%252900988-2%26sid%3Dliteratum%253Aachs%26aulast%3DSeelen%26aufirst%3DW.%26aulast%3DSh%25C3%25A4fer%26aufirst%3DM.%26aulast%3DErnst%26aufirst%3DA.%26atitle%3DSelective%2520ring%2520N-protection%2520of%2520aminopyrazoles%26jtitle%3DTetrahedron%2520Lett.%26date%3D2003%26volume%3D44%26spage%3D4491%26epage%3D4493%26doi%3D10.1016%2FS0040-4039%2803%2900988-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01227&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-23%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01227" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01227" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67999109ccec1995","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
